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Abstract 
Introduction 
The general purpose of this thesis was to study prognosis in traumatic brain injury 
(TBI) patients, with the aim of providing useful and practical information in clinical 
practice and clinical research. The specific objectives were: to develop and validate 
practical prognostic models for TBI patients and to assess the validity of the Modified 
Oxford Handicap Scale (mOHS) for predicting disability at six months. 
Methods 
A survey was first conducted to understand the importance of prognostic information 
among physicians. A systematic review of prognostic models for TBI patients was then 
carried out. Prognostic models were developed using data from a cohort of 10,008 TB! 
patients (CRASH trial) and validated in a cohort of 8,509 TBI patients (IMPACT study). 
Two focus groups and a survey were conducted to develop a paper-based prognostic 
score card. The correlation between the mOHS and the Glasgow Outcome Scale (GOS) 
was assessed, the validity of different mOHS dichotomies was assessed, and the 
discriminative ability of the mOHS to predict GOS was evaluated. 
Results 
Doctors considered prognostic information to be very important in the clinical 
management of TBI patients, and believed that an accurate prognostic model would 
change their current clinical practice. Many prognostic models for TBI have been 
published, but they have many methodological flaws which limit their validity. Valid 
prognostic models for patients from high income countries and low & middle income 
.countries were developed and made available as a web calculator, and as a paper 
based score card. The mOHS was strongly correlated with and was predictive of GOS 
at six months. 
Conclusion 
The prognostic models developed are valid and practical to use in the clinical setting. 
The association between mOHS and GOS suggest that the mOHS could be used for 
interim analysis in randomised clinical trials in TB! patients, for dealing with loss to 
follow-up, or could be used as simple tool to inform patients and relatives about their 
prognosis at hospital discharge. 
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Chapter 1 
Introduction 
1.1 Traumatic brain Injury 
1.1.1 Definition 
Traumatic brain Injury (TBI) Is caused by a blow or jolt to the head or a penetrating 
head injury that disrupts the normal function of the brain. 1 TBI Is also called 
traumatic head Injury but strictly the latter could be any traumatic injury In the 
head, face or skull and mayor may not be associated with a TBI. 
1.1.2 Pathophysiology 
Primary injury occurs Immediately after the Impact; this Is followed by a secondary 
injury which, some authors believe, Is responsible for part of the neurological 
damage observed in TBI. 2 Oedema formation, both vasogenic and cytotoxic, In a 
rigid structure such as the skull, Is followed by increased intracranial pressure (ICP) 
once the compensatory mechanisms are surpassed. The Increased ICP reduces 
cerebral perfuslon and the consequent ischemia generates further neurological 
damage.3 
1.1. 3 Classification 
TBI can be classified by severity, mechanism or structural damage. 4 
1.1.3.1 Severity 
TBI Is a heterogeneous condition encompassing a wide range of manifestations, 
from minor symptoms to profound coma. The Glasgow Coma Scale (GCS) Is the 
standard method used to evaluate level of consciousness and comprises three 
different domains (motor, verbal and ocular}.5 Adding the different components, the 
GCS can be rated from 3 to 15 pOints (table 1.1). Patients who suffer a TBI and 
have a GCS S 8 are claSSified as having severe TBI, those with GCS between 9 and 
12 are considered moderate cases, and those patients with GCS ~ 13 are 
considered mild. The GCS was developed as a practical scale for assessing the 
depth and duration of Impaired consciousness and enhanced communication among 
physicians In reporting of neurologic status after TBI. Gradually It has become 
accepted worldwide and has been shown to be a good predictive tool for 
determining outcome In TBI patients. It Is not clear how classification of the GCS 
for mild, moderate and severe TBI was establlshed.6 
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Table 1-1 Glasgow Coma Scale 
Eye opening 
Spontaneous 4 
To sound 3 
To pain 2 
None 1 
Total eye score 1 to 4 
Motor response 
Obeys commands 6 
Localising 5 
Normal flexion 4 
Abnormal flexi on 3 
Extending 2 
None 1 
Total motor score 1 to 6 
Verbal response 
Orientated 5 
Confused speech 4 
Words 3 
Sounds 2 
None 1 
Total verbal score 1 to 5 
Total GCS score 3 to 15 
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1.1.3.2 Mechanism 
TBI can be classified as closed or penetrating. While closed TBI Is related with road 
traffic crashes, penetrating TBI Is more commonly related with gunshot wounds.7 
Some studies have shown that penetrating TBI Is associated with a worse outcome. 
For example Peek-Asa and collaborators studied 795 patients with moderate or 
severe TBI. After adjusting for GCS, age, gender, and presence of multiple trauma, 
patients with penetrating injuries had an odds ratio of 6.6 (95% Cl = 3.9-11.1) for 
mortality In comparison with patients with closed Injurles.8 
1.1.3.3 Structural damage 
The structural damage can be assessed by neurolmaglng (Computed Tomography). 
It can be divided Into diffuse axonal Injury, focal contusions and intracranial 
bleeding. The latter can also be classified according to the location within the 
cranium. Epidural haematoma refers to the collection of blood between the skull 
and the outer layer of the meninges (the dura mater) and Is usually caused by a 
tear In the middle meningeal artery. Subdural haematoma refers to collection of 
blood between the dura mater and pia layers and has a typical crescent-shaped 
appearance in imaglng. Subarachnoid haemorrhage Is the accumulation of blood In 
the subarachnoid space and Intraparenchymal haemorrhages occurs within brain 
parenchyma. 
1.1.4 Outcomes 
In-hospital mortality and disability at six months are the most frequently used 
outcome measures considered In TBI research. According to the International 
Classification of Functioning, Disability and Health (ICF), disability can be defined 
under a biopsychosoclal model that Includes biological, Individual and social 
perspective on health.9 Disability Includes: a) Impairments (problems In body 
functions), b) activity limitations and c) participation restrictions. Different scales 
have been used for assessing disability In TBI. 10 The Glasgow Outcome Scale (GOS) 
devised more than 30 years ago Is the most widely used In TBI research. 11,12 This 
scale reflects disability In terms of activity limitations and participation restriction, 
rather than Impalrment. 13 It encompasses five categories: death, vegetative state, 
severe disability, moderate disability, and good recovery. In randomlsed clinical 
trials, It Is generally dlchotomlzed Into favourable (moderate disability, good 
recovery) and unfavourable outcome (severe disability, vegetative state, death). 
GOS assesses how well patients function In their dally social Interactions and Is 
generally completed six months after hospital discharge. The fact that one of the 
main outcomes In clinical trials of TBI patients Is measured at six months 
Introduces a potential source of bias, as loss to follow up Is a common problem In 
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this population. A 1998 survey of TBI trials found an average loss to follow up of 
19% at six months. 14 Loss to follow up reduces study size, causing effect estimates 
to be less precise, and may Introduce bias. Loss to follow up appears to be 
particularly common In TBI trials, possibly because they mostly Involve young 
males from disadvantaged social groups who are highly geographically moblle. 1s At 
the moment there Is no disability outcome measured at hospital discharge that 
predicts long term disability. Such a measure could be potentially useful when 
dealing with loss to follow-up, for Informing Interim analysis, and potentially could 
also be useful In clinical practice when communicating with patients and relatives. 
The Disability Rating Scale (DRS) is another measurement of disability which has 
been used for TBI patients. 16 Neuropsychological tests and generiC quality of life 
instruments, such as SF-36, EuroQol and the WHO-Qol, have also been 
recommended for assessing outcome in TBI patlents. 17 
1.1.5 Public health importance 
1.1.5.1 Global Injuries 
Injuries account approximately for 12% of the world's burden of disease In 2000, 
and it Is expected that by the year 2020 road traffic crashes will become the third 
cause of disability worldwlde. 18 More than 90% of the world's deaths from Injuries 
occur In low and middle-Income countries. 19 
1.1.5.2 Traumatic Brain injury 
TBI Is one of the main causes of death In patients with Injuries and Is a leading 
cause of death and disability in young people.2 Every year approximately 1.5 million 
people die and at least 10 million are killed or hospitalized because of a TBI. 20,21 
The Incidence, fatality and disability rates of TBI vary by region and higher rates 
are observed in low and middle Income countrles. 22 For example, according to the 
Global Burden of Disease Study, the latin America region has the highest Incidence 
of TBI related with road traffic crashes and violence at 163 per 100,000 and 67 per 
100,000 In comparison with the world average of 106 per 100,000 and 42 per 
100,000 respectlvely.23 
Some general trends are universal, a trl-modal age specific Incidence has been 
described with peaks In early childhood, late adolescence/early adulthood and In 
the elderly. Men are about twice as likely as females to experience a TBl.2o 
Falls are the main cause In children and elderly populatlons, while violence and road 
traffic crashes predominate In adolescents and young adults. 24 
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Most of the patients admitted to hospitals present with mild TBI while 20% are 
classified as moderate or severe. In severe cases about one third of patients die In 
hospltal.25 
1.2 Prognosis 
1.2.1 Definition 
Prognosis, (from the Greek ''pro'' meaning before and "gnosis "meaning knowledge) 
Is defined as "the result of looking forward". 26 In the context of clinical 
epidemiology prognosis can be defined as "the probable course and outcome of a 
health condition over time" or as "the future risk of adverse outcomes among 
people with existing disease". 27,28 
1.2.2 Importance of prognosis In clinical practice 
Clinical practice Involves three main activities: Identifying diseases (diagnosis), 
treating diseases (therapy) and predicting diseases course and outcome 
(prognosis). Although the three activities are Interrelated, distinctions between 
them are made in clinical research. Prognostic related research Is considered to be 
the most neglected one. 28,29 
Prognosis was historically one of the most Important activities of medical practice. 
Until the end of the nineteenth century, 10% of the content of medical textbooks 
was dedicated to prognosis however, by 1970 this had decreased to almost zero. 30 
Predicting the future was what both priests and doctors were supposed to do for 
many centuries but the appearance of effective therapies has shifted the dominance 
of the clinical encounter to diagnosis and therapy.31 However, In most recent years 
there has been an Increasing Interest In prognosis research. 28 Among the reasons 
for this resurgence, Chrlstakls proposed: 32 
1. Interest In human terminal care and the decision of withdrawing or not life 
support, from critical patients 
2. Avoidance of futile treatment for reasons of justice or costs 
3. Availability of new "technologies" (e.g. genetic tests, and blomarkers) 
4. Increasing emphasis on patient autonomy 
5. Increasing prevalence of chronic diseases 
1.2.3 Classification of prognosis research 
Prognostic studies can be classified Into 2 according to their objective; explanatory 
studies or outcome prediction studles.27 
21 
Explanatory studies focus on the casual association between predictors and 
outcome. Some authors propose a further division into three stages: phase 1, 
identifying associations; phase 2, testing independent associations; and phase 3, 
understanding prognostic pathways. 27 
Outcome prediction studies, also known as prognostic models, combine different 
variables to obtain a probability of the outcome. According to the use of the 
estimated probability, these studies can be further divided into studies which are 
used : 33,34 
1. To inform doctors to make decisions for individual patients 
2. To inform patients and relatives 
3. For research purposes (for example, in the selection of patients, 
adjustment for baseline imbalances, or risk stratification in clinical 
trials) 
4. To compare health services by allowing adjustment for case mix 
Variables influencing prognosis (predictors) can be classified into the following three 
categories according to their characteristics: 28 
a) Environment (e.g. country, social class, hospital care) 
b) Host (e.g. age, comorbidities) 
c) Disease ( e.g. genes, severity) 
Figure 1- 1 Classification of predictors 
Host 
Environment Disease 
I 
I 
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1.2.4 Prognostic models 
1.2.4.1 Definition 
Outcome prediction studies have received different names such as prognostic 
models, prediction models, risk scores, prognostic indices, clinical prediction rules, 
clinical prediction guides, or clinical decision rules. 3s 36 37 38 39 
. 
According to some authors the term "clinical decision rules" only applies to those 
models that also provide a diagnostic or therapeutic recommendatlon.4o 
Throughout this thesis I will use the term "prognostic model" defined as the 
"mathematical combination of two or more patient or disease characteristics to 
predict outco.me", although I acknowledge that a model could also be developed 
using only one variable. 41 
1.2.4.2 Performance of prognostic models 
The performance of prognostic models refers to how "accurate" the model's 
predictions are in relation to observed data.33 According to Rothman, "accuracy In 
estimation implies that the parameter that is the object of measurement is 
estimated with little error".42 In the particular context of prognostic models, 
accuracy has two main components: calibration and dlscrlmlnatlon. 43 
Calibration refers to the agreement between predicted and observed probabllltles. 44 
For example If, according to the model, TBI patients with certain characteristics 
have a probability of mortality of 30%, It would be expected that 30 out of 100 
patients with those characteristics would die If the model was perfectly calibrated. 
Calibration can be measured in different ways; graphically by plotting observed 
against predicted outcomes, or through a statistical test such as the Hosmer-
Lemeshow test. This test compares the observed number of people with events 
within risk groupings (e.g. deciles of risk) with the number predicted by the model. 
A small p value Implies lack of fit. 
Discrimination Is a measure of how well a model separates those who develop the 
outcome from those who do not.44 It Is generally measured through the area under 
the receiver operator curve (ROC) or the e statistic. A ROe Is constructed by 
plotting pairs of true positive rate (sensitivity) and false positive rate (l-speclficity) 
for several cut-off values of probability of the outcome. The area under the ROC 
can be Interpreted as the probability that a randomly selected person with the 
outcome, will have a higher predicted probability than a randomly selected person 
without the outcome.4S For example, If a model has an area under the ROC (or C 
statistiC) of 0.7, this means that the model will estimate a higher probability of the 
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outcome for subjects with the outcome 70 out of 100 times If we choose a random 
pair of subjects with and without the outcome. 
The relative Importance of calibration and discrimination will depend on the 
Intended application of the prognostic model.43 For example, for counselling an 
Individual patient calibration of the model will be more relevant, while for triage In a 
setting with limited resources discrimination could be more Important. . 
In addition to the measures of discrimination and calibration we might be Interested 
In perf~rmance measures for specific thresholds when a clinically relevant cut-off Is 
already established. The accuracy rate (or correct classification rate) Is calculated 
as: (true positive +true negative)/total and, the complement that Is the error rate 
(misclassification rate) that Is defined as (false positive + false negative)/total. The 
problem with these measures is that equal weight Is given to positive and negative 
results whereas, In general, false negatives are more Important than false positives. 
Furthermore the accuracy rate will be high, by definition, for a frequent or 
Infrequent outcome. For example, If the average mortality for a condition Is 7% the 
accuracy rate would be 93% If the model classifies all the patients as survlvors.44 
More recently new measures have been proposed, such as the net reclassification 
Improvement (NRI). The NRI has four components: proportion of Individuals with 
events who move up or down a category and the proportion of individuals without 
events who move up or down a category. The NRI Is obtained by combining the 
four components, but they should also be reported separately. 46 
Finally there are also overall performance measures such as the R2• , which Is the 
amount of explained variation on the outcome explained by the model, and the 
Brier score which Is a measure of the difference between actual outcomes and 
prediction. These measures do not distinguish among' the different performance 
components, calibration and discrimination, so they are not very useful.44 
1.2.4.3 Inaccuracy of clinical prediction 
The lack of Interest In prognosis has led to a weak medical training In this area and 
so It Is not surprising that doctors feel poorly prepared and that they often disagree 
or are Inaccurate In their predlctlons.32 47 
There are numerous studies showing that physicians make errors when formulating 
a prognosis. In many of these studies the term accuracy Is used In the more 
general. epidemiological sense (measured with little error), and they did not 
necessarily use the standard specific measures of accuracy described above for 
evaluating prognostic models. 
A systematic review compared physicians' clinical predictions of survival In 
terminally III cancer patients with actual survlval.48 The authors found eight studies 
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(including 1563 Individuals) and reported that the median clinical prediction of 
survival was 42 days and the actual median survival was 29, overall there was poor 
agreement (weighted kappa 0.36) between clinical prediction and actual survival. 
A cohort study was conducted Involving 16 Dutch nursing homes Including 515 
terminally ill non cancer patients. The authors compared physicians' predictions 
with actual survival. Physicians were asked to predict death In the following 
periods: one week (0 to 7 days), 8 to 21 days, or between 22 to 42 days. The 
positive predictive value of physicians' predictions was high for those patients 
expected to die within one week (92%), but much lower for patients who were 
expected to die within 8 to 21 days (16%), or within 22 to 42 days (13%).49 
In other areas, such. as cardiovascular disease, similar results have been reported. 
For example, Plgnone and collaborators developed 12 primary prevention scenarios 
with a five year risk of cardiovascular heart disease events, and conducted a survey 
among 79 physicians to compare their predictions with values calculated from 
Framingham risk equations. For the analysis the authors divided the estimated risk 
by the Framingham estimated risk and considered results between 0.67 to 1.5 to 
be "accurate". They reported that only 24% of their predictions were accurate. 50 
The main limitation of this study was with the use of hypothetical cases, thus the 
predictions could not be compared with actual survival. 
In a cohort study that Included 850 patients admitted for Intensive care, physicians' 
prediction was 'compared with actual survival at hospital discharge and 
approximately 70% of the patients that were estimated to have a 30% chance of 
survival actually survived. But unlike for cancer patients, doctors' predictions were 
In general pessimistic rather than optimistic. 51 
1.2.4.4 Clinical prediction versus prognostiC models 
According to studies in cognitive psychology the human brain is poorly prepared for 
making and updating precise quantitative prediction. 52 Psychologists have been 
studying the question of clinical versus statistical prediction for more than 50 
years. 53 Since then the results have generally shown that prognostiC models are as 
accurate as, or more accurate than, clinical judgment. 
Grove and collaborators conducted a systematiC review of studies that compare 
statistical versus clinical prediction. Studies from the area of psychology and 
medicine which predicted outcomes such as human behaviour, disease diagnosis, or 
a disease prognosis were Included. 54 They used a 25 page manual to code each 
study for publication variables and study design characteristics. Investigators were 
trained and two coders extracted the data with very high reliability (r=.97). A total 
of 136 studies were Included. The authors used the term accuracy referring to the 
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error In the estimation of each of the methods In comparison with a gold standard. 
Different measures were reported In the studies so the authors standardized the 
different measures In a common metric (effect slze-ES-). For this they first found a 
suitable transformation for each measure with a known variance and an 
approximate normal distribution, then they estimated the difference between the 
clinical and statistical prediction. Positive ES indicates superiority of statistical 
prediction. To conduct the meta-analysis they gave a weight to each ES that was 
Inversely proportional to the variance. The weighted summary statistic for the ES 
was 0.086. This Indicates that on average statistical prediction was approximately 
10% more "accurate" than clinical prediction. Because there was evidence of 
statistical heterogeneity (Qt=1635.2 p <0.0001) the authors also reported the 
results using a different method. For this they considered that ES <-0.1 as 
substantially favouring clinical prediction, ES between -0.1 and 0.1 as being 
relatively equal, and those >0.1 as substantially favouring statistical prediction. 
With these criteria In 46% of the studies the statistical prediction ~asmore 
accurate than the clin.ieal prediction, in 48% a similar result was obtained with both 
methods, and in only 6% of the studies clinical prediction was superior. The authors 
used meta-regression to evaluate the effect in certain subgroups, such as year of 
publication, study design or type of setting (general medicine, mental health, 
education, etc.) and concluded that they did not find any exception to the general 
equivalence or superiority of statistical prediction. However, it is not clear from the 
report whether the study had enough power to evaluate the effect in these different 
subgroups. Another limitation of this study was that the authors did not evaluate or 
discuss the possibility of reporting bias. 
1.2.5 Evaluation of prognostic models 
There are two main levels to evaluate prognostic models. First we want to know if 
the model performance, in terms of discrimination and calibration, works 
satisfactorily for patients other than those from whom the data were derived. This 
Is called "validation" of the model. The other level refers to the evaluation of the 
model in terms of change In behaviour of medical doctors (medical management) or 
changes In patient outcome. Some authors refer to this as the "Impact" of the 
model. 
Several guidelines have been proposed for the development and evaluation of 
prognostic models. The most recently was proposed by Rellly and collaborators, 
who defined five stages: 
1) Derivation of the prognostic model: Identification of the predictors for 
multivarlable model 
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2) Narrow validation: Assessment of the accuracy of the prognostic model In 
one setting 
3) Broad validation: Assessment of the accuracy of the prognostic model In 
varied settings 
4) Narrow Impact analysis of prognostic model used as decision rule: 
Prospective demonstration that the prognostic model Improves physicians' 
decisions In one setting 
5) Broad Impact analysis of the prognostic model used as decision rule: 
Prospective demonstration that the prognostic model Improves physicians' 
decisions In varied settings. 
According to Reilly and collaborators the two last stages (impact analysis) should be 
only applied to clinical decision rules (those prognostic models that recommend a 
diagnostic or therapeutic action according to the estimated probability), and they 
also consider that randomlsed controlled trials are the Ideal study design for these 
two stages.40 
During the rest of my thesis I refer, unless specified otherwise, to prognostiC 
models that do not provide a specific course of action. Some consider that these 
models should also be evaluated through randomised controlled trials, while for 
others their evaluation could be restricted to the validation stages. 37 
To the best of my knowledge, the only randomlsed clinical trial evaluating the use 
of a prognostic model (that does not provide a course of action) was the SUPPORT 
; 
study (Study to Understand Prognoses and Preferences for Outcomes and Risks of 
Treatments). This study enrolled 8,329 adult seriously III patients with a 50% 
chance of death within six months.55In a first phase Including 4,301 patients a 
prognostiC model to estimate 180 days mortality was developed and, In a second 
phase Including 4,028 patients, the Investigators randomly allocated half of the 
physicians to receive the prognostiC model estimates and patient's preferences for 
end life care. In this study physician's and model's discrimination were Identical 
(area under the receiving operator curve 0.78) but physicians' predictions were 
worse calibrated In comparison with the prognostiC model. The best discrimination 
was obtained when combining both physicians and the prognostiC model estimates 
(area under the receiver operator curve 0.82). The study did not find a difference In 
physician's performance nor In patients' outcomes. 
However, other studies have found different results. Murray and collaborators 
studied 1025 patients with severe TBI, with the objective of evaluating whether 
providing doctors with computer-based predictions Influenced patient 
management. 56 According to their previous hypotheSiS there was a decrease of 
27 
39% in the use of intensive management In patients with the worst prognosis, 
including osmotic diuretics, ventilation and Intracranial pressure monitoring. Among 
the limitations of this study it should be mentioned that It was a before/after 
design. 
The results of the SUPPORT study were unexpected and discouraging for those 
advocating the use of prognostic models. However, these results do not necessarily 
mean that every prognostic model would be Ineffective. Other studies, as the one 
mentioned by Murray and collaborators, showed different results and It can be 
argued that the Impact of prognostic models would vary according to the context In 
which they are applied. Their Impact will bedetermined not only by Its accuracy but 
by the following contextual variables: 
Users: How much doctors believe In the prognostic model and incorporate its 
prediction into their practice is of paramount importance. There is some evidence 
that models which are "home grown" facilitate implementation. 57 
Setting: In settings with scarce resources doctors will need to prioritise among 
patients and it is plausible that accurate prognostic information could be more 
useful.41 
Condition: The impact on patient outcome is related to the evidence of the 
effectiveness of Interventions according to baseline risk. For example the evidence 
for interventions according to risk In primary prevention in cardiology is well 
established, so prognostic estimates can be easily translated into treatment 
recommendations. 58 
Taking into account the previous conSiderations, some authors argue that 
prognostic models should be developed to be accurate and their Impact would vary 
according to the context where they are applied. As Kellett stated In a recent paper. 
" ... it is unlikely that (prognostic models) worsen clinical judgment. Therefore a good 
physician should no more refuse use them than a good driver should refuse to use 
his car's headlights at nlght,,31 
1.3 Prognosis in traumatic brain Injury 
1.3.1 Potential role of prognosis research In TBI 
1.3.1.1 Potential role of prognostic models 
Prognostic Information could potentially be useful for decision making. Taking Into 
account that most TBI cases occur In low and middle Income countries, accurate 
prognostic Information could be of paramount Importance. 
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The usual difficulty for the human brain of collecting and summarizing quantitative 
data to make predictions, Is even more extreme in emergency situations such as in 
the treatment of TBI patients. It has been shown that in emergency situations there 
are some common problems such as stress, fatigue, poor communication, 
Interruption of thinking, which are accentuated by the need to take rapid 
decisions. 59 Therefore prognostic models have a potential role for the management 
of TBI patients. 
In the context of TBI, clinical prediction models rather than clinical decision models 
would be more appropriate, because of the lack of evidence of effective 
interventions according to baseline risk. However, clinical prediction models stili 
have the potential to Influence TBI management. As mentioned before, Murray and 
collaborators demonstrated that' the Introduction of computer-based outcome 
prediction altered TBI patient management. 56 The potential Impact of accurate 
prognostic information could be particularly Important in low and middle Income 
countries where resources are limited. 
Furthermore, in such a critical setting, accurate and consistent prognostic 
information provided by a prognostic model may also be helpful in the counselling 
of patients and relatives. It has been shown that physicians change their own 
predictions when they need to communicate them to patients or relatives.6o 
Therefore the use of prognostic models may not only result In more accurate 
predictions but may also Increase the conSistency when communicating with 
patients and relatives. 
1.3.1.2 Potential role of explanatory prognosis studies 
The Identification of prognostic variables In causal pathways could Inform the design 
of randomlsed clinical trials of potential Interventions. This Is particularly Important 
in the context of TBI research where there Is a lack of evidence of effective 
Interventions.61 There are two main pathophysiological mechanisms susceptible to 
be Interfered after a TBI. The first Is related with the Inflammatory response; so far 
there have been numerous trials targeting Inflammatory response (neuroprotectlon 
studies) but to date no evidence of a clinical effect has been found. The only trial 
large enough to detect a clinically plausible effect, the CRASH (Corticosteroid 
Randomlsatlon After Significant Head Injury) trial reported an Increase In 
mortality.62,63 The second potential pathway of Intervention Is related with 
Intracranial bleeding (IB). Although there Is evidence that IB Is associated with 
worse a prognOSiS, Its relationship Is not well characterized. Most of the studies 
evaluating this association were small and had methodological limitations. 
Explanatory prognosis studies could shed some light on this aSSOCiation, which 
would be useful to Inform the design of future trlals.64 
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1.3.2 What is already known about prognosis In TBI 
1.3.2.1 Individual prognostic factors 
The Brain Trauma Foundation conducted a systematic review of the Individual early 
Indicators of prognosis In severe TBI. 6S 
The authors evaluated each of the studies Included In the systematic review 
according to criteria Intended to establish study strength. These criteria Included: 
. 1. Twenty-five or more patients In the series with complete follow-up. 
2. Outcomes measured - Glasgow Outcome Scale or Mortality - at six months or 
more. 
3. Data gathered prospectively, although retrospective examination from a 
database creating an ongoing cohort of patients could be used. 
4. Glasgow Coma Scale score measured within 24 hours. 
S. Appropriate statistics (e.g., multlvarlate analysis) used to Include adjustment for 
prognostiC variables. 
According to these criteria they reported the evidence of prognosis as shown below: 
Class I: Those papers containing all of the above characteristics. 
Class II: Those papers containing four of the five characteristiCS, Including 
prospectively collected data. 
Class Ill: Those papers containing three or fewer of the above characteristics. 
They also constructed 2 X 2 tables and evaluated the positive predictive value for 
mortality for each of the potential predictors. 
The following evidence was reported for each of the most Important predictors: 
Glasgow Coma Scale.: Class I evidence of an increasing probability of poor outcome 
with a decreasing GCS In a continuous, step wise manner was reported. 6s 
Sln~e Its Introduction In 1974, the GCS has conSistently showed a correlation with 
outcome, the lower the score the worse the prognosis. However, some 
controversies remain. For example, the type of relationship with the outcome 
(linear or non linear) and the In'f1uence of the timing of GCS measurement on Its 
valldlty.66 It has been suggested that with more Intensive pre-hospltal management 
which Includes sedation and Intubation, a valid GCS Is more difficult to obtain. 
Despite these concerns GCS continues to be considered an Important predictor In 
TBI. The motor component of the GCS has also been found to be aSSOCiated with 
outcome.67 68 
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Age: Class 1 evidence of an increasing probability of poor outcome with increasing 
age, in a step wise manner was reported. 65 
It is well established that an older age predicts poor outcome after TBI. It has been 
proposed that this could be related to an Increased risk of intracranial haematomas 
and a decreased capacity for repair of the brain with age.65 In addition, as In any 
other condition, It is possible that the worse prognosis associated with age Is 
related with concomitant co morbidities. A meta-analysis evaluating the relationship 
between age and poor outcome In TBI patients, reported that this relationship was 
better expressed as a linear and quadratic term, and that the best fitting threshold 
was 40 years.69 
Blood pressure: A systolic blood pressure less than 90 mm Hg was found to have a 
positive predictive value of 67% for poor outcome. 65 
Hypotension, defined as a systolic blood pressure less than 90 mmHg, Is associated 
with a poor prognosis. Early hypotension appears to exacerbate the development of 
intracranial hypertension. A single episode of hypotension has been associated with 
a doubling In mortality.65 
Pupillary light reflex: Class 1 evidence of a positive predictive value of at least 70% 
for poor outcome was reported for bilaterally absent pupil/ary light reflex. 65 
Abnormalities of the pupillary light reflex are Indirect measures of herniation and 
bralnstem Injury. Dilation and fixation of one pupil signifies herniation while 
bilaterally dilated and fixed pupils represent bralnstem Injury. It has been 
estimated that one fixed pupil Is associated with a mortality of 54% whereas those 
patients with bilateral fixed pupils have twice the mortality (90%).70 Direct 
oculomotor trauma should be excluded when considering the prognostiC Information 
of pupil abnormalities. 
CT Scan characteristics: Class 1 and Class 11 evidence of a positive predictive value 
of at least 70% for poor outcome was reported for: abnormalities in first er scan, 
Traumatic Coma Data Bank (TCDB) er classification, compressed or absent basal 
cisterns and traumatic subarachnoid haemorrhage. 65 
Different er classifications have been proposed to be predictors of unfavourable 
outcome in TBI.71 72 The Traumatic Coma Data Bank (or Marshall) claSSification 
(table 1.2) Is the most widely used and has been shown to be aSSOCiated with 
increased mortality in most of the studies, although not In all.72 65 73 
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Table 1-2 Marshal CT Classification 
Diffuse Injury I (no visible pathology) No visible intracranial pathology seen on CT scan 
Diffuse Injury 11 
Diffuse Injury III (swelling) 
Diffuse Injury IV (sh ift) 
Evacuated mass lesion 
Non-evacuated mass lesion 
Cisterns are present with midl ine shift 0-5mm and/or lesions 
densities present, no high or mixed densities lesion >25 cc, 
may include bone fragments and foreign bodies 
Cisterns compressed or absent with midl ine shift 0-5mm, no 
high or mixed densities lesion> 25 cc 
Midl ine shift > 5mm, no high or mixed lesion > 25 cc 
Any lesion surgically evacuated 
High or mixed lesion > 25 cc, not surg ically evacuated 
The following individual CT characteristics have been shown to be associated with 
higher mortality: midline shift> 5mm, compression and obliteration of the basal 
cisterns . Intracranial bleedings (IB) are divided into extracerebral (epidural, 
subdural and subarachnoid) and intracerebral or parenchymal. All types of IB are 
associated with a worse prognosis. 65 Although there have been some studies 
showing an association between size of IB and prognOSiS, the empirical evidence is 
limited, most studies having small sample sizes and restricted populations. 74-77 
Despite being widely accepted and biologically plausible, currently there is no clear 
empirical evidence showing the relationship between size of IB and poor prognosis. 
The further division between evacuated and non -evacuated haematomas proposed 
in the TCDB classification is criticized by some authors because, they argue, it could 
be influenced by differences in patient management between centres. 73 Recently it 
has been proposed that it is preferable to combine individual CT predictors rather 
than to use the TCDB classification for prognostic purposes. 78 
Other predictors not included in the Brain Trauma Foundation Review: 
Genes: The presence of the apolipoprotein E4 (APOE4) allele has been aSSOCiated 
with poor outcome after TB!. 79 A recent systematic review identified 14 cohort 
studies, including 2527 partiCipants. Only seven studies (1,868 participants) 
presented dichotomous data on GOS and could be included in the meta -analysis. 
The APOE4 allele was Significantly associated with a poor outcome of TBI (RR = 
1.36; 95% Cl, 1.04- 1.78)80 However, the risk of bias was high in the majority of 
the included studies, with only two studies having assessed outcome blinded to 
genotype and a follow -up larger than 80%. 
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Biomarkers: The protein S100B Is a marker of brain damage and has been 
proposed as a marker of poor outcome after TBI. A review found 18 studies that 
evaluated this association and, reported that patients with high levels of S100B 
may have a higher risk of dlsabllity.81 However, this systematic review has many 
limitations as it did not evaluate the risk of bias of the Included studies, nor did It 
address the probability of reporting bias. 
1.3.2.2 Prognostic models In TBI 
Since the publication of a prognostic model in TBI patients by Jennet and 
~ollaborators 30 years ago, many prognostic models have accumulated.82 
Nevertheless, there Is still not one universally accepted and widely used model. A 
comprehensive review of all models Is stili lacking, but In a recent paper 
Hukkelhoven et al. described ten models In severe TBI. The authors found that 
most of them were based on small samples, were not well calibrated, had not been 
validated In external cohorts, and that hence their generallzablllty and utility was 
judged to be IImlted.83 If a simple and accurate prognostic model for TBI patients 
could be developed then this might improve clinical practice, resource allocation, 
and the counselling of patient and relatives. 
1.4 Aim and objectives of this thesis 
The general purpose of this thesis was to study prognosis In TBI patients with the 
aim of providing useful and practical information in clinical practice and clinical 
research. 
The two main objectives were 
1) To develop accurate and practical prognostic models which could be used at 
the bedside in the early management of TBI patients. In order to achieve 
this objective I: 
a. Conducted a survey among doctors to describe the Importance and 
use of prognostic Information In the context of the management of 
TBI patients (Chapter 2) 
b. Evaluated existing prognostic models for TBI patients and critically 
appraised them (Chapter 3) 
c. Developed and validated prognostic models for the initial 
management of TBI patients using data from a large International 
cohort of TBI patients from the CRASH trial (Chapter 4) 
d. Developed a user friendly Interface (paper based score card) for the 
prognostic models (Chapter 5) 
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2) To evaluate the validity of a simple disability scale (Modified Oxford 
Handicap Scale) completed at hospital discharge, to predict disability at six 
months, which could Inform Interim analysis In randomlsed clinical trials, 
could be used to help tackle the problem of loss to follow-up, or could. be 
used to Inform patients and relatives at hospital discharge. (Chapter 6) 
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Chapter 2 Doctors' perceptions of the importance of 
prognosis for TBI 
2.1 Introduction 
In Chapter 1 I discussed the major features of TBI, prognosis In clinical practice and 
research, characteristics of prognostic models and, In particular, the potential role 
of prognosis (and prognostic models) In the context of managing TBI patients. 
In this chapter I will explore physicians' perceptions In relation to different ~spects 
related to prognostic Information In the context of the management of TBI patients. 
Although prognosis has been always an essential part of the practice of medicine, 
Its practice Is often Informal and non expliclt. 84 Prognostic Information Is used when 
making treatment decisions and when communicating with patients and rei atlves. 29 
However, the role of prognostic Information from the perspective of physicians who 
routinely treat TBI patients Is currently unknown. 
An excellent opportunity to explore this issue occurred with the final meeting of the 
CRASH trial. The CRASH trial was a randomlsed controlled clinical trial that 
allocated adults patients (aged 16 years or older) with a TBI and a GCS of 14 or 
less to either a 48 hour infusion of methylprednisolone or a matching placebo within 
eight hours of Injury.63 A total of 10,008 patients from 239 hospitals In 48 countries 
were randomlsed. Primary outcomes were all cause mortality within 14 days and 
death and disability six months after Injury .. 
I conducted a survey among the collaborators attending the final meeting of the 
CRASH trial to assess their perception In relation to the Importance of prognostic 
Information In the management of TBI patients and the potential use of a 
prognostic model In this context. Furthermore, I Inquired their preferences In terms 
of predictors to be Included, outcomes to be predicted, and ways of expressing 
prognosis for a prognostic model for TBI patients. 
2.2 Methods 
2.2.1 Sample 
The sampling frame for the survey was all doctors participating In the final results 
meeting of the CRASH trial.63 The principal Investigators from centres that recruited 
at least 30 patients were Invited to the final CRASH trial meeting In April 2005. A 
session about prognostic models In TBI was planned where all the collaborators 
were to be given a self-completed questionnaire about prognosis In TBI. 
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2.2.2 Questionnaire 
Before the meeting a questionnaire was developed. (Appendix 2.1) 
Four domains were defined: 
• Attributes: Physicians' soclo-demographlc characteristics 
• Behaviours: What do physicians do In relation to prognosis In TBI? 
• Beliefs: What do physicians think about prognosis In TBI? 
• Attitudes: What do physicians want In relation to a prognostic model In TBI? 
Items were developed for each of the domains and revised five times In Iterative 
procedures by an expert In questionnaire design (PhI! Edwards) until a final version 
was obtained. Fourteen closed-ended questions (five of them also Included an 
open-ended option) and two open-ended questions were developed. After 
developing the first draft, an evaluation of the questionnaire was made by three 
reviewers: one neurosurgeon (Jonathan Wasserberg), one expert in clinical 
epidemiology (lan Roberts) and one epidemiologist expert In qualitative research 
(Caroline Free). The revised questionnaire was then tested on a convenience 
sample (7 respondents) and written comments were obtained regarding the 
Instructions and the face validity of the questionnaire. Finally the revised version 
was checked by the expert In questionnaires. As one third of the CRASH 
collaborators that attended the final meeting were Spanish speaking, the final 
version was translated Into Spanish. 
2.3 Results 
2.3.1 Attributes 
A total of 91 collaborators were Invited to attend the final CRASH trial meeting of 
which 67 were able to attend. The session about prognostic models In TBI was 
attended by 60 (90%) of the collaborators. 
The mean age of the 60 respondents was 44.9 years (SO 8.3 years) and 48 (81%) 
were males. Regarding their speCialities, 20 (34%) were neurosurgeons, 19 (33%) 
Intensive care speCialists, 12 (20%) emergency care speCialists, 4 (7%) 
anaestheslologlsts, 2 (3%) general surgeons and 2 (3%) had other speCiality. Most 
doctors worked In low and middle Income countries: 15 (25%) In Latin America & 
the Caribbean, 12 (20%) In Africa, 11 (19%) In Asia and 5 (9%) In Eastern Europe 
& Central Asia; while 16 (27%) were from Western Europe~ Most worked In 
hospitals with Intensive care (100%), computed tomography (97%), and 
neurosurgical facilities (92%). 
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2.3.2 Behaviours 
A total of 51 respondents (85%) reported using a score to assess prognosis, of 
which the summated Glasgow Coma Scale (GCS) was the most popular, used by 41 
(80%) of them. A total of 43 (72%) reported recording prognosis in clinical notes. 
(Figure 2.1) 
Figure 2-1 Behaviour in relation to prognosis in TBI patients 
2.3.3 Beliefs 
Record prognosis in clinical 
notes 
Use of a score to assess 
prognosis 
0 % 20% 40% 60% 80% 100% 
- Never - Almost Never Sometimes _ Usually - Always 
A total of 22 (37%) of the respondents believed that they currently assess 
prognosis accurately. Forty respondents (67%) said that a more accurate 
prognostic model could change the way that they manage patients and for 52 
(88%) it would also change the way that they currently tell the prognosis to a 
patient or relative (table 2.1). 
Table 2- 1 Beliefs about prognosis in TBI patients 
Totally Totally 
disagree Disagree Unsure Agree agree 
0/0 0/0 0/0 0/0 0/0 
Currently assess prognosis 
8 27 27 25 12 accurately (n:S9) 
An accurate prognostic model 
wou ld change the way they manage 2 10 22 35 32 
patients (n: 60) 
An accurate prognostic model 
would change communication with 3 3 5 46 42 
patient or relative (n : 59) 
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2.3.4 Attitudes 
Accurate prognostic information was considered to be very important for a number 
of clinical decisions. The need to undertake a decompressive craniotomy, who 
should receive intensive care, and the decision on treatments were the three 
categories for which accurate prognosis was more frequently considered very 
important. On the other hand accurate prognostic information was deemed as not 
important in approximately one third of the respondents to decide in which patients 
to conduct a CT scan or which patients need rehabilitation. It is noteworthy that 50 
(86%) respondents considered accurate prognostic information as important, or 
very important, to withdrawn treatment (table 2.2). 
Table 2-2 Situations for which accurate prognostic information 
is important 
To decide wh ich patients need 
decompressive craniotomy 
(n:59) 
To decide wh ich patients need 
Intensive Care Unit (n: 58) 
To decide which patients 
should receive treatment(e.g. 
hyperventilation, barbiturates, 
mannitol) (n:58) 
To give counsell ing to patients 
and/or relatives (n: 57) 
To decide in which patients 
treatment should be withdrawn 
(n :58) 
To decide in which patients 
intracranial pressure should be 
monitored (n: 58) 
To decide which patients need 
surgery (n: 59) 
To decide in which patients er 
scan should be done (n: 59) 
To decide which patients need 
rehabil itation (n: 57) 
Very 
important 
0/0 
61 
60 
55 
54 
52 
50 
49 
19 
14 
38 
Important Not 
important 
0/0 0/0 
27 12 
26 14 
26 19 
37 9 
34 14 
40 10 
32 19 
49 32. 
53 33 
The outcomes considered most important to predict were in -hospital death, need 
for intensive care, need for surgery and major disability (Table 2.3). 
Table 2-3 Outcomes considered important to predict 
In-hospital 
death (n:60) 
6 month death 
(n:58) 
Need for 
surgery (n: 59) 
Need for 
Intensive Care 
Unit (n: 59) 
Days of stay in 
hospital (n: 58) 
Major disability 
(n:59) 
Minor 
disability(n: 58) 
Need for 
rehabilitation 
(n:58) 
Very 
important 
0/0 
73 
40 
57 
68 
9 
56 
21 
31 
Important Not important 
0/0 0/0 
20 7 
48 12 
34 9 
25 7 
60 31 
41 3 
60 19 
52 17 
The most favoured way of expressing the prognosis was as a percentage followed 
by a qualitative scale and as survival time (Table 2.4). 
Table 2- 4 Preferences on ways for expressing prognosis 
Very Useful Useful Not useful 
% % % 
As a percentage 
62 35 3 (n :60) 
Qualitatively 
22 60 18 (n:60) 
As survival time 
(n :60) 20 57 23 
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In relation to prognostic variables, age, presence of extracranlal Injury, GCS and 
pupil reactions were considered among the most important predictors; abnormal CT 
scan results, In particular midline shift and obliteration of the third ventricle, were 
also considered as very important predictors by the majority of the respondents. 
(Table 2.5) 
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Table 2-5 Variables considered important predictors 
Demographics 
Age (n:60) 
Gender (n:60) 
Injury related 
Cause of injury (n:59) 
Presence of major extracranial injury (n:60) 
Time since injury to hospital arrival (n :60) 
Clinical Examination 
Total GCS (n :60) 
Eye component of the GCS (n:59) 
Motor component of the GCS (n :60) 
Verbal component of the GCS (n:59) 
Pupil reactions (n:59) 
Complications 
Presence of complications (n :60) 
Wound infection (n:59) 
Gastrointestinal bleeding (n:59) 
Seizures (n:59) 
Pneumonia (n:60) 
CT scan results 
Abnormal CT scan (n:59) 
One or more petechial haemorrhages within the brain 
(n:60) 
Obliteration of the third ventricle or basal cisterns 
(n:60) 
Subarachnoid bleed (n: 59) 
Midline shift over 5mm (n:60) 
Non evacuated haematoma (n:57) 
Evacuated haematoma (n:58) 
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Very Not 
important Important important 
0/0 % 0/0 
57 38 5 
2 13 85 
34 42 24 
60 35 5 
58 38 3 
82 15 3 
36 44 20 
58 33 8 
29 53 19 
80 20 0 
48 47 5 
8 61 31 
17 66 17 
51 34 15 
37 52 12 
69 29 2 
30 63 7 
73 27 o 
36 58 7 
88 12 o 
72 28 o 
36 55 9 
2.4 Discussion 
2.4.1 Principal findings 
In a survey of doctors who routinely treat TBI patients I found that many believe 
that they make Important decisions about the care of patients with TBI, Including 
the decision to withdraw care, based on judgments about prognosis. Nevertheless, 
most of the doctors believe their prognosis Is not accurate and think that a more 
accurate method of assessing prognosis could change clinical management in TBI 
patients, as well as communication with patients and relatives. Age, GCS, pupil 
reactivity, major extracranlal Injury, time to Injury and abnormal CT scans were 
among the predictors considered most Important. Gender, wound infection and 
cause of Injury were among those considered least Important. In-hospital mortality 
and major disability were among the outcomes considered most Important to 
predict accurately and days of stay In hospitals among the least Important. 
2.4.2 Comparison with other studies 
In a survey about attitudes and practice regarding prognostication among 
Internlsts, Chrlstakls and collaborators found similar results.32 More than 80% of 
the respondents face several Situations that require formulation of a prognosis and 
almost 60% reported that "they find It difficult to make predictions". 
To the best of my knowledge the only study about the role of prognosis when 
treating TBI patients was conducted more than 20 years ago.8S It Included 59 
neurosurgeons who also attended a conference, but unlike our study most of the 
partiCipants were from high Income countries. They also reported that assessment 
of prognosis was a frequent practice when treating a patient with TBI. Almost 90% 
of the respondents estimated prognosis preoperatlvely and, they thought that 
statistical prediction would Improve their prognosis. Almost two thirds of the 
neurosurgeons considered that "computer predictions" would be more, or as 
reliable as, those predictions of an experienced physician. 
2.4.3 Strengths and weaknesses 
A key strength of the survey Is that It Includes physicians treating TBI patients from 
different speclaltles and from diverse regions of the world, mainly from developing 
countries, where the major burden of TBI occurs. Furthermore the response rate of 
those attending the conference was high (90%). 
This survey Is not free of limitations. It should be mentioned that this was a 
convenience sample and It was not Intended to represent doctors worldwide. 
Furthermore, It could be argued that It was a biased sample as the respondents 
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were high recruiters from a clinical trial. This could be the explanation for the high 
rate of availability of facilities reported (Intensive care, CT scans and 
neurosurgery). The extent to which the results may be generalized to other settings 
Is therefore a matter for judgment. However, It might be argued that the need for 
prognostiC Information In settings with fewer resources could be even more 
important. 
Another limitation is that doctors "reported" their current practice and this could be 
a source of Information bias. The explicit use of a prognosis score and the recording 
of prognosis in clinical· notes were quite prevalent and It might be likely that 
observation of actual practices of these doctors could show different results. 
Another potential type of bias could be "desirability" bias as collaborators were 
aware of the Intention to develop a prognostiC model using the CRASH trial data, 
however, we limited this source of bias because It was a self-completed and 
anonymized questionnaire. 
2.4.4 Implications of the findings and future research 
More than 20 years have passed since the previous survey on this topic and the 
results are remarkably similar. Doctors use prognostiC Information frequently, 
prognosis Influences Important decisions on patient management, and the majority 
of doctors would welcome a more accurate way of estimating prognosis such as by 
a prognostic model. The question Is why are doctors still demanding prognostiC 
models although many have been published? To answer this question is necessary 
to conduct a systematiC review of existing prognostiC models for TB!. 
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Chapter 3 Systematic review of prognostic models in 
TBI 
3.1 Introduction 
In the previous chapter I showed that some doctors believe that a more accurate 
way of predicting outcome would be clinically useful In the management of TBI 
patients and the counselling of patients and relatives. 
A systematic and critical appraisal of existing prognostic models would enable 
doctors to know which of the available models are accurate and clinically useful. It 
would also help to critically appraise existing models, and to Inform the 
development of future studies. 
So far, there has not been any comprehensive systematic review of prognostic 
models In traumatic brain Injury. Previous reviews of prognostic studies In TB! have 
only focused on individual predictors, or have been restricted to prognostic models 
of some type of traumatic brain Injury or outcome.65,S3 It has, therefore, become 
Increasingly Important to Identify and evaluate prognostic models In TBI patients. 
In this chapter a systematic review of prognostic models in TBI patients Is 
presented. 
3.2 Objectives 
The objectives were to: 
(a) identify prognostic models In TBI 
(b) describe the characteristics of prognostic models In TBI 
(c) Investigate the quality of prognostic models in TB I, and 
(d) describe the models that were validated in an external population. 
3.3 Methods 
3.3.1 Eligibility criteria 
3.3.1.1 Type of studies 
Studies that gave an overall estimation of prognosis after TBI combining the 
predictive Information from at least two variables were Included. Studies could 
develop new prognostic models (derivation studies) or evaluate previous ones 
(validation studies). Studies published prior to 1990 were excluded because patient 
management and diagnostic techniques may have changed since this time. Studies 
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that Investigated more than one variable but did not combine them for obtaining a 
prediction of outcome were excluded. 
3.3.1.2 Type of exposures 
Only variables that were collected before hospital discharge were considered as 
predictors. The Glasgow Coma Scale (GCS) was considered as one predictor 
variable. 
3.3.1.3 Type of participants 
Patients could be of any age, with any type, or severity of TBI. 
3.3.1.4 Type of outcome measures 
Studies that predicted any outcome in a TBI patient (e.g. neurological Impairment, 
disability, survival, etc.) were Included. There was no time restriction for the 
evaluation of the outcomes. 
3.3.2 Search strategy for identification of studies 
I developed jOintly with a librarian (Relnhardt Wentz) the search strategy which Is 
presented In appendix 3.1. I used the terms related with TBI and search strategies 
recommended by Altman for prognostic studles. 34 I conducted the search In Medllne 
(Pubmed version), and Embase databases. The reference lists of Included studies 
were Inspected for further possible studies meeting the Inclusion criteria. A forward 
search (citing references In the Web of Knowledge) was conducted with selected 
seminal papers, and some of the citing papers, not found by the database search, 
were Inspected for relevance and possible Inclusion. All records were Imported Into 
an Endnote database. 
3.3.3 Trial Identification and selection 
I examined titles, abstracts and keywords of records from electronic databases, for 
eligibility. The full text of all potentially relevant records was obtained and I 
assessed whether each met the pre-defined Inclusion criteria. This procedure was 
also done Independently by another reviewer (PhI! Edwards). Disagreement 
between me and the other reviewer was resolved by a third reviewer (lan Roberts). 
3.3.4 Quality assessment 
Quality assessment scores for controlled clinical trials and diagnostic studies have 
been criticized. 86 87 The main problem with quality scores Is to determine the 
weight that each item should contribute to the overall score. The abundance of 
quality scores shows that there Is no consensus on this Issue. Instead, a component 
approach appraisal allows one to evaluate each methodological aspect. Depending 
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on the question and on the study design, some components may be more relevant 
than others. Recently It has been proposed that the term "risk of bias" should be 
used Instead of quality assessment, as one study could have been conducted 
according to the highest possible standards yet stili have an Important risk of bias 
(e.g. with a surgical Intervention blinding of the patient and careglver would be 
unachievable).88 However, because of Its wide acceptance, I will use the term 
"quality assessment" throughout my thesis. 
In studies of prognostic models In particular, although diverse quality assessment 
criteria have been proposed, none Is widely accepted. 35,36,38 89 I analyzed the 
quality of the prognostic models Included In this systematic review according to two 
main domains: 
3.3.4.1 Internal validity 
This refers to the systematic error of the study and Is related to study deSign, 
variables and analysis strategy. 
3.3.4.2 External validity or generallzablllty 
This refers to the extrapolation of the study to other settings. For making 
judgments about generallzablllty It Is Important to consider the characteristics of 
the sample from which the model was derived, how clearly the results were 
presented , and Ideally the model should be evaluated (validated) In a different 
sample from the origlnal.43 Justice and collaborators distinguishes two components 
of "generallzabllity".43 
a) Reproducibility or internal validation means that the model should replicate 
Its accuracy In the setting where the model was developed. There are different 
methods for evaluating reproducibility such as re-sampling techniques 
(bootstrapplng) or cross validation. These techniques are particularly Important 
when the sample used to develop the model is small. 
b) Transportability or external validation means that the model should replicate 
Its accuracy In patients from a different but plausible related population 
Finally, for a model to be used In clinical practice Wyatt and Altman argued that 
prognostic models should be "clinically credible"; by this they mean that It should 
be clearly explained how to use the model and Ideally It should be simple to 
calculate a predictlon.37 
3.3.4.3 Questions assessing quality of prognostiC models 
Taking Into account these two domains, 18 questions were considered for each of 
the models Included. The quality assessment was restricted to the reports that 
Included derivation studies. 
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Internal validity 
Study 
1) Did the patients have an adequate follow-up? In the case of prognosis in 
TBI all the studies are conceptually cohort studies, although the method of data 
collection could be either prospective or .retrospective (i.e. use of databases). In 
cohort studies a large loss to follow-up could lead to attrition bias. To minimize 
attrition bias the follow-up should be at least 90% of the original cohort. 
Variables 
2) Was a discussion Included about rationale to include the predictors? The 
variables included should be important predictors reported in previous studies (e.g. 
for early indicators in severe traumatic brain injury the systematic review 
conducted by the Brain Trauma Foundation identified five: GCS, age, pupillary 
reflex, hypotension, CT scan features). 
3) Were the predictive variables clearly defined? Variable definition and 
measurement should be clearly described in the method section of the report. 
4) Were the outcomes predicted valid? Validity, for outcomes other than 
mortality, should be reported. GOS is the most frequent outcome considered in TBI 
studies and its validity has been reported previously. 
5) Were missing data adequately managed? Imputation strategies are 
preferable to complete case analysis when the amount of missing data is large. 
Analysis 
6) Was an adequate strategy performed to build the multivariable model? 
Multivariable analYSis strategy should consider clinical criteria when entering 
variables in the model and not only automatic selection strategies such as stepwise. 
In some cases Important clinical predictors could be "forced" into the model. 
7) Were Interactions between the variables examined? When a multivariable 
analysiS is performed interactions between variables should be explored. 
8) Were continuous variables handled appropriately? It is preferable to keep 
continuous variables as originally recorded because they can give more information 
and are more powerful to detect an association. Categorization of a variable into 
groups assumes a constant risk In each group created, which is often not true. In 
the case where variables are categorized, the rationale for the cut-point should be 
clearly explained. 
9) Were more than 10 events per variable Included? The estimates may be 
unreliable if the data contain less than 10 outcome events relative to the number of 
parameters. 
External validity or generallzablllty 
10) Was the description of the sample reported? For making judgments about 
generalizability it is important to know the characteristics of the sample from which 
the model was derived, so It is very Important that studies Include Information 
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about the population Included: e.g. time of Inclusion of the patients In relation to 
the injury, time of the measurement of the variables, treatment received. 
11) Was it clearly explained how to estimate the prognosis? For a prognostic 
model to be clinically useful it should be clearly explained how to estimate the 
prognosis In a clinical setting. Probability of the outcome could be obtained through 
simple scores, nomograms, or simple figures. Reporting just the coefficients of the 
multivariable model is not enough to be clin.ically practical in the emergency 
setting. 
12) Were measures of discrimination reported? To evaluate a model's 
performance Its discrimination and calibration should be assessed: Discrimination 
refers to the ability to rank in the correct order individuals with different prognosis. 
It is usually measured with the area under the Receiving Operator Curve (R.O.C) or 
c statistic. 
13) Were measures of calibration reported? For assessing the usefulness of a 
model the calibration should be reported. Calibration refers to the ability to predict 
correctly the prognosis (not too high or too low). It could be measured graphically 
or with the Hosmer-Lemeshow test. 
14) Were confidence intervals presented? Clinicians that will use the model 
should know the preCision of the estimates derived from the model. 
15) Was the model validated? For a prognostic model to be generalized to a 
population different from the one from which the model was derived, it should be 
evaluated (validated) In a different set of patients. 
16) Was the model internally validated? Internal validation assesses the 
validity of the model for the setting where the development data originated from. It 
is evaluated through different techniques, such as bootstrapplng or cross validation. 
17) Was the model externally validated? Refers to the evaluation of the model 
in a different population (e.g. different geographical region, historical periods or 
different methods of data collection). 
18) Was the clinical credibility of the model evaluated? For a model to be 
used it should be well accepted by physicians. Ideally the "acceptability" and 
"practicality" of a model should be evaluated. 
3.3.5 Data extraction 
I extracted the Information from each study for assessing the quality of reporting In 
, 
each of the questions Into an excel file. 
3.3.6 Description of models externally validated 
The characteristics and performance of models that were validated In external 
samples were reported. Those models that were reported by the authors as 
evaluated In a different cohort of TBI patients from the derivation set were 
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considered as externally validated. Only TBI specific models, as opposed to general 
trauma scores, were fully described. 
3.4 Results 
A total of 3354 records were Identified. After reading all the records, 92 reports 
were Identified and read In full. Thirty nine were excluded for the following reasons: 
18 analyzed individual predictors but did not combine them In a single score, eight 
did not Include in-hospital predictors, six Included patients without TBI, five were 
not original research (e.g. discussion, letter), and in two the objective was not to 
evaluate prognosis In TBI patients. The remaining 53 reports described 102 
prognostic models (Figure 3.1). 
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Figure 3-1 Study selection process for the systematic review 
Total reports Identified from 
electronic searches: 3354 
Reports excluded after 
Icreenlng abltracts: 
. 3262 
Reports Included from electronic search: 
92 
Reports excluded with reason (39): 
• 18 only analyzed Individual predictors 
• 8 did not Include In-hospital predictors 
• 6 Included patients without TBI 
• 5 were not original research 
• 2 the objective was not to develop or 
evaluate a prognostic model 
Total of reports Included: 53 
(102 models) 
so 
3.4.1 General characteristics of the prognostic models 
3.4.1.1 Population included 
A total of 48 of the models were derived from an adult population, 12 were derived 
from a child population, while 21 were derived from a population that included both 
adults and children. In 21 of the models it was not clearly reported from which 
population they were derived. For details see appendix 3.2 (list of included studies) , 
and appendix 3.3 (characteristics of each study included). 
In relation to the severity of the TBI studied, 45 models included all grades of 
severity, 31 included severe TBI, nine moderate or severe TBI, nine mild TBI and in 
eight the severity of TBI was not clearly reported . 
A median of 319 patients (range 22-7764 patients) were included per model. Three 
quarters included less than 500 patients (Figure 3.2). 
Figure 3-2 Number of patients included per model 
•• • •• • • • 
I I I 
o 2,000 4,000 6,000 8.000 
Number of patients included 
A total of 95 models included populations from high income countries, five included 
populations from middle income countries and in two the population was from a low 
income country. 
3.4.1.2 Objectives 
A total of 66 models reported were derived for the first time (derivation models) 
while 35 were validating pre-existing models (validation models) . The objective of 
one model was unclear. 
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3.4.1.3 Variables Included as predictors In the model 
A total of 89 variables were Included In the prognostic models. A mean of 5 
variables were Included In each model (range 2 to 13). GCS was the most common 
predictor Included In the models (50%), followed by age (46%) and pupil reactivity 
(26%). Overall clinical variables were Included In 66% of the models, demographic 
variables were included as predictors In 50% of the models, er scan predictors 
were used In 19% of the models and 7% Included variables related to 
characteristics of the Injury. In 7% of the models other predictors were Included 
(e.g. other complementary tests or existing scores). 
3.4.1.4 Outcomes 
Mortality was the main outcome In 30% of the models and GOS In 28%. Other 
functional outcomes were reported In 31% of the models. The presence of a er 
scan lesion was the main outcome In 7%, the need of neurosurgical intervention in 
2%, and raised Intracranial pressure In 1%. 
3.4.2 Analysis 
In the multlvarlable analysis for the development of prognostic models (n=66) 
logistic regression was used in 31 (47%) models. Regression tree analysis was 
reported In 14 (21%) and neural networks In nine (13%). Other methods of 
analysis were performed In nine (14%) models while In three (4%) no multlvarlable 
analysis was performed. 
3.4.3 Quality assessment 
The quality assessment was restricted to the 66 derivation models. Some of the 
quality assessment Items could only be applied to the models that used 
multivarlable logistic regression (Table 3.1). 
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Table 3-1 Quality assessment of prognostic models 
I NTERNAL VAUDITY 
STUDY 
Loss to follow-up 
<10% 
>10% 
Not reported 
VARIABLES 
Discussion about pred ictors 
Yes 
No 
Description of measurement of predictors 
Yes 
No 
Validity of outcome reported 
Yes 
No 
Not applicable 
Handling of missing data 
Estimated statistically 
Excluded 
Not reported 
All models 
N=66 
10 (15%) 
19 (29%) 
37 (56%) 
21 (32%) 
45 (68%) 
12 (18%) 
54 (82%) 
31 (47%) 
20 (30%) 
15 (23%) 
4 (6%) 
36 (55%) 
26 (39%) 
Logistic 
regression 
N=31 
5 (16%) 
7 (23%) 
19 (61%) 
11 (35%) 
20 (65%) 
8 (26%) 
23 (74%) 
14 (45%) 
7 (23%) 
10 (32%) 
4 (13%) 
16 (52%) 
11 (35%) 
Other 
N=35 
5 (14%) 
12 (34%) 
18 (52%) 
10 (29%) 
25 (71%) 
3 (9%) 
32 (91%) 
17 (49%) 
13 (37%) 
5 (14%) 
0 
20 (57%) 
15 (43%) 
. --- -- -- -- ---- -- -- -- -A-NALYSiS -- --- -- ----- ----- ---- ------- -- -- -------- --------- ------- ---- ---------- ----- --- ---- -----
Multivariable analysis 
Stepwise backwards 12 (39%) 
Stepwise forwards 3 (10%) 
Stepwise not specified 10 (32%) 
Not reported 5 (16%) 
Other 1 (3%) 
Interactions examined 
Yes 4 (13%) 
Not reported 27 (87%) NA 
Handling of predictors variables 
Continuous 6 (19%) 
Categorical 16 (52%) 
Unclear 9 (29%) 
More than 10 events per variable 
Yes 9 (29%) 
No 16 (52%) 
Not reported 6 (19%) 
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Continuation table 3.1 
EXTERNAL VALIDITY All models Logistic regression Other 
N=66 N= 31 N=35 
Description of the sample 
Yes 55 (83%) 28 (90%) 27 (77%) 
No 11 (17%) 3 (10%) 8 (23%) 
Presentation of t he prognostic model 
Nomogram 1 (1%) 1 (3%) 0 
Simplified score 8 (12%) 4 (13%) 4 (11%) 
Figure 13 (20%) 1 (3%) 12 (34%) 
Regression formula 15 (23%) 12(39%) 3 (9%) 
Not explained 29 (44%) 13(42%) 16 (46%) 
Performance reported 
Area under ROe (Discrimination) 
Yes 18 (58%) 
No 13 (42%) 
c.r. presented 8 out of 18 (44%) 
H-L (Calibration) NA 
Yes 7 (23%) 
No 23 (74%) 
Other 1 (3%) 
Overall accuracy 
Yes 37 (56%) 15 (48%) 22 (63%) 
No 29 (44%) 16 (52%) 13 (17%) 
Validation 
Yes 25 (38%) 17 (55%) 8 (23%) 
External 7 (11%) 7 (23%) 0 
No 41 (62%) 14 (45%) 27 (77%) 
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3.4.3.1 Internal validity 
In over half of the models loss to follow-up was not reported. Ten models (15%) 
reported less than 10% loss to follow-up. 
Most models (68%) did not Include a discussion about the rationale for including 
the predictors in the model. A detailed description of the measurement of the 
predictors was absent in 82% of the models. In one third of the models the validity 
of the outcome measures was not reported. 
In relation to the analysis of the models that used multlvarlate logistic regression, 
stepwise was the most common approach (81%). Interactions were examined In 
13% of the models. Predictor variables were analyzed as continuous in 19% of the 
models. A third (29%) of the models Included at least 10 events per variable 
analyzed as predictor. The most common strategy to handle missing data was 
exclusion of observations (55%). 
3.4.3.2 External Validity 
The sample was described In almost all the models (83%). The procedure to obtain 
the score was explained in approximately half of the models (56%). However, In 
those that used logistic regression only 19% Included a user-friendly presentation. 
In relation to the performance of the models, discrimination was reported in 58% of 
the models through the area under the ROC, 44% of which included the respective 
confidence interval. Calibration was reported with the Homer-Lemeshow test in 
27% of the models. Almost half the models (56%) reported their overall accuracy. 
Less than half of the models (38%) were validated, of which 11% were validated in 
an external population. None of the models evaluated their clinical credibility. 
3.4.4 Description of externally validated models 
Seven models were developed that also reported an external validation (Table 3.2). 
55 
Author 
Pillai et al. 
Signorini et al 
Signorini et al 
Hukkelhoven et al. 
Table 3-2 Characteristics of the models externally validated 
Derivation 
sample 
289 patients from India wit h 
severe TBI 
372 patients from Scotland 
with moderate and severe 
TBI 
110 patients from Scotland 
with moderate and severe 
TBI 
275 patients from 
Netherlands with moderate 
and severe TBI 
Validation 
sample 
26 patients 
from the same 
centre 
520 patients 
from the same 
centre 
140 patients 
from the same 
centre 
205 patients 
from the same 
centre 
Predictors 
I-oculocephalic 
reflex 
2-motor GCS 
3-midline shift 
1-GCS 
2-ISS 
3-pupils reactivity 
4-haematoma (CT 
scan) 
1-GCS 
2-ISS 
3-pupils reactivity 
4 -haematoma (CT 
scan) 
5-ICP measures 
I-age 
2-motor GCS 
3-pupils reactiv ity 
4-pupillary size 
5-hypotension 
6-1SS 
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Performance 
Outcomes in the validation 
sample 
Death or Sensitivity (75%) 
vegetative Specificity (67%) 
state PPV 50% 
ROC (0.835) 
Survival at 1 
Error rate (15.2%) 
Brier score (0 .1160) 
year 
Hosmer-Lemeshow 
(p<O.OOl) 
Survival at 1 
Not reported 
year 
ROC (0 .50) 
Hosmer-Lemeshow 
Ra ised l CP (p=0 .18) 
Presentation of a 
simplified score 
No 
Nomogram 
No 
No 
Hukkelhoven et al. 
Hukkelhoven et al. 
Hukkelhoven et al. 
275 patients from 
Netherlands with moderate 
and severe TBI 
2269 patients from 2 trials 
in high income countries 
with moderate and severe 
TBI 
2269 patients from 2 tria ls 
in high income countries 
wi th moderate and severe 
TB! 
Continuation table 3.2 
205 patients 
from t he same 
centre 
796 patients 
from Europe 
796 patients 
from Europe 
and 746 from 
the United 
States 
1-age 
2-cause of injury 
3-pupils reactivity 
4-pupillary size 
5-hypotension 
6-ISS 
1-age 
2-motor GCS 
3-pupils reactivity 
Surgical 
removable 
les ions 
4-hypoxia Death or 
5-hypotension disability at six 
6-CT classif ication months 
7-subarachnoid 
haemorrhage 
1-age 
2-motor GCS 
3-pupils reactivity 
4-hypoxia 
5-hypotension 
6-CT classification 
7-subarachnoid 
haemorrhage 
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Death at 6 
months 
ROC (0.67) 
Hosmer-Lemeshow 
(p=O.Ol) 
ROC (0.83) 
Hosmer-Lemeshow 
(p=0.05) 
ROC (0.87/0.89) 
Hosmer-Lemeshow 
(p=0.42/ <0.001) 
No 
Score chart 
Score chart 
Pillai and collaborators developed a prognostic model to predict unfavourable outcome 
(death or vegetative state) at one month.9o They developed the model In a cohort of 
289 patients and validated the model In 26 patients from the same centre. The 
predictor variables were oculocephalic reflex, motor score of the GCS and midline ~hift 
score. They developed a predictor score that could then be transformed in a binary 
outcome (favourable or unfavourable). In the validation set they reported sensitivity 
(75%), specificity (67%), predictive value of unfavourable outcome (50%), predictive 
value of favourable outcome (86%), percentage of false optimistic results (25%), and 
percentage of false peSSimistic results (33%). They did not report the model's 
performance measured in the derivation set. Confidence Intervals of the estimates 
were not reported. Although the authors reported how to calculate the prediction 
score, they did not present It in a user-friendly fashion. 
Signorini and collaborators developed two prognostic models, for one they used only 
clinical variables and for the other they added variables on secondary insults. In both 
models the outcome was survival at 1 year. 91 The first model was validated In 520 
patients who attended the same centre. The predictors were age, GCS, Injury Severity 
Scale (155), pupils reactivity and presence of haematoma on the CT scan. They 
reported measures of discrimination: area under the ROC (0.835), error rate (15.2%) 
and calibration: Brier score (0.1160), Hosmer-Lemeshow (p <0.0001). They included a 
graph with the 95% confidence Interval of the calibration of the model. The second 
model was validated in 140 patients who attended the same centre. The predictor 
variables were the same as the first model plus ICP measures. Although they 
mentioned that Brier score, error rate, area under the ROC were higher than the 
original dataset they did not report the actual estimates. They reported a nomogram to 
predict probability of survival that is user-friendly for physicians. 
Hukkelhoven and collaborators reported four different models. 92,93 The predicted 
outcomes were: raised Intracranial pressure (ICP), surgically removable lesions (SRL), 
unfavourable outcome (death, vegetative state or severe disability) and mortality. For 
the validation of the first two outcomes they used an historical (previous) sample of 
205 patients from the same centre. The predictors for ICP were age, motor score, pupil 
size, pupillary reactivity, hypotension and 155. For SRL the predictors were the same 
except for motor score which was not, and cause of Injury that was added. For the 
validation of the model for unfavourable outcome they used one database and for 
mortality two data bases, none of these data bases was related with the population of 
the derivation set. The predictor variables were age, motor score, pupil reactivity, 
hypotension, hypoxia, CT classification and traumatic subarachnoid haemorrhage. They 
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reported the models discrimination: area under the ROC of 0.50 (95% Cl 0.41-0.58), 
0.67 (95% Cl 0.60-0.75), 0.83 (95% Cl 0.80-0.86), and 0.87(0.84-0.89) for ICP, SRL, 
unfavourable outcome, and mortality respectively. They also reported the model 
calibration: Hosmer-Lemeshow test of 0.18, 0.01, 0.05 and 0.42 «0.001), for ICP, 
SRL, unfavourable outcome and mortality respectively (the calibration of the mortality 
model was validated in two different databases). The mortality and unfavourable 
outcome models were presented in a user-friendly fashion (a numerical score 
accompanied by a figure). 
In relation to the 3S models that validated pre-existing models, 29 (83%) validated 
general trauma score. One validation model was reported in a letter and the 
information provided was limited. Three other models validated prognostic scores that 
were developed before 1990. Therefore only two studies that reported the validation of 
(post 1990) TBI prognostic models are described. 
Bush and collaborators validated a model previously developed by the same group.94 
Their model was intended to allow better understanding of factors influencing 
functional outcomes and was not intended to predict Individual outcomes. It was not 
clearly reported whether the patients came from the same original population. They 
used path analysis to evaluate the predictors (functional status, injury severity and 
cognitive status) on functional outcomes (disability rating scale, community integration 
questionnaire and return to employment). The reported different indexes of goodness 
of fit showed that the original model fitted better than the validation model. They did 
not report any discrimination measures. 
Benzer and collaborators validated a model that used an existing scale, although they 
did not provide details of when and how it was developed.95 They did not use any kind 
of multivariable analysis. The used a score based on the following variables: reaction 
to acoustic stimuli, reaction to pain, body posture, eye opening, pupil size, pupil 
response to light, position and movements of eyeballs and oral automatisms to predict 
mortality at 21 days. They did not report any performance measure, but just the chi 
square test for survival of those with low versus high score. They presented the score 
in a user-friendly way. 
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3.5 Discussion 
3.5.1 Principal findings 
This systematic review shows that although publications of prognostic models for TBI 
patients are very frequent, their quality is relatively poor. In addition they are rarely 
validated on external populations or presented to physicians in a user-friendly way. 
Furthermore, few are developed using populations from low and middle income 
countries where most trauma occurs~ 
Patients from all severity spectra were investigated but prognostic models for 
moderate and severe TBI patients were more frequent. It is noteworthy that only 2% 
of the models included patients from low income countries taking into account that 
90% of trauma occur in these countries. Although biologically prognostic factors should 
be the same worldwide, it is reasonable to consider that the baseline risk and the 
strength of the association could differ depending on the medical care received. This 
difference could affect the accuracy of the prognostic models in different settings. 
GCS, age and pupil reactivity were the most common variable~ analyzed as predictors 
whereas, GOS and mortality were the most common outcomes investigated. Multiple 
logistic regression was the multivariable analysis most frequently used. 
Several limitations in the quality of the models were found. The majority did not 
include a thorough discussion of the rationale for Including predictor variables. Only a 
minority had a loss to follow-up of less than 10%. Potentially this is an important 
limitation as the loss to follow-up could be related to prognosis and this could lead to 
bias. Furthermore only four models handled the missing data by using statistical 
imputation. In relation to the mul'tivariable analysis, automatic procedures (stepwise) 
were quite common in logistic regression. There is no agreement in relation to the 
appropriateness of this strategy. This Is shown, for example, in conflicting 
recommendations In quality assessment for prognostiC studies; while in one study the 
use of stepwise was conSidered as good quality in another it was considered as a 
flaw.96 One of the limitations was that most of the studies did not explicitly consider 
clinical criteria to enter the variables in the model beyond the automatic procedures. 
Interactions were hardly ever explored, although this Is strongly recommended In 
multivarlable analysls.97 Another common weakness was the lack of power of the 
models, most of them were derived from small samples and It Is well established that 
large samples are required for reliable selection of predlctors. 98 Only one third Included 
at least 10 events per variable, and It has been proposed that this is the minimum 
ratio of events to variables which Is large enough to allow an adequate precision of the 
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estimates.97 I did not attempt to obtain an overall quality assessment and instead I 
evaluated its different components. This approach makes a cross comparison between 
different analytical strategies difficult because, for example, many of the criteria only 
apply to logistic regression analysis. 
It is also important to report how well the model works and to report performance 
measures. Remarkably only two thirds reported a measure of discrimination and only 
one fifth reported a measure of calibration. Even when a discrimination measure was 
reported, less than half presented confidence intervals to provide readers with an 
estimation of its precision. 
For a model to be generalizable to other populations it is important to conduct an 
external validation:'3 Only seven models (three reports) developed and validated a 
model, but in only two of them was the validation performed on patients of a different 
centre. 
Finally, to be useful, the method to estimate prognosis should be clearly reported and, 
to be clinically practical, it should be user-friendly. Only half of the models clearly 
explained how to obtain the prognostic score, and only one tenth were reported in 
such a way that coLild be easily applicable in a clinical setting. None of the models 
evaluated the clinical credibility of the different presentations. 
Two models developed by Hukkelhoven and collaborators, one for mortality and the 
other for unfavourable outcome, were those which fulfilled most of the methodological 
and clinical criteria.93 A thorough discussion of the predictors was Included, missing 
data were handled appropriately, the assumptions of the model were tested, external 
validation in two different populatlons was performed, and discrimination and 
calibration measures were presented. The sample size was 2,269 patients and 1,542 
patients for the validation. Furthermore a simple score chart was developed to 
estimated the outcome probability. The predictors Included in the final model were 
age, GCS motor score, pupil reactivity, hypoxia, hypotension, CT scan abnormalities 
and presence of traumatic subarachnoid haemorrhage. The discrimination of the model 
was higher than 0.8 for both outcomes, however, the calibration was poor. As a 
limitation these models only included patients from developed countries and were 
restricted to moderate and severe TBI cases. 
3.5.2 Comparison with other studies 
There has only been one previous systematiC review of prognostiC models In TBI by 
Hukkelhoven and collaboratos.83 These authors found 10 reports, all of which were also 
Identified In my systematic review. Unlike my systematiC review, Hukkelhoven and 
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collaborators restricted their systematic review to models that used baseline 
characteristics to predict mortality or unfavourable outcome (defined by GOS) in 
moderate and severe TBI patients. Furthermore the search strategy was not specified. 
After the publication of my systematic review a new systematic review was by 
Mushkudianl and collaborators. These authors included prognostic models with 
variables available at hospital admission and they restricted the population to 
moderate and severe TBI.99 They found thirty one studies and their conclusions were 
very Similar to the one reported in this chapter. Most prognostic models Included GCS, 
age and pupil reactivity, they were developed from small sample sizes, and they were 
rarely externally validated or presented in a practical way. 
Systematic reviews of prognostic models for other diseases have found similar results 
to the one reported in this chapter. For example Counsel and collaborators conducted a 
systematic review of prognostic models in patients with acute stroke.89 They found 83 
prognostic models but they concluded that none of them was sufficiently well 
developed and validated. 
3.5.3 Strengths and weaknesses of this systematic review 
This is the first comprehensive systematic review of prognostic models for TBI. I 
developed a comprehensive search strategy and Included TBI of all severities. I also 
critically analysed the development and validation strategies from an epidemiological 
perspective to highlight limitations, to Inform potential users of prognostiC models, and 
to improve future designs of prognostiC models in this area. 
Some limitations should be acknowledged In this systematiC review. Firstly, only 
studies that expliCitly combined two predictors were Included, and by doing so some 
reports could have been missed. Secondly, studies that assessed clinical decision rules 
were not included. The methodological framework to assess such studies Is 
fundamentally different from prognostiC models. Thirdly, the search was restricted to 
1990 onwards so, some relevant prognostiC models published prior to that date could 
have been missed. However, because of changes In management and diagnostic 
technology in recent years it Is doubtful whether prognostiC models prior to 1990 could 
be useful for the current medical care of TBI patients. Finally, there is not yet a clear 
methodological framework to conduct systematiC reviews of prognostiC models, 
therefore, I faced some common challenges that any author conducting systematiC 
reviews of this study design confront. For example, although I used a search strategy 
recommended for prognostic studies there Is not a validated one for prognostiC 
62 
models, and I developed my own methodological framework to assess the quality of 
the included studies. 
3.5.4 Implication of the findings and future research 
Reasons for the poor quality found in the studies included in this systematic review are 
not clear but, as mentioned before, it seems that this is not an exception in systematic 
reviews of prognostic studies. Among the possible explanations Is that most of these 
studies include a small series of patients from single hospitals and give the impression 
that they were conducted by physicians who "wanted to know" the predictors among 
their patients. Most of the studies lack a clear theoretical framework and a clear 
question to address. One way to move forward and improve the quality of this type of 
study is to set up clear guidelines for prognostic studies and establish International 
collaboration to address prognostic questions. There are some signs of Improvement in 
this field, for a example there is an initiative to create a Prognosis Systematic Review 
Methods Group within the Cochrane Collaboration. 100 
The findings of this systematic review could be used to Inform researchers who are 
involved in the development of prognostic models in TBI. Future studies should 
consider the following issues to develop valid prognostic models: 
• Thorough discussion with physicians of potential predictors that are clinically 
relevant 
• Clear description of the measurement and validity of variables included in the 
model 
• Large sample size to ensure precise estimates 
• Adequate handling of continuous variables and missing data 
.• Assessment of Interaction In the multivarlable analysis 
• Internal validation 
• External validation 
• Adequate report of model performance measures 
• Clear description of the calculation of the prognostiC score and 
• User-friendly presentation 
It should also be encouraged that more studies Include populatlons from low and 
middle Income countries where most of the burden of TBI occurs. 
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The three main predictors that were consistently associated with poor outcome in TBI 
patients were age, GCS and pupil reactivity. According to these findings these variables 
should always be present in a prognostic model for TBI patients. 
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Chapter 4 Development and validation of prognostic 
models 
·4.1 Introduction 
In the previous chapters I described the Importance of prognostic information for 
clinical practice, in particular in the context of TBI patients, and have shown that 
physicians who routinely treat TBI patients would welcome a more accurate way of 
assessing prognosis. I have also described why prognostic models are likely to be more 
accurate than simple clinical predictions, and how some studies have shown that the 
use of a prognostic model can influence TBI patient management. 
The systematic review presented in Chapter 3 showed that although hundred of 
prognostic models for TBI have been reported, the majority have limitations. Most 
models are developed on small samples, most are methodologically flawed and few are 
validated in external populations. Only a small number are presented in a clinically 
practical way, or developed in populations from low and middle Income countries 
where most trauma occurs. 
The CRASH (Corticosteroid Randomisation After Significant Head injury) trial is the 
largest clinical trial conducted in patients with TBI and presents an unique opportunity 
to develop a prognostic model for TBI. 63,101 The trial had prospective inclusion of 
patients within eight hours of the Injury, used standardised definitions of variables and 
achieved almost complete follow-up at 14 days and at six months. Furthermore, the 
large sample size (10,008 patients) allows precise estimates. The high recruitment of 
patients from low and middle income countries means that models developed using 
these data are relevant to these settings. 
Using data from the CRASH trial, I have developed and validated prognostic models for 
death at 14 days, and death and severe disability at six months in TBI patients. 
4.2 Methods 
4.2.1 The sample of patients 
The study cohort was all 10,008 patients enrolled In the CRASH trial. Adults with TBI, 
who had a score on the Glasgow Coma Scale (GCS) of 14 or less, and who were within 
eight hours of injury, were eligible for Inclusion in the trial. 
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4.2.2 Outcomes 
The primary outcomes were: 
Death at 14 days: Patient death was recorded on an early outcome form which was 
completed at hospital discharge, death or 14 days after randomisation (whichever 
occurred first). 
Unfavourable outcome at six months: This outcome was defined using the Glasgow 
Outcome Scale (GaS). The GaS was assessed at six months with a validated 
questionnaire that was mailed to patients or their carers, administered by telephone 
interview, or undertaken during a home visit or hospital appointment (Appendix 
4.1).102 The questionnaire included six questions addressing disability: three dealing 
with functional disability or dependency (extent of help needed in the home, ability to 
shop and travel), and three addressing psychosocial disability (ability to work, take 
part in social and leisure activities, and relationship problems). Patients were classified 
as having a good recovery (able to return to work), moderate disability (able to live 
independently but unable to return to work or school), severe disability (able to follow 
commands but unable to live independently) or death at six months. 
For the purpose of this analysis, outcome at six months was dichotomised into 
favourable (moderate disability or good recovery) and unfavourable outcome (dead or 
severe disability).l1 
4.2.3 Prognostic variables 
As I intended to develop clinically practical models for the early management of TBI 
patients, I selected those variables which are generally available at hospital admission. 
The following variables were considered for the prognostic model: age, gender, cause 
of injury, time from injury to randomisation, GCS score at randomisation, pupil 
reactivity, whether the patient sustained a major extracranial injury, computerised 
tomography (CT) scan results, and country income region (high Income countries(HIC) 
or low & middle income countries(LMIC». 
4.2.4 Analysis 
4.2.4.1 General strategy 
For descriptive purposes, proportions were calculated for each variable for the total 
population and by country income region. Chi squared tests were performed to 
evaluate the differences in characteristics between the different regions. 
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Most of the variables initially considered for the prognostic models have been 
previously associated with prognosis in TBI, so all of them were included In a first 
multivariable logistic regression analysis.65 Analyses were adjusted for trial treatment 
since this has been reported to be related with mortality.63.l0l Interactions between 
country income level and all the other predictors were evaluated using a likelihood 
ratio test. 
Different models were developed for each of the two outcomes: a basic model and a 
Cl model. For the basic models, all the clinical and demographic variables were first 
analysed and only those variables that were statistically significant at the 5% level 
remained in the final basic models. 
For the CT models I included only those clinical and demographic variables that 
remained in the basic models, and added all the Cl scan variables. A multivariable 
analysis was performed and only those variables that were statistically significant at 
the 5% level remained in the final Cl models. 
Data were explored for missing values. There were 30 (0.3%) patients without data on 
mortality at 14 days, 454 (4.5%) without data on disability at six months, 335 (3.3%) 
without data on mortality at six months, 143 (1.4%) without data on cause of injury, 
238 (2.4%) without data on presence of major extra-cranial injury and 130 (1.3%) 
without data on the Cl scan result. Due to the small number of missing data a 
complete case analysis was performed. 
4.2.4.2 Analysis of individual predictors 
4.2.4.2.1 Age 
Age has been modelled In many different ways when Included in prognostic models of 
TBI populations, some studies have treated age as a continuous variable whereas 
others have identified age thresholds.69 Age was available as a continuous variable. To 
assess the best way to analyse age, I grouped It into five year Intervals and graphically 
displayed its relationship with 14 day mortality. 
4.2.4.2.2 Gender 
Gender was analysed as a binary variable (male or female). 
4.2.4.2.3 Cause of injury 
Cause of injury was included in the analysis as a categorical variable. Three categories 
were used: road traffic crash (RTC), fall and other. 
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4.2.4.2.4 Time from injury 
Time from Injury to randomlsation to trial treatment was available as a continuous 
variable (in hours). Three categories were pre-speclfied in the CRASH Trial: less than 
one hour, between one and three hours, and more than three hours. For descriptive 
purposes it was reported both as continuous and categorical. In the multlvariable 
analysis it was treated as a categorical as defined by the CRASH trial protocol. 
4.2.4.2.5 GCS 
GCS was measured on admiSSion before randomisation. If the patient was intubated 
and the GCS could not be assessed, the most recent GCS was reported instead. GCS 
was coded as "currentR or "recentR according to the time of measurement. 
The GCS was available as categorical variable for the motor, verbal and eye 
components and also as categorical for total GCS (3 to 14). For descriptive purposes 
total GCS was reported as mild (14-13), moderate (9-12), or severe (8 or less). 
For deciding how GCS would be included In the model, I performed likelihood ratio 
tests comparing a model for predicting 14 days mortality with all the components of 
the GCS (total GCS) against different models with each of the three components (eye, 
verbal or motor). I also estimated the discrimination ability of each of them through 
the c statistic. 
To assess if GCS could be analyzed as a continuous variable, I graphically displayed 
the relationship between GCS categories and the log odds ratio for 14 days mortality. 
4.2.4.2.6 Pupil reactivity 
Pupil response was evaluated for each eye and coded as reactive to light, not reactive, 
or unable to assess. For the analysis It was coded as both pupils reactive, one reactive, 
none reactive, or unable to assess. 
4.2.4.2.7 Major extracranial injury 
The presence of major extracranlal injury was reported as present, if according to the 
physician, the patient presented with an extra-cranial injury requiring hospital 
admission within Its own right. For the analysis it was coded as a binary variable (yes 
or no). 
4.2.4.2.8 CT scan results 
The following CT scan results (from the first CT scan available) were reported by the 
principal investigator as present or absent: normal scan, one or more petechial 
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haemorrhages within the brain, obliteration of the third ventricle or basal cisterns, 
subarachnoid bleed, midline shift over 5 mm, non evacuated haematoma, and 
evacuated haematoma. All the CT scan results were analyzed as binary variables (yes 
or no). The collaborators completed an outcome form with all the possible CT scan 
results (Appendix 4.2). A guideline was provided to the collaborators with definitions 
and images for each of the different possible CT scan results (Appendix 4.3). 
4.2.4.2.9 Country income 
Data on the country of origin were available for each patient. To explore the influence 
of different regions I divided the countries according to the World Bank 
Classification103• The following countries were considered high Income (HIC): Australia, 
Austria, Belgium, Eire, Germany, Greece, Italy, New Zealand, Saudi Arabia, Singapore, 
Spain, Switzerland and United Kingdom. The following countries were considered low 
and middle income (LMIC): Albania, Argentina, Brazil, Chile, China, Colombia, Costa 
Rica, Cuba, Czech Republic, Ecuador, Egypt, Georgia, Ghana, India, Indonesia, Iran, 
Ivory Coast, Kenya, Malaysia, Mexico, Nigeria, Pakistan, Panama, Paraguay, Peru, 
Romania, Serbia & Montenegro, Slovakla, South Africa, Sri Lanka, Thailand, Tunisia, 
Turkey, Uganda and Vietnam. This claSSification was not defined a priori In the CRASH 
protocol as this was a secondary analysis, but it Is a well accepted one and widely 
used. 
4.2.5 Performance of the models 
The performance of the models was assessed in terms of calibration and 
discrimination. 
Discrimination was assessed using the c statistic (an equivalent concept to area under 
the receiver operator characteristic curve).98 I used the terminology suggested by 
some authors that a c statistic over 0.7 Is "acceptable", and over 0.8 as "good".44 
Calibration was assessed graphically (plotting the observed versus expected 
probabilities of the outcomes by deciles of risk) and with the Hosmer-Lemeshow test. 
This statistic evaluates the difference between observed and expected probabilities 
where a small p value Indicates lack of fit. 
4.2.5.1 Internal validation 
The internal validity of the final model was assessed by the bootstrap re-sampling 
technique. Regression models were estimated In 100 models. For each of 100 
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bootstrap samples the model was refitted and tested on the original sample to obtain 
an estimate of predictive accuracy corrected for overflttlng.44 
4.2.5.2 External validation 
It Is considered that a good prognostic model should be generallzable to populatlons 
different from that in which it was derived.43 The external validation was conducted In 
an external cohort of 8509 patients with moderate and severe TBI from 11 studies 
(eight randomlsed controlled trials and three observational studies) conducted between 
1984 and 1997 in HIC (the IMPACT dataset).l04 
4.2.6 Web based score development 
A web calculator was planned to allow clinicians to estimate probabilities of the 
outcomes for individual patients. The estimated probability Is obtained by combining 
the predictor values with the regression coefficients and obtaining the linear predictor 
for the model, which is then transformed to a predicted probability through the logistic 
transformation. The web calculator was planned that would be available at the CRASH-
2 web page and would be accessible to clinicians internationally. 
4.3 Results 
4.3.1 General characteristics 
The characteristics of the patient cohort are shown In table 4.1. The patients were 
more frequently men (81%) and from LMIC (75%). Over half (58%) of participants 
were Included within three hours of Injury. Road traffiC crash (RTC) was the most 
common cause (65%) of injury. 
For the majority of patients (80%) the current GCS was reported. Almost 40% 
presented with a severe TBI, as defined by GCS, while 30% presented with a moderate 
TBI and 30% with a mild TBI. 
In 83% of the patients both pupils were reactive and In only 3% the pupil reactivity 
could not be assessed. Approximately 23% of patients presented a major extra-cranial 
injury. 
A er scan was performed in the majority (79%) of participants. 
A total of 1,948 patients (19%) died In the first two weeks, 2,323 patients (24%) were 
dead at six months, and 3,556 patients (37%) were dead or severely dependent at six 
months. 
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4.3.1.1 Comparison between patients from LMIC and HIC 
In comparison with patients from HIC, those from LMIC were on average 5 years 
younger and were more frequently male. 
On average patients from LMIC were recruited 0.8 hours (48 minutes) later than 
patients from HIC and RTC was reported more frequently as a cause of TBI In LMIC. 
All the patients had a GCS value but for a higher proportion of LMIC patients (86% vs. 
61%) GCS was obtained at the moment of recruitment (current GCS). This means that 
in 14% of the patients from LMIC and in 39% of the patients from HIC the GCS was 
obtained before recruitment into the CRASH Trial (e.g. pre hospital assessment). 
LMIC patents were categorized as less severe in comparison with patients from HIC. 
While almost 44% presented with a severe TBI in HIC, the proportion in this category 
was 38% for patients from LMIC. 
In LMIC CT scan was performed in 76% of the patients, while for patients from HIC it 
was performed in 88%. Abnormal CT scan results were more commonly reported in 
LMIC patients. 
Although patients from LMIC experienced higher mortality at 14 days (21% vs. 16%), 
there was no strong evidence of a difference in unfavourable outcome at six months. 
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Table 4-1 General characteristics of the study population 
Low &. Middle High income 
Total income countries countries 
(n=10,008) (n=7, 526) (n=2,482) 
Prognostic Variables Categories % % % P v a lue* 
Age mean in years (SO) 37± (17.1) (35 .8 ± 16) (40.6 ± 19.4) <0.001 
Gender 
Hours since injury mean (SO) 
Cause of head injury 
<20 12.3 
20-24 17.0 
25-29 13.0 
30-34 10.7 
35-44 17.9 
45-54 12.5 
~ 55 16.7 
---- ----------- ------------
Female 
Male 
< 1 
1 to 3 
>3 
19.0 
81.0 
3.4 ±( 2.7) 
26.8 
31.0 
42.3 
12.5 
17.8 
13.5 
10.9 
18.5 
12.3 
14.5 
18.3 
81.7 
(3.6 ± 2.8) 
24.0 
30 .1 
45 .9 
11.8 
14 .4 
11.2 
10 .1 
15 .9 
13.3 
23.4 
21.1 
78.9 
(2. 8 ± 2 .0) 
35.2 
33.7 
31.1 
0 .002 
<0.00 1 
----- --- ------- ---------- ---- ---- ------ ---- --- -- --- . ------ --- - -----. ---- -- -- --------- --- ---- ---_ . . 
RTC 65.1 69 .9 50 .2 
Fall >2 mete rs 13.3 11.1 20 .0 < 0.001 
Othe r 21.7 19 .0 29.8 
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Prognostic Variables 
Current Glasgow Coma Scale 
Total Glasgow coma score 
Pupil reactivity 
Major extra-cranial injury 
continuation of table 4.1 
Categories 
Mild (14-13) 
Moderate (12-9) 
Severe (3-8) 
Both reactive 
One reactive 
None reactive 
Unable to assess 
No 
Yes 
Total 
(n=10,008) 
0/0 
79.9 
30.2 
30.4 
39.5 
82.8 
6.3 
8.2 
2.7 
77.3 
22.7 
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Low &. Middle 
income countries 
( n=7, 526) 
0/ 0 
86.3 
29.4 
32 .6 
38.0 
83.S 
6.2 
8 .0 
2 .3 
77.3 
22.7 
High income 
countries 
(n=2,482) 
0/0 
60.7 
32.6 
23.6 
43.8 
80.7 
6.3 
9.1 
3.9 
77.S 
22.S 
p value* 
<0.001 
<0.001 
<0.001 
0.801 
continuation of table 4.1 
Prognostic Variables Categories 
CTscan 
No scan 
Normal scan 
Petechial haemorrhages 
Obl iteration of the third ventricle or basal 
cisterns 
Subarachnoid bleed 
Non evacuated haematoma 
Midline shift 
Evacuated haematoma 
Total 
(n=10,008) 
0/0 
21.1 
22.8 
28.7 
23.4 
31.6 
27.1 
14.6 
12.7 
Low & Middle 
income countries 
(n=7,526) 
0/0 
24.0 
20 .0 
28 .7 
28.6 
33.5 
27 .3 
15.9 
14.4 
High income 
countries 
(n=2,482) 
0/0 
12.0 
30. 2 
28.7 
9.6 
26.4 
26 .5 
11.1 
7.9 
p value* 
<0.001 
<0.001 
0.970 
<0.001 
<0.001 
0.475 
<0.001 
<0.001 
------- - - ------------- - -- -- - --------- -- -------- - ----- - ----------- -----------------.----------- --- -- ---------- -- ---------- ----------------------------- ---- -- ------ --
Outcomes 
14 days mortality 19 .5 20 .7 16.0 <0.001 
6 months death or severe disability 37.2 36.8 38 .5 0.150 
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4.3.2 Relationship between age and 14 days mortality 
The relation between age and the log odds ratio for death at 14 days showed no clear 
association until the age of 40, after which there was a linear increase. Age was 
therefore modelled as 0 until 40 years and then equal to age minus 40 after this age 
(age=D if age::;40, age-40 if age>40) (Figure 4.1). 
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Figure 4- 1 Relation between age and mortality 
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4.3.3 Selection of GCS variable 
In table 4.2 it is shown that there was strong evidence of an association between total 
GCS (and each of its components) and 14 days mortality. 
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Table 4-2 Association between GCS and mortality 
Odds ratios 95 Ofo Cl 
Total Glasgow coma Scale 
14 1 
13 1.5 1.05 2.17 
12 2.0 1.40 2.97 
11 2.5 1.73 3.71 
10 5.2 3.70 7.40 
9 6.1 4.4 8.7 
8 7.7 5.5 10.8 
7 9.7 7.1 13.3 
6 14.7 10.6 20.2 
5 26.7 19.2 37.3 
4 43.4 31 .0 60.8 
3 29.8 21 .7 40.9 
GCS Motor 
Obeys commands 1 
Localising 3.2 2. 6 3 .9 
Normal flexion 6.6 5.3 8 .2 
Abnormal flex ion 14.6 11 .6 18.3 
Extending 29.5 23.1 37.6 
None 18.0 14.5 22.5 
GCS Eye 
Spontaneous 1 
To sound 0 .9 0.7 1.2 
To pain 3.0 2.4 3.7 
None 8.3 6.9 9.9 
p value for 
trend 
<0.001 
<0.001 
<0.001 
-------------- - ----- - ----- - ----------- - - -- - ----- - --- - --------------- --------------------------------_ .. -------- .... _--
GCS Verbal 
Orientated 1.0 
Confused speech 1.3 0.9 2.1 
<0.001 
Words 2.7 1.7 4.1 
Sounds 8.6 5.6 13.0 
None 14.3 9.6 21.5 
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When different models to predict mortality at 14 days containing either total GCS or 
each of the different components were compared, there was strong evidence that the 
model with total GCS was better than any of the models containing each of the 
individual components (motor, eye or verbal) (p values for LHR tests were <0.001 for 
all of comparisons). 
In table 4.3 it is shown that in terms of discrimination, total GCS also was superior to 
each of its components . 
Table 4-3 Discrimination of total, motor, verbal and eye GCS and 
for mortality 
GCS Tota l GCS Motor GCS Verbal GCS Eye 
C statistic 0.79 0.77 0.75 0.74 
(95% Cl) (0.78-0.80) (0.75-0.78) (0.74-0.76) (0 .73-0.75) 
P va lue¥ <0.001 <0.001 <0.001 
¥ All comparison with GCS total model 
4.3.4 Relationship between GCS and 14 days mortality 
The relationship between GCS and 14 day mortality was reasonably linear and 
therefore GCS was included as a continuous variable (Figure 4.2). 
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Figure 4-2 Relation between GCS and mortality 
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4.3.5 Interactions between income level and predictors 
Statistically significant interactions were found between country Income level and 
several predictors, therefore, two models were developed, one for LMIC and another 
for HIC. Older age was a stronger predictor of 14 day mortality in HIC (interaction 
p<O.OOl). On the other hand, lower GCS was a stronger predictor in LMIC (interaction 
p=O.003) (figures 4.3 and 4.4). Obliteration of the third ventricle and a non-evacuated 
. haematoma were both associated with a higher risk in HIC (interaction p<O.OOl and 
p=O.03 respectively). 
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4.3.6 Multivariable predictive models 
In total eight models were developed: for patients from the two re.glons (LMIC and 
HIC), two types (basic and CT models), and for predicting the two outcomes (mortality 
at 14 days and unfavourable outcome, as defined by GOS, at six months. 
Through this section I referred to mortality at 14 days as "mortality" and to 
unfavourable outcome defined by GOS (severe disability and death) at six months, as 
"unfavourable outcome". When I am referring to both outcomes I used the term "poor 
outcome". 
4.3.6.1 Multivariable analysis for the basic models 
The results of the multivariable analysis Including all the demographic and clinical 
variables are shown in table 4.4. 
4.3.6.1.1 Age 
There was strong evidence that age after 40 years was associated with an increased 
risk of mortality and unfavourable outcome in both regions. 
4.3.6.1.2 Gender 
There was no evidence of an association between gender and any of the outcomes In 
any region. 
4.3.6.1.3 Hours since Injury 
There was ·strong evidence that patients from LMIC who were randomlsed more than 
one hour after the injury had a higher risk of mortality and unfavourable outcome, in 
comparison to those randomised In the first hour. However, there was no strong 
evidence of such an association In HIC patients. 
4.3.6.1.4 Cause of TBI 
There was strong evidence of a decreased risk In mortality In patients from LMIC 
whose cause of TBI was coded as "other", In comparison to those patients whose cause 
of Injury was coded as "road traffic crash". There was no strong evidence of any other 
relationship between cause of TBI and poor outcomes. 
4.3.6.1.5 Glasgow Coma Scale 
There was strong evidence of an Inverse association between GCS and mortality and 
unfavourable outcome for patients from LMIC and HIC. 
4.3.6.1.6 Pupil reactivity 
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There was strong evidence of an increased risk of mortality and unfavourable outcome 
for patients with either one or both pupils not reactive in comparison to those patients 
with two reactive pupils in both LMIC and HIC. 
4.3.6.1.7 Major extra-cranial injury 
There was strong evidence of an increased risk of unfavourable outcome for patients 
with a major extracranial injury in comparison to those without such an injury in both 
LMIC and HIC. There was also strong evidence of an increased risk in mortality for HIC, 
and a weaker association was found for LMIC. 
Considering the Z score value, GCS was the strongest predictor of outcome in LMIC 
and age was the strongest predictor in HIC, while the absence of pupil reactivity was 
the third strongest predictor in both regions. 
4.3.6.1.8 Final basic models 
For the basic model only the four predictors which were associated with poor outcome 
in both regions were retained in the model: age, GCS, pupil reactivity and the presence 
of major extra-cranial injury. 
4.3.6.2 Multivariable analysis for the CT models 
The results of the multivariable analysis including those variables selected for the basic 
models (age, GCS, pupil reactivity and presence of major extra-cranial injury) and all 
the CT characteristics are presented in table 4.5. 
4.3.6.2.1 Basic model predictors 
There was still strong evidence of association for all the variables from the basic model 
with poor outcome in both regions. There was a further decrease in the strength of the 
association between presence of major extra-cranial injury and mortality in LMIC. 
4.3.6.2.2 CT scan predictors 
The following CT characteristics were strongly associated with the outcomes in addition 
to the predictors included in the basic models: obliteration of the third ventricle or 
basal cisterns, subarachnoid bleeding, midline shift and non-evacuated haematoma. 
There was also strong evidence of an association between presence of petechial 
haemorrhages and poor outcome in LMIC and some weaker evidence of such an 
association in patients from HIC. There was no evidence of an association between 
evacuated haematoma and poor outcome in either region. 
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Considering the Z value, obliteration of the third ventricle and midline shift were the 
strongest CT scan predictors of mortality, and non-evacuated haematoma was the 
strongest predictor of unfavourable outcome. 
4.3.6.2.3 Final CT models 
For the CT model I Included all the variables in the basic model and the following CT 
scan characteristics: presence of petechial haemorrhages, obliteration of the third 
ventricle or basal Cisterns, subarachnoid bleeding, midline shift and non-evacuated 
haematoma. 
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Table 4-4 Multivariable analysis for the basic models* 
14 da}'!S ~ortalLty Six months death or severe disability 
Low & Middle Income Low & Middle Income 
High Income Countries Countries High Income Countries Countries 
(n=2,294) (n=7,412) (n=2,185) (n=7,119) 
O.R. 95% Cr z O.R. 95% cr z O.R. 950/0 cr 
Upper Prognostic Variables ( 95010 Cl) Lower Upper score (95% Cl) Lower Upper score (95% Cl) Lower 
~¥_*: : _______ ___ ________ _________ ~ __ ~._~? ______ 1:~! ___ ____ 1-,_~~ _____ 1_~:~~_ L~:~~ ____ L~~ __ ___ ::~~ _____ l_~:~?_L ~:?_3 1.64 
I I : 
! 
1.82 
Gender 
Female 1 1 1 
. . i Male : 0.95 0.69 1 .31 -0.32: 1. 19 0.99 1.43 1.82 i 0 .86 0.67 1.12 
H~~~-~i~~~- i;j-';;Y --------------;- ------------------. --------. -------. -:--. ---------------------------------r ------
< 1 hour 1 1 i 1 i 
1-3hours 1.04 0.74 1.46 0.21 1.23 1.01 1.50 2.05 j 0.98 0.76 1.27 
> 3 hours . 0.85 0.61 1.19 -0 .96. 1.26 1.05 1.51 2.46 j 1.03 0.80 1.33 
z O.R. 95% cr 
score (95% Cl ) Lower Upper 
15.99 1.70 1.63 1.77 
-1.12 0.96 0.82 1.13 
1 
-0.13 1.19 1.00 1.42 
0 .24 1.30 1.11 1.53 
Z 
score 
18 .58 
-0.45 
1.99 
3.23 
---------------------------------~ -----------. ------. -------------------:- ---------------------------------. -1------- ---.-- ------- ----- ... . --- --- - -- -- ------ -- --- --- --- ---- ----
~~e : : 
. . 
Road Traffic Crash : 1 : 1 i 1 
Fall 1.21 0.86 1.70 1.08 1.05 0.84 1.31 0.43 I 1.25 
Other : 0 .83 0.58 1.18 -1.04: 0.75 0.62 0.91 -2.88 i 1.00 __ __ ____ _ __ _ _ ____ ___ _____ _ ___ _ ___ ~ _______ _ _____ _ __________ _ __ ___ ___ _ _ _ _ ~_ ____________________ ____ ___ _____ _ _ _ J ____ _ _ _ _ 
_~~~~!l..C?~_ ~"-'!!~_ ~~!~: ________ ~ __ ~ ._~~ _____ .1:!? ______ ~.!_~ _____ l_~ :~~_ j __ ~:~_~ _____ :._~~ _____ ::~~ ____ ~_~._~?_j __ ~:~_~ _ 
0.95 
0.78 
1.18 
1. 64 1.61 
1.30 0 .03 
1 
1.07 
0.96 
0.88 1.30 0.65 
0.81 1.13 -0.54 
_ _______ _ __ _ __ ___ J _ _ _ • __ _ _ • __ __________ _ ___ ____ _ _ _ __ __ • 
1.25 12.84 ; 1.42 1.39 1.45 30.64 
. 1 I 1 1 Pupil reactivity Both reactive 1 
One reactive : 2.57 1.65 4 .00 4.17: 1.91 1 .53 2.39 5 .69 j 2.43 1.62 3. 66 4.26 2.01 1.59 2.56 5.81 
None reactive ; 5.49 3.70 8 .15 8.45 ; 3.92 3 .14 4.90 12.07 ! 3.28 2.20 4.89 5.85 4.54 3.38 6.11 10.03 
-;.;~j~~-~;t;~~~~_.;~i~i -i;'j~;:'; --l-- -------- ---- -- ------------- --- -------;-- ------ ---- --- ----- ---- ----------- -r -------.- -- -- -- ------- ----. -. ----------------------------- -------- -- ---
No 1 1 i 1 1 
Yes 1.53 1. 11 2 .09 2.62 1.15 0.99 1.34 1. 78 i 1.62 1 .26 2.07 3.82 1. 73 1.51 1.99 7.76 
* Includes age, gender, hours since inj ury, cause of injury, GCS, pupil reactivity and presence of major extra cranial injury * Per 10 years increase 
after 40 years r Per decrease of each value of the GCS 
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Table 4-5 Multivariable analysis for the eT models * 
14 days mortality Six montl!~death or severe disability 
High Income Countries Low & Middle Income Countries 
(n=2, 030) (n=5,635) 
I O.R. 95% CI Z O.R. 95%CI Z Prognostic Variables (95% Cl) Lower Upper score (95% Cl) Lower Upper score 
! 
Age* 1.73 1.62 1.84 13.33 1.4 6 1.39 1 .54 12.54 ! 
Glasgow Coma Scale ¥ 1.18 1.12 1.23 6.87: 1.27 1.24 1.31 16.68 
________ _ __ _ ____ __ _ _ ___ _____ __ __ L _______ _ ___ _ __________ _____ ____ ___ _____ ~ ------- ------_-- --- -- ---- -- ----- --- _ __ _ _ 
Pup i l reactivity 
Both reactive 1 1 
One reactive 2.00 1.25 3.20 2.88 1.45 1.14 1.86 2 .97 
None reactive 4.00 2.58 6.20 6.21 3 .12 2.46 3 .97 9.31 
. . 
------------------ -- ----- ------ - ~ _. ----- --------- -- -- ------- ------ ---- -- -,--- --- ---- ----------- - -- ----- --- ---- -- --
Major extra-cranial injury 
No 
Yes 
CT scan 
Petechial haemorrhages 
Obliteration of the third: 
ventricle or basal cisterns 
Subarachnoid bleed 
Midline shift 
Evacuated haematoma 
Non evacuated haematoma 
1 
1.53 
1.15 
4.46 
1.48 
2.77 
0 .78 
2.06 
. 
1 
1.10 2 .13 2.53 1.08 0.91 1 .28 0.89 
___ __ _____ ____ ____ _ ______ ..J __ ___ __ ___ ____ __ _____ ___ ____ _ _ __ ___ _ ___ _ 
. 
0.83 1.59 0.84 1.26 1.07 1.47 2.82 
2.97 6 .68 7.23 1.99 1.69 2.35 8.25 
1.09 2.02 2.51 1.33 1.14 1.55 3.60 
1.82 4.21 4.77 1.78 1.44 2 .21 5.35 
0.45 1.35 -0.89 1.01 0.80 1.28 0.08 
1.49 2 .84 4.40 1.48 1.24 1.76 4.43 
High Income Countri es Low & Middle Income Countries 
(n = 1,955) (n = 5,394) 
O.R. 95% CI Z O.R. 95%CI Z 
( 95% Cl) Lower Upper score (95% Cl) Lower Upper score 
1.73 1.63 1.83 14.94 1.72 1.64 1.81 17.74 
1.18 1.14 1.22 9.83 1.34 1.30 1.37 22.32 
------- -~----------- --- - - --- --- ------ - -------- - --
1 1.00 
2 .12 1.39 3 .24 3.47 1.54 1.20 1.99 3.35 
2.83 1.84 4 .35 4.73: 3 .56 2.60 4 .87 7.92 
----------- - ,- - -------------- ------------- --- ----- ----
1 1.00 
1.55 1.20 1 .99 3.37 : 1.61 1.38 1.88 6.03 
- -------------------------------------- - '- -------- ---- - ----- ----------------------
1.21 0.95 1.55 1.56 1.49 1.29 1. 73 5.33 
2.21 1.49 3.30 3.95 1.53 1.31 1.79 5.30 
1.62 1.26 2. 08 3.79 1.20 1.04 1.39 2.49 
1.93 1.3 0 2 .87 3.24 1.86 1.48 2 .32 5.42 
1.35 0 .8 7 2. 08 1.33 1.18 0. 94 1.48 1.46 
1.72 1.33 2.22 4.15 1.68 1.43 1.97 6.34 
, Includes age, GCS, pupil reactivity, presence of major extra cranial injury, and all er characteristics* Per 10 years increase after 40 years r Per decrease of each value 
the GCS 
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4.3.7 Performance 
4.3 .7.1 Discrimination 
4.3.7.1.1 Comparison of discrimination between the models 
Table 4.6 displays the discrimination of each of the eight models developed. For 
estimating the c statistic for the basic and CT models, I used the same samples (those 
with a CT scan available) so a direct comparison could be made. 
All models showed good discrimination, with c statistics over 0.80. CT models showed 
higher discrimination than basic models. 
Table 4-6 Discrimination of the prognostic models 
LMIC 
Basic Model 
C statistic 
14 days 
Mortality 
0.81 (0 .80-0.83) 
Six months 
unfavourable 
outcome 
0.82 (0.81 -0.84) 
CT Model 0.84 (0.82-0.85) 0.84 (0.83 -0.85) 
- - . - -- - _____ -. --- - - - -- - - ---- - - - - -- ----- ----- -- - ------ --- - ---- - --- --- ---- - - --- - --- - - __ e. - - ___ - - _______ - __ - __ _ 
HIC 
Basic Model 0.84(0.82-0.87) 0.81 (0.79-0.83) 
CT Model 0.88 (0.86-0.90) 0.83 (0.81 -0.84) 
The internal validation through bootstrapping revealed no over optimism in any of the 
final model's predictive c statistics. 
4.3 .7.1.2 Comparison of discrimination between the models and individual predictors 
Figure 4.5 and figure 4.6 display the c statistics for each of the individual predictors 
included in the basic model for both outcomes (14 days mortality and six months 
unfavourable outcome) and compares them with the c statistics of the basic and CT 
models. For all the estimation I used the same sample (those patients with a CT scan 
available) so that a direct comparison could be made. GCS was analysed as a 
continuous variable and as a categorical variable (mild, moderate and severe) because 
the latter is the way it is commonly used in clinical practice. It can be seen that both 
models had higher discrimination than any of the single predictors; although GCS in 
LMIC when analyzed as a continuous variable showed an acceptable discrimination. 
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Figure 4-5 Discrimination of predictors, basic and CT models in LMIC 
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Figure 4-6 Discrimination of predictors, basic and CT models in HIC 
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4.3.7.2 Calibration 
4.3.7.2.1 calibration of basic and CT models 
Figures 4.7 to 4.14 display the relationship between predicted and observed probability 
of outcome according to deciles of risk for the CT and basic models in both regions. 
The red line on the 45° shows the line of perfect prediction. Each circle represents a 
declle of risk. If the circle lies on the line, the prediction coincided with the observed 
frequency of the outcome in that group of patients. If the circle lies below the line it 
means that the model predicted a higher probability in comparison to what was 
observed, and if the circle lies above the line the model predicted a lower probability of 
the outcome than that was observed. 
Graphically most of the models showed adequate calibration, but in general the models 
from LMIC showed an apparently better calibration as the circles were closer to the 45° 
line. The other common pattern observed in most of the models was that the groups 
with intermediate risk were those with the worse calibration (circles further from the 
45° line). 
When analysed with the Hosmer Lemeshow test all the models had good calibration, 
that is with p >0.05, except the CT models for LMIC patients for 14 days mortality 
(p=0.04) and six months unfavourable outcome (p=0.03). 
4.3.7.2.2 Comparison of calibration between GCS and basic model in LMIC 
As GCS when analyzed as a continuous variable showed good discrimination for 
predicting mortality in LMIC, I compared graphically its calibration with that of the 
basic model. It can be seen in figure 4.15 that calibration, particularly for groups with 
intermediate risk was better for the basic model. Similarly when tested with the Homer 
Lemeshow test, there was evidence of lack of calibration for GCS (Hosmer Lemeshow 
test=0.03) but not for the basic model (Hosmer Lemeshow test=0.39). 
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Figure 4-7 Calibration of basic model for mortality in HIC 
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Figure 4-8 Calibration of basic model for mortality in LMIC 
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Figure 4-9 Calibration of basic model for unfavourable outcome in 
HIC 
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Figure 4-10 Calibration of basic model for unfavourable outcome in 
LMIC 
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Figure 4-11 Calibration of CT model for mortality in HIC 
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Figure 4-12 Calibration of CT model for mortality in LMIC 
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Figure 4-13 Calibration of CT model for unfavourable outcome in 
HIC 
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Figure 4-14 Calibration of CT model for unfavourable outcome in 
LMIC 
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Figure 4-15 Calibration of GCS and the basic model for mortality in LMIC 
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4.3.8 External validation 
Because an external cohort of patients from LMIC was not available, validation was 
only performed for the models that included patients from HIC. The IMPACT dataset 
used for the validation Included patients with moderate and severe TBI (GCS <13) and 
did not Include data on mortality at 14 days. Therefore only models for unfavourable 
outcome at six months could be validated. I validated the basic model with the 
variables: age, GCS and pupil reactivity. The variable 'major extracranlal Injury' was 
not included as it was not available in the validation sample. For the CT models, the 
following variables were added to the basic model: obliteration of the third ventricle or 
basal cisterns, subarachnoid bleeding, midline shift and non-evacuated haematoma. 
Similarly the variable 'petechial haemorrhages' was excluded as this wa.s not available 
in the validation sample. 
For the validation process I first ran the models In the CRASH trial patients from HIC, 
and I then applied the corresponding coeffiCients In the validation sample (IMPACT 
patients). Although discrimination was, as expected, lower than In the original data, It 
was still acceptable for both the baSic and CT models (c statistics: 0.77 (95% Cl 0.76-
0.78), and 0.77 (95% Cl 0.76-0.78) respectively). The calibration was good for the CT 
model and poor for the basic model when evaluated graphically, but poor for both 
according to the Homer-Lemeshow test (p<O.Ol) (figure 4.16). 
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4.3.9 Clinical score 
A web based calculator, which is available at the CRASH-2 trial web page, was 
developed to obtain individual probability of outcomes (www.crash2.lshtm.ac.uk). 
By entering the values of the predictors, the expected risk of death at 14 days, and of 
death or severe disability at six months can be obtained for LMIC and HIC patients with 
TBI. For example, figure 4.17 shows a sample screenshot of the predictions for a 26 
year old patient from a low and middle Income country (Argentina), with a GCS of 11, 
one pupil reactive and absence of a major extra-cranial Injury. According to the basic 
model this patient has a probability of death at 14 days of 10% and a 23.9% risk of 
death or severe disability at six months. 
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Figure 4-17 Screenshot of the web based calculator 
Head injury prognosis 
These prognostic models may be used as an aid to estimate mortality at 14 days and death 
and severe disabi lity at six months in patients with traumatic bra in injury (TBI) . The 
predictions are based on the average outcome in adult patients with Glasgow coma score 
(GCS) of 14 or less, within 8 hours of injury, and can only support - not replace - clinical 
judgment . Although individual names of countries can be selected in the models, the 
estimat es are based on two alternative sets of models (high income countries or low & 
middle income countries) . 
Country Argentina v i 
Age , years ~ 4 0 v i 
Glasgow coma score 11 v i 
Pup ils react to light One v i 
Major extra- cranial inj ury? ~ I No v i 
CT SCan available? D 
Prediction 
Reset 
Reference: 
The MRC CRASH Trial Collaborators. Predicting outcome after traumatic brain injury: Practical prognostic 
models based on an international cohort of 10,008 patients. 2007; (submitted). 
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4.4 Discussion 
4.4.1 Principal findings 
4.4.1.1 Prognostic models 
I have developed prognostic models for predicting two clinically relevant outcomes in 
TBI patients using variables that are available at the bedside. The models have good 
discrimination and good fit using internal validation. The models for HIC patients with 
moderate or severe TBI also showed acceptable discrimination when externally 
validated. 
The basic model includes the variables: age, GCS, pupil reactivity and major 
extracranial injury. The CT model includes the same variables as the basiC model plus 
the CT scan findings: petechial haemorrhages, obliteration of the third ventricle, 
midline shift, subarachnoid haemorrhage and non evacuated haematomas. As I found 
evidence for interaction between some of the predictors and the outcome I developed 
different models for HIC and LMIC. All the models have been made available on the 
internet. 
For selecting the variables I chose those for which there was strong evidence of an 
association with the outcomes In both regions, so a common core of variables could be 
selected. The rationale for this strategy was that a common model for the different 
regions and outcomes would be simpler to use. In doing so, I took some decisions such 
as leaving out the variable "hours since Injury" because there was only strong evidence 
of an association in LMIC but not in HIC. 
On the other hand the variable "presence of major extracranlal Injury" there was 
strong evidence of an association with six month unfavourable outcome In the two 
regions with both models, but there was weaker evidence for an association with 
mortality in LMIC. In the basic model the OR was 1.15 (95% Cl: 0.99-1.34) and the 
strength of this association weakened In the CT model (OR: 1.08 95% Cl: 0.91-1.28). 
Nevertheless, I decided to keep this variable In all the models. Similarly, for the 
presence of petechial haemorrhages in the CT scan there was strong evidence for an 
association In LMIC but in HIC the association was weaker However, I decided to keep 
this variable in all the models. 
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4.4.1.2 Individual predictors 
4.4.1.2.1 Demographic and clinical predictors 
Age 
Increasing age was associated with worse outcomes but this association was most 
apparent after 40 years of age. A similar threshold has been reported elsewhere. 91 In 
their systematic review, Hukkelhoven and collaborators, found the best fitting 
threshold for age was 39 years, however, they reported that the best way to analyse 
age was a linear and a quadratic term.69 For simplicity In the model I did not explore a 
more complex relationship, such as quadratic, but Is possible that a better fit could 
have been found. Furthermore, I acknowledge that It does not seem biologically 
plausible that the increased risk associated with age only starts after 40 years of age. 
However, it is unlikely that a different way of analysing the variable age would have 
changed the main conclusions of this study. Whatever way Is chosen to describe this 
variable, the evidence is quite conSistent that a positive association exists between age 
and poor outcome. Plausible explanations for this relationship Include extracranial co-
morbidities, changes In brain plasticity, or differences In clinical management 
associated with increasing age. Further research Is needed to explore these 
mechanisms. 
Glasgow Coma Scale 
Total GCS showed a clear Inverse linear relationship with mortality. The finding that 
mortality was lower in patients with a GCS of three than In patients with a GCS of four, 
may be due to GCS scores of sedated patients being reported as GCS three. Previous 
studies have suggested that total GCS could have become less useful as a predictor In 
an era of early sedation and pre-hospital Intubation. 105 However, In this study I found 
that GCS has still an acceptable discriminative ability, particularly In LMIC. When GCS 
was analyzed as a categorical variable (mild, moderate and severe), although It 
showed an acceptable discrimination, It was lower than the discrimination of GCS as a 
continuous variable. 
In terms of discrimination, total GCS was superior to each of the Individual 
components (motor, eye and verbal). Among the different GCS components the motor 
Item was the most discriminative. In a recent review of the predictive ability of GCS In 
TBI patients, the authors concluded that the motor has the same discriminative ability 
as total GCS.106 However, according to the findings of this study total GCS Is superior 
in terms of discrimination to the motor component. 
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Pupil reactivity 
In concordance with previous studies the absence of pupil reactivity was a strong 
predictor of poor outcome.65 The effect estimate (odds ratio) for mortality was among 
the highest of all predictors. However, when measured with the Z score it was only the 
third strongest predictor after age and GCS. This finding could be explained by random 
error as the standard errors were larger due to the relatively low frequency of the pupil 
abnormalities (6% with one pupil non reactive and 8% with both pupils no reactive). 
Major extracranial injury 
Patients with a major extracranial injury showed an Increased risk of poor outcome. 
Other studies have shown an independent effect of extracranial Injury, for example 
Signorini and collaborators found that extracranial injuries measured with the Injury 
Severity Score (ISS) were an independent predictor of mortality. Other studies have 
failed to report such an associatlon.107 Nevertheless, it Is well accepted that other 
variables which could be a consequence of presenting extra-cranial Injuries, such as 
hypotension, are associated with poor outcome In TBI patlents.65 
Hours since Injury 
Only patients from LMIC who were randomised more than one hour after the injury 
had a higher risk of poor outcome In comparison to those randomised In the first hour. 
Although there Is clinical consensus that TBI patients should receive rapid treatment 
after the injury, there is no empirical evidence demonstrating the association between 
time since Injury and poor outcome. 108 Furthermore, the CRASH trial cohort has limited 
information to evaluate this association as only patients who were hospitalized within 
eight hours of injury were Included. 
Cause of injury 
Cause of Injury was not found to be an Independent predictor of poor outcome. In a 
previous meta-analysis of 11 studies, the authors found that the cause "fall" was 
associated with Increased mortality, but after adjustment for age It did not remain as 
an Independent predlctor. 109 The only category that I found to be an Independent 
predictor was "other", which was associated with a decreased risk In mortality when 
compared to the cause "road traffic crash" In LMIC. Unfortunately the "other" category 
includes a wide range of diverse causes, and It was not possible to disentangle the 
possible explanation for this finding. 
Gender 
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There was no strong evidence for an association between gender and poor outcome. 
Although some studies have claimed a better outcome In female patients, a recent 
systematic review concluded that there Is no evidence of such a difference In outcome 
according to gender. 110 
4.4.1.2.2 er scan predictors 
Most of the previous publications have used the er Marshall classification, referred to 
in chapter 1, to evaluate the predictive ability of er findings, however I used Instead 
the individual er scan variables as these are more useful and practical from a clinical 
perspective. Recently it has been suggested that analysis of Individuals' er predictors 
is a better strategy.11l I found that all abnormal er scan results, except evacuated 
haematoma, were aSSOCiated with poor'outcome. 
The er category "obliteration of third ventricle or basal cisterns" was most strongly 
aSSOCiated with poor outcome. This result is in keeping with the recent findings that 
absence of basal cisterns is the strongest predictor of six month mortality.78 As 
previously reported, traumatic subarachnoid haemorrhage was found to be an 
independent predlctor.73 The finding that a non-evacuated haematoma was associated 
with an increased risk of poor outcome, is consistent with studies that have showed 
that there is an increased risk of poor outcome with different type of Intracranial 
haematomas.112 Unfortunately, in the CRASH trial there were not enough data to 
explore this association more In detail. In appendix 7 of this thesis I will further 
investigate this association using a dataset that Includes more details in relation to 
intracranial bleeding. 
4.4.1.3 Differences between patients from LMIC and HIC 
4.4.1.3.1 Early mortality 
Patients from LMIC had worse early outcome than those from HIC. Regional differences 
in TBI outcome between Europe and North America have been reported previously, but 
the difference In mortality between LMIC and HIC has not been explored. 113 
The adjusted odds ratio for mortality at 14 days, for LMIC patients in comparison with 
HIC patients, was 1.94 (95% Cl: 1.64-2.30). It Is not possible with the data available 
in the CRASH trial to reach a conclusion about the causes for this difference. However, 
some findings could raise hypotheses that might be evaluated in future studies. For 
example, in comparison with patients from HIC, those from LMIC arrived later to the 
hospital, and a larger proportion had data on current GCS, a possible indicator that a 
smaller proportion of LMIC patients was Intubated or sedated at hospital admission. 
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These two findings Indicate that patients from LMIC receive more delayed treatment In 
comparison with those from HIC. Furthermore, a lower proportion of LMIC patients 
underwent a er scan. It Is therefore possible that for some patients, with potential 
treatable lesions, a er scan was not performed. 
4.4.1.3.2 Six months unfavourable outcome 
Another interesting finding was that although 14 days mortality was higher In patients 
from LMIC, there was no evidence for a difference for six months unfavourable 
outcome. This could be related to the fact that those patients from HIC who did not die 
early had a higher frequency of disability, or alternatively It could be related to the fact 
that disability at six months was measured with the GOS, the Interpretation of which 
could vary between different settings. 
4.4.1.3.3 Differences in the strength of association of predictors 
The other important finding was the difference observed In the strength of association 
between some of the important predictors and outcome. Mine is the first study to 
report such differences according to whether patients are from HIC or LMIC. 
Although GCS was a strong predictor of poor outcome in both regions, I found that It 
had a higher discriminative ability In LMIC patients than in HIC patients. This might 
relate to quality of care, or alternatively it could be that low GCS scores In HIC are 
related to greater use of sedation, rather than to TBI severity. 
In LMIC GCS (measured as a continuous variable) had a similar C statistic to both the 
basic and er model, while in HIC the difference between the C statistic of the models 
and the GCS was larger. 
The other variable that showed different strength of associations according to the 
region was age. Increasing age had an even worse prognosis In HIC compared with 
LMIC. This result probably arises because of even lower risks at younger ages In HIC, 
while HIC and LMIC have similar risks at older ages. In Figure 4.4 It can be seen that 
the log odds ratio are similar In both regions for patients older than 64 years but are 
substantially lower for patients under 40 years In HIC. 
Regarding er scans, some abnormal findings were stronger predictors In HIC 
compared to LMIC. This could be due to better technology and therefore more accurate 
er diagnosis in HIC. 
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4.4.2 Comparison with previous studies 
The systematic review reported In Chapter 3 Identified over 100 prognostic models for 
TBI patients, but methodological quality was considered adequate In only a few. 114 
Two of the more methodologically robust models showed similar findings to my 
models, with good discrimination but worse calibratlon.91,93 They too Included GCS, 
age, pupil reactivity and CT scan results as predictors but, unlike my models, they did 
not include the presence of major extracranial Injury, and none of them included 
patients from LMIC. 
Subsequent to the publication of the prognostic models reported in this theSiS, the 
investigators from the IMPACT study, the database in which the CRASH prognostic 
models were validated, developed a series of prognostic models for TBI patients. 115 
The IMPACT dataset included 8,S09 patients with moderate and severe TBI from 11 
studies conducted between 1984 and 1997 in HIC. They developed three types of 
model to predict mortality at six months, and unfavourable outcome at six months, as 
defined by the GCS. The three models developed were: 
1) A core model that included age, motor score component from GCS, and puplllary 
reactivity. 
2) An extended model that Included the core model variables plus secondary Insults 
(hypoxia and hypotension) and CT characteristics (Marshall CT claSSification, 
subarachnoid haemorrhage and epidural haematoma). 
3) A laboratory model that included the variables from the core and extended models, . 
plus glucose and haemoglobin. 
The core model was developed using the whole dataset (8,S09 patients), while the 
other two models used smaller samples as they were forced to restrict the sample to 
studies with the relevant variables. The extended model was derived from 6,999 
patients and the laboratory model from 3,SS4 patients. Because of missing values on 
some of the variables in the different studies, they used the method of chained 
equations to impute missing data. A total of S%, 13% and 8% of the values were 
imputed ?n the core model, the extended model and the laboratory model 
respectively. For the Internal validation, the area under the ROe was calculated with a 
cross-validation procedure, were each study omitted In turn. The discriminatory ability 
of models for predicting six months unfavourable outcome In the Internal validation 
ranged from 0.66 to 0.87, with the highest discrimination (0.87) reported for the 
extended model to predict mortality when evaluated in one of the observational 
studies. The core and extended models were externally validated in 6,681 patients 
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with moderate or severe TBI from the CRASH trial. The area under the ROC for 
unfavourable outcome was 0.78 and 0.80 for the core and extended model 
respectively. The calibration was poor for all the models when assessed with the 
Hosmer Lemeshow test (p<O.OOl) and graphically. When they restricted their 
validation to' patients from HIC the discrimination did not change but the graphical 
display of the calibration for the extended model to predict six months mortality 
improved. The authors presented a simple score with an accompanying figure and also 
made the models available as a web-based calculator. 
The models developed by the IMPACT study have some aspects In common with those 
that I derived from the CRASH trial. In relation to the variables Included the IMPACT 
core model and my basic model, both included age, pupil reactivity and the GCS 
(although IMPACT models Included the motor component, while mine included total 
GCS). Both CT models included subarachnoid haemorrhage as a predictor. A direct 
comparison of the strength of the association was not possible as the IMPACT study 
reported proportional odds logistical regression and the effect measures are not 
comparable with the one that I reported in this thesis. Importantly for both studies, 
internal and external validation was performed. Finally both studies attempted to make 
the models easily available to doctors worldWide with a web-based calculator and a 
simple paper based format. However, they presented some differences. My models 
were derived from patients from HIC and LMIC while the IMPACT models were derived 
only from patients from high Income countries. Another difference is that the CRASH 
models were derived from a more recent period (1999-2004) in comparison with the 
IMPACT models (1984-1997). Also, the CRASH dataset had very few missing variables, 
while for the IMPACT models Imputation methods were necessary to handle the extent 
of missing data. On the other hand, some of the IMPACT models Included more 
variables which also have been shown to be strong predictors of poor outcome (I.e. 
hypotension, hypoxia, haemoglobin and glycaemia). Finally, a common feature of the 
external validation for both studies was that the discrimination was acceptable but the 
calibration was poor when assessed with the Hosmer-Lemeshow test. 
4.4.3 Strengths and weaknesses of the study 
Among the study's strengths are the use of a well-described Inception cohort of 
patients, prospective and standardised collection of data on prognostic factors, few 
missing data, very low loss to follow-up, and the use of a validated outcome measure 
at a fixed time following the injury. All of these factors provide reassurance about the 
internal validity of the models. The large sample size In relation to the number of 
prognostic variables examined Is also another particular strength. 
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In relation to its external validity, there are only a few prognostic models developed 
from LMIC patients, and to the best of my knowledge the models I have developed are 
the first with a large sample size and adequate methodology.114 The external validation 
confirmed the discriminatory ability of the models in patients from HIC and showed, 
graphically, good calibration for the CT model. Unlike most published prognostiC 
models, my models included the complete spectrum of TBI patients ranging from mild 
to severe. Finally, the data required to make predictions with the model are easily 
available to clinicians, and a web based risk calculator was developed. 
There are some limitations: the data from which the models were developed originate 
from a clinical trial and this could therefore limit Its external validity. For example, the 
patients were recruited within eight hours of Injury and the accuracy of the models for 
patients evaluated beyond this time window cannot be estimated. Nevertheless, the 
CRASH trial was a pragmatic trial that did not require any additional tests and 
therefore included a diversity of 'real life' patients. I did not Include other known or 
potential predictors of poor outcome In TBI patients. Following the conceptual 
framework referred to In chapter 1 (figure 1.1) some of these "missing" variables are 
related to a} the enVironment, for example variables related with quality of care, b} the 
host, for example social class, and c) the condition, for example type of bleeding, such 
as hypotenSion or hypoxia. Unfortunately none of these variables were available In the 
CRASH dataset. However, although these variables have been reported to be 
independent predictors, it has also been shown that they do not add much to the 
performance of prognostic models when most important predictors (age, GCS and 
pupil reactivity) are already in the model. 116 A limitation, common In this type of study 
is related to "self-fulfilling prophecy" bias. All of the variables Included In the model are 
known predictors of poor outcome and It Is possible that physicians changed their 
medical behaviour according to the presence of these variables. For example, an order 
not to resuscitate could be recommended for elderly patients with low GCS therefore 
influencing the association of these variables with poor outcome. 
Another limitation was that I was only able to validate the models from HIC. 
Furthermore, the variables "major extra cranial Injury" and "petechial haemorrhages" 
were excluded, because they were not available in the IMPACT sample. However, 
neither of these variables was among the strongest predictors. The external validation 
showed good discriminatory ability, but this was somewhat lower than In the original 
data. 
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4.4.4 Implications of the study 
I have developed methodologically valid, simple and accurate models that may help 
health care decisions for Individual patients and counselling for relatives and patients. 
It is important to emphasise, however, that whilst prognostic models may complement 
clinical decision making they cannot replace clinical judgement. This Is particularly 
important in the context of judgements regarding the withdrawal of care or clinical 
triage. 
4.4.4.1 Implications for patients In LMIC 
Most of the burden of TBI is in LMIC countries where case fatality Is high and resources 
are limited. I found that several predictors differed in their strength of association with 
outcome according to country income level, suggesting that It may be Inappropriate to 
extrapolate from models based on HIC populatlons to poorer settings. My models 
showed good discrimination and my basic models also show good calibration In this 
setting. 
However, GCS used as a continuous variable demonstrated an acceptable ability' to 
discriminate poor outcome In TBI patients from LMIC. When the discrimination was 
evaluated with categorical GCS, as it is used in clinical practice (I.e. mild, moderate 
and severe), Its discrimination was lower. 
In terms of calibration the models showed a better agreement than total GCS between 
predicted probability and observed outcomes when analysed graphically, In particular 
for those patients with Intermediate risk. 
4.4.4.2 Implications for patients In HIC 
Basic and CT models showed good discrimination and the latter showed the highest 
discrimination of all the models developed. The calibration of the models was good 
when evaluated with the Hosmer-Lemeshow test. Most Importantly, when externally 
evaluated, the models kept an acceptable discriminative ability although the 
calibration, in particular for the basic model, was poorer. 
In HIC both models substantially Increased the discriminatory ability of GCS. The CT 
model in particular showed a very good calibration In the external validation In this 
setti~g. 
4.4.4.3 Other Implications 
These prognostiC models can also help for research purposes such as In the design 
and analysis of clinical trials, through prognostic stratification, or can be used In clinical 
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audit by allowing adjustment for case-mlx.ll In this thesis I focused In the Implications 
of prognostic models for clinical practice, but In the final chapter I will discuss briefly 
some of the potential implications of prognostic models for research. 
4.4.5 Future research 
The differences found between the prognostic models for LMIC and HIC patients are 
important. Although most of the burden of trauma occurs in LMIC, most research takes 
place in HIC.19 My systematic review reported In Chapter 3 found that very few 
prognostic models for TBI were developed In LMIC. 114 More research Is therefore 
needed in LMIC in order to obtain reliable data from these settings. An Improved 
understanding of the differences between these regions might also clarify the 
mechanisms of predictors that are not Immediately obvious when analysing a 
homogeneous population. 
The models were developed and validated throughout a rigorous methodological 
process to ensure their Internal validity. However, for prognostic models to be used 
they need to be user friendly. Research In relation to the different ways for presenting 
the models to physicians Is needed to ensure that the models are practical to use In 
the clinical setting. 
As the models were developed using data from a clinical trial, further prospective 
validation in independent cohorts Is needed to strengthen the generallzability of the 
models. This particularly applies to the models from LMIC which I have been unable to 
validate in an external cohort. 
I acknowledge that the development, validation and presentation of models are some 
of the necessary stages of prognostic models research, but the final challenge Is the 
evaluation of their Impact on patient outcomes.40 One of the problems In relation to the 
impact of risk scores for TBI patients Is related to the lack of treatment 
recommendations according to the baseline risk. However, even In the absence of 
evidence of effective treatments according to baseline risk, the use of risk scores could 
unveil how medical care Is already strongly Influenced by prognosis, although In an 
implicit way. In the final chapter I. will discuss In more detail potential uses of 
prognostic models for TBI patients. 
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Chapter 5 Development of the CRASH score card 
Focus group and survey 
5.1 Introduction 
In Chapter 4 I developed prognostic models based on the CRASH trial cohort of 
traumatic brain injury (TBI) patients to predict mortality at 14 days and unfavourable 
outcome at six months. m The models showed good discrimination and good 
calibration, when measured graphically, for both Internal and external validation. One 
of the major strengths of these models Is that, unlike previous studies, the CRASH 
models Included patients from low and middle Income countries. 
But even a valid prognostic model will not be used if its presentation is Inadequate or 
complicated. Methodological guidelines stress the Importance that prognostic models 
should be easy and simple to use and well accepted by physicians. 36,38 Simplicity of 
presentation is even more relevant In the context of the emergency situation when 
treating patients with TBI. 3 
In the systematic review reported In Chapter 3 I found 102 prognostic models for TBI 
patients but very few of them presented the prognostic model In a simple way.114 Two 
different formats were Identified: Hukkelhoven and collaborators presented a 
numerical score accompanied by a figure. 93 and Signorlnl and collaborators presented a 
nomogram.91 However, none of them Investigated If they were considered practical or 
used appropriately by doctors. 
There are many issues that are Important to consider when developing a simple 
prognostic model, for example: the platform by which they are presented (Internet or 
paper based); the way the risk Is estimated (regression formula or numerical scores); 
the precision with which the estimated probability Is reported (i.e. when using scores 
the exact estimated probability can be obtained using a table, or alternatively an 
approximate estimate can be obtained using different graphs such as score charts or 
nomograms) or whether or not there Is a need to display the confidence Interval of the 
estimated probability. 
The CRASH models are available online. However, to be used In the emergency setting, 
particularly In low and middle Income countries, a practical and simple paper based 
prognostic model is needed. 
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The aim of this study was to develop a practical and easy to use format for the CRASH 
prognostic model that predicts mortality at 14 days for patients from low and middle 
income countries. 
I conducted this study in two phases. In the first phase, focus groups were undertaken 
with the purpose of obtaining information to develop a CRASH score card. In the 
. second phase, a survey was conducted to evaluate if the CRASH score card developed 
in the first phase was used appropriately and whether it was considered "practical" by 
doctors. 
5.2 First phase: Focus groups 
5.2.1 Methods 
Two focus groups were conducted one with Peruvian doctors and a second with Indian 
doctors. 
5.2.1.1 Research Team 
I conducted the focus group in Peru. I am a physician and epidemiologist with 
experience in emergency medicine. I coordinate the CRASH-2 Trial in Latin America. 
No previous relationship existed with the partiCipants. Ian Roberts conducted the focus 
group in India; he is a physician and epidemiologist with experience in emergency 
medicine. He is the principal investigator of the CRASH-2 Trial. No previous 
relationship existed between the interviewer and the partiCipants. 
5.2.1.2 Study design 
5.2.1.2.1 Participant selection 
The partiCipants were selected by convenience. Doctors participating in CRASH-2 
national meetings and with experience in treating TBI patients were asked if they 
would participate in the focus group. There were four partiCipants In each of the focus 
groups. None of the doctors approached refused to partiCipate 
5.2.1.2.2 Setting 
The focus group In Peru took place in the emergency department of Hospital Unanue in 
Lima Peru, and the focus group in India met In a hotel room where the CRASH-2 
national meeting was being held. Only Interviewers and partiCipants were present 
during the focus groups. 
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The participants in Peru were three males and one female, three of them were 
emergency physicians and one a neurosurgeon. The four Indian participants were all 
male and neurosurgeons. 
5.2.1.2.3 Data Collection 
Participants were first asked to sign an informed consent. Then they were Introduced 
to the concept of prognostic models, in particular for TBI patients, and were Informed 
about the CRASH prognostic model. As previously mentioned, based on the systematic 
review of prognostic models for TBI patients, I identified two different formats of 
presentation (score accompanied by a figure, and a nomogram).114 Furthermore, I also 
selected two other formats of presentation used In cardiovascular risk scores that I 
considered could be adapted for TBI patients (a numerical score without figure, and a 
coloured chart) 118,119 We presented physicians with the four different formats and 
explained how they work. (Appendix 5.1) 
We then asked them: In the context of the clinical management of TBI patients, what 
would you use a prognostic score for? 
For each of the formats the following questions were asked: Would you use this 
format? Mention some strengths and/or weaknesses for this format and how would you 
improve it? These questions were only the Initial focus from which to develop a non 
structured discussion. Each focus group discussion was recorded. The duration of the 
focus groups was between 30 and 60 minutes. 
5.2.1.2.4 Analysis 
Transcripts were assessed and data derived from the themes Identified in advance. 
Participant quotations were presented to Illustrate the different themes. 
5.2.2 Result 
5.2.3 The potential role of a prognostic model for the management of TBI 
patients 
Almost all the participants emphasized the Importance of prognostic Information for 
patients with TBI. Two main potential uses were Identified for a prognostic model 
available at the bedside: making treatment decisions and communicating with patients 
or relatives. 
Some of the participants highlighted the importance of prognosis for making 
management decisions, for example one physician said: "'Prognosls Is Important to 
assess if the patient Is recoverable or not to decide what treatment they should 
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receive" this was, according to another physician, particularly Important In the context 
of limited resources where they work, he said: "We have scarce resources so It would 
be good for triage patients to decide for example which patients go to Intensive care. " 
The other main use mentlpned was for communicating with relatives, one physician 
said: "As emergency doctors It Is very useful to provide Information to the relatIves, it 
will give us more support and we would be better covered for potential legal problems" 
Although another physician mentioned that he would prefer to provide a very 
pessimistic prognosis so that if the patient recovered, the relatives would be happy and 
if the patient dies, they have been forewarned. 
5.2.4 Format of the prognostic model 
There was consensus, In both focus groups, that the first presentation (a numerical 
score with an accompanying figure) was preferred. One doctor, summarizing his 
preference said: 
"This Is the best option; It Is clear to calculate at the bedside, graphs are easier" 
Nomograms on the other hand were not well accepted, one physician observed: 
"It Is not very exact and adding up Is complicated" other comments were "Not very 
practical, I don't go with a rulerl" "This requires more time than the previous one""I 
find It difficult" and "it does not look precise" 
The third option, a numerical score without a graph, was In general well accepted but a 
doctor argued that It is not very practical If the score range is large: 
"It is practical and simple because It Is more straightforward than the graph but only If 
the score value Is less than 50 otherwise a graph would be better. " 
Another doctor added: 
"Better with a graph because we are familiar with them" 
Finally the coloured chart was not considered a good option, some of the comments 
regarding this format were: 
"It is nice but less precise" "It will need more training" "the first Impression makes me 
dizzy!" 
Another doctor argued that It will not be very useful: 
"if the number of variables Included In the model Is very large there would be too 
many boxes" 
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There were also some general recommendations to improve the preferred format 
(numerical score plus figure) some of the suggestions were: 
"The line of the figure should be larger and the confidence Interval line It Is not very 
helpfu/!H "It would be easier to Interpret with a squared paper" "definitions of the 
variables used should be Included" 
Among other suggestions some of the respondents recommended that we include 
other variables such as hypotension or hypoxia which they considered to be strong 
predictors of mortality. One doctor expressed the preference to report outcome as 
mortality instead of survival: 
.... If we use the word survival relatives will stick to that no matter how low the 
probability" 
5.3 Second phase: Survey 
5.3.1 Methods 
5.3.1.1 Development of the CRASH score card 
With the information obtained In the first phase and the participant's suggestions I 
developed a CRASH score card which Included a numerical score and accompanying 
figure on a squared paper. 
To develop the CRASH Score, I first needed to adapt the way of Including some 
variables so they can be used In a paper based score. 
Age was included as a categorical variable «40, 40-49, 50-59, 60-69 and >69). Total 
GCS was also Included as a categorical variable (3 to 14). In addition, the same 
variables Included In the CT model for predicting mortality at 14 days were Included 
(pupil reactivity, presence of major extra-cranial Injury and the CT scan results: 
petechial haemorrhages, obliteration of the third ventricle, midline shift, subarachnoid 
haemorrhage and non evacuated haematomas). 
The discrimination of the CRASH Score model (using age and GCS as categorical 
variables) was Similar to the one-reported for the CT model for LMIC reported In 
Chapter 4 (C statistic 0.84 in both). 
For estimating the values corresponding to each category of predictor I ran the CRASH 
Score model and multiplied the predictors' ~ coefficients by 10 and rounded them. For 
example the 13 coefficient for the age categories (40-49, 50-59, 60-69 and >69) were 
0.40, 0.59, 1.10 and 1.77 so after multiplying by 10 their value for the CRASH Score 
were 4, 6, 11 and 18 respectively. 
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In designing the figure, I obtained the predicted probability associated with each 
CRASH score value. For example, a score of 31 corresponds to a probability of 25% of 
morality at 14 days, and a score of 41 to a probability of 50%. 
The CRASH score card presents the value for each category of the predictors and 
includes the figure displaying the predicted probability according to the total score 
obtained by adding the different predictors' values (Figure 5.1). 
For example, if a patient is from Colombia, is 77 years old, has a total GCS of 6, has 
one pupil reactive, no major extra-cranial Injury and a non-evacuated haematoma, the 
CRASH score value would be 47 (18+21+4+4) and would correspond to a probability 
of death of about 62%. 
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Figure 5-1 CRASH score card for predicting mortality in LMIC 
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5.3.1.2 Sample 
I conducted the survey in a convenience sample of doctors participating In the CRASH-
2 Trial who routinely treat TBI patients. The CRASH network consists of approximately 
200 doctors from 36 countries. Doctors who were good recruiters and considered 
communicative by regional coordinators were Identified and selected. A total of 40 
doctors from low and middle income countries were asked to participate. 
5.3.1.3 Data collection 
Physicians received the material (CRASH score card) by post and completed a 
questionnaire (which was available on paper and electronically) (appendix 5.2) 
I first asked the respondents about their demographlcs characteristics (age, sex, 
country of residence) medical related characteristics (speciality, average number of 
TBI patients treated by month). I then presented the physicians with the following 
vignette: "Male aged 52 years who had a road traffic crash; on physical examination 
the total Glasgow Coma Score is 10 and both pupils are reactive. The CT scan shows 
midline shift of 8 mm. The patient does not have a major extra cranial injury" and 
asked them to calculate the CRASH score value and the corresponding probability of 
death according to the CRASH score card. I also presented them the following 
statement "The format of the CRASH Score Card Is practIcal for use In the clinical 
setting" and asked them to answer a Llkert scale 
a) Strongly agree b) Agree c) Neither agree nor disagree d) Disagree e) Strongly 
disagree 
I finally left a space for them to write any further suggestion to Improve the CRASH 
score card. 
The questionnaire was tested on a convenience sample (4 respondents) and written 
comments were obtained regarding the Instructions and the face validity of the 
questionnaire. The questionnaire and the CRASH' score card were translated Into 
Spanish as some of the respondents were Spanish speakers. 
5.3.1.4 Data analysis 
I reported the frequencies of the characteristics of the respondents. The CRASH score 
card uses a figure to display the probability of death, therefore, there would be some 
expected variations on the probability estimated. The correct score for the vignette 
presented was 26 and the corresponding probability of death was 17% but I defined an 
Interval of :t: 2% as acceptable (15-19%). I reported the frequencies of responses for 
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the score, death probability and the different categories of the Llkert scale. I did a 
content analysis of the last open question about how to Improve the CRASH score card. 
5.3.2 Results 
37 out of 40 doctors responded to the survey (92% response rate).Table 5.1 shows 
their general characteristics. 
The average age was 41.8 % 8.2 years. More than half of the respondents were either 
surgeons or neurosurgeons. The doctors were from seventeen different countries from 
Latin America, Africa and Asia. The countries that contributed with the larger number 
of doctors were India, Thailand and Colombia. The median number of TBI patients that 
doctors reported to treat each month was 30. 
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Table 5-1 Characteristics of participants 
Pat ients 
Special itv n (Ofo) Countries n (Ofo) per month n (Ofo) 
Surgery 13 (35) India 6 (16) Less than 10 10 (27) 
Neurosurgery 10 (27) Thailand 6 (16) 10 to 100 19 (51) 
Orthopaedics 4 (11) Colombia 4 (11) >100 8 (23) 
Emergency 3 (8) Mexico 3 (8) 
Anaesthesiology 3 (8) Georgia 2 (5) 
internal medicine 2 (5) Malaysia 2 (5) 
Community Medicine 1 (3) Nigeria 2 (5) 
Paediatrics 1 (3) Peru 2 (5) 
Zambia 2 (5) 
Argentina 1 (3) 
Cameroon 1 (3) 
Ecuador 1 (3) 
Egypt 1 (3) 
Ghana 1 (3) 
Indonesia 1 (3) 
Iran 1 (3) 
Tanzania 1 (3) 
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A total of 34 respondents (92%) correctly calculated a score of 26 and of these 33 
(97%) estimated a death probability that was in the range defined as acceptable (15 -
19%) (Figure 5.2). 
Figure 5-2 Estimated score and probability of death by the 
respondents 
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The three doctors who answered incorrectly obtained the following scores: 27, 30 and 
31. The first two estimated a death probability that were within the range of 
acceptable for the score that they calculated (20% vs. 21 %, 29% vs. 27%) but the 
doctor who calculated a score of 31 estimated a death probability of 26% while the 
correct death probability for that score value was 29%. 
A total of 30 respondents (81%) agreed or totally agreed that the CRASH score card 
was practical 6 were unsure and only one doctor disagreed . 
The last open section allowed the respondent to include comments and suggestions. 
These were some of the positive comments included: "Very practica/!" " .. looks very 
useful and from my point of view might have practical usage in a clinical setting " "1 
think this score card is simple and practical" "It will be useful tool" " .. . liked the way 1 
could show relatives a more objective measure of outcome instead of just giving 
personal opinion" "Completely practical" 
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Some of the recommendations suggested to Improve the CRASH score card were: 
"should instruct when the tlmeframe of the observed parameters be recorded" "Add 
footnote referring to original article" "card should be plastic or laminated for durability" 
"eT Scan Is not routinely available for many patients. Exclusion of Imaglng 
Investigation like er Scan will make the scoring system universally applicable" "eT 
Scans are not available In Resource Limited settings" "eT Scan not readily available In 
al/ settings" Other respondents suggested to Include more variables such as: 
aspiration, heart disease, liver disease, renal disease or diabetes. 
5.4 Discussion 
5.4.1 Main results 
I developed a score card to predict In-hospital mortality for TBI patients which was 
deemed as practical and was appropriately used by the majority of respondents In a 
survey conducted among doctors from low and middle Income countries who routinely 
treat TBI patients. 
The focus groups showed that the main potential two uses of a prognostic model for 
TBI at the bedside are for deCision making and for communicating with relatives. It 
also Identified the numerical score with an accompanying figure as the preferred 
presentation format. Nomogram and coloured chart formats were considered difficult 
to Interpret by the partiCipants. 
The survey allowed Improving the original version of the CRASH score card. Some of 
the partiCipants suggested developing a Similar CRASH score card but without CT scan 
as this Is not always available In poor resource settings. Others suggested Including 
more variables (I.e. hypoxia and hypotension) which they considered to be Important 
predictors. For "clinical acceptability" It Is always desirable to Include variables which 
are considered relevant by doctors. However, In this case these data were not available 
In the CRASH trial so could not be Incorporated. Furthermore, It has been shown that 
hypotenSion and hypoxia are strongly aSSOCiated with poor outcome In crude analysis 
but their relative prognostiC value decreased markedly after adjustment by age, GCS 
and pupil reactivity, predictors which are Included In the CRASH model,116 
5.4.2 Comparison with other studies 
In the previous survey described In Chapter 2 respondents reported that prognostiC 
Information was Important to make treatment decisions and counselling TBI patients 
(or relatlves).120 The studies reported In this chapter, which Included a different sample 
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of doctors, agreed with the previous finding and highlighted the relevance of 
prognostic Information particularly when dealing with limited resources. 
To the best of my knowledge this Is the first study to explore different ways of 
presenting prognostic models to physicians treating TBI. However, research In related 
areas reported similar findings. A qualitative study with general practitioners showed 
that graphical presentation of Information was favoured over numerical Informatlon.121 
Some of the participants referred to the Importance of a negative framing (predict 
mortality Instead of survival) to avoid unrealistic expectations from the relatives. This 
attitude of physicians to give a pessimistic prediction (which means a worse prediction 
than they really believe) when treating critically ill patients has been previously 
reported. 29 
5.4.3 Strengths and weaknesses 
The two phases of this research allowed to complement qualitative and quantitative 
information to better understand the role of prognostic Information In the context of 
emergency treatment of TBI. It also helped to develop a score tailored to the needs of 
doctors, from low and middle Income countries, who routinely treat TBI patients. The 
focus group methodology capitalized the interaction with a peer group to obtain data. 
The survey provided quantitative information about the accuracy of the Implementation 
of this model and the doctor's preferences. One of the strengths Is that I Included 
physicians from low and middle Income countries from all the regions of the world, who 
would be potential users of this score. Finally It should also be highlighted that 
response rate for the survey was high (92%). 
The study Is not free of limitations, the sample was a convenience sample and 
therefore not necessarily representative of doctors from low middle Income countries 
who treat TBI patients. The other limitation is related with the use of a vignette, which 
does not represent real life, so the real accuracy In the emergency situation could be 
lower than the one we reported. However, vignettes have been extensively used In 
different settings as a way of standardizing patient Information. m-m Because the 
respondents knew that this prognostiC models was developed by our group It Is 
possible that a type of "desirability" bias could have been Introduced when assessing 
the practicality of the CRASH score card. Finally, the discrimination reported for the 
CRASH score card applies for the exact estimates of the model but when used by 
doctors, as reported In this chapter, only an approximation of the exact probability 
provided by the model Is obtained. Total GCS has been shown to be highly 
discriminative and It Is possible that the CRASH score card, when used In normal 
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practice, does not add substantial discrimination in comparison to the routine use of 
the GCS by physicians. 
5.4.4 Implications and future research 
I have previously developed prognostic models which have shown good performance 
and are available online. However, to be practical in low and middle income countries 
where internet availability In the emergency room is very unlikely, they should be 
paper based so they can be used at the bedside. I developed a paper based score card 
and showed that doctors from low and middle income countries can use it 
appropriately and that they consider it practical. Nevertheless, a few doctors made 
mistakes which could be avoided when using the web based model. The practicality of 
using the CRASH score card should be further evaluated in a larger sample In a "real 
life" situation and, ideally, future studies should compare the performance of the 
CRASH score card against routine clinical prediction by doctors without the CRASH 
score card. 
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Chapter 6 Association between the Modified Oxford 
Handicap Scale and GOS 
6.1 Introduction 
In evaluating the effectiveness of clinical interventions for TBI two main outcomes are 
commonly evaluated, mortality and disability. 
The Glasgow Outcome Scale (GOS) is the most widely used disability outcome 
measure in randomised controlled trials (RCT) in TBI patients, and is usually completed 
at six months after the injury.12 14 The GOS claSSifies patients into five categories, 
dead, persistent vegetative state, severe disabled, moderate disabled and good 
recovery. There are structured interviews to assess the GOS that have shown to 
increase its reliabllity.11,13 Among the strengths of the GOS, is that it covers all possible 
outcomes, forms clinically meaningful categories and can be completed by patients or 
proxies.16 However, the use of the GOS for research and for clinical practice is not 
without problems. 
A practical problem with the use of six months GOS as an outcome is that it lags 
behind in time, so that it takes time to be available. In the context of RCT In TBI 
patients, Data Monitoring Committees (OMC) do not have an early disability outcome 
and can only use In-hospital mortality and six month GOS, which Is not available for all 
the patients included. If an early measure of disability was on hand that could predict 
long term disability, it might also be potentially useful to inform Interim analysis. 
Another problem with the measurement of the GOS at six months Is that loss to follow-
up is frequent in clinical trials of TBI patients. In a review of 208 clinical trials 
conducted on TBI patients the average loss to follow-up was 19%.14 Large losses to 
follow-up reduce the precision of estimates and may introduce bias. If an early 
outcome measure was available that could predict long term disability, It might be 
useful for dealing with loss to follow-up, which can be considered as a type of missing 
data. Missing data has been defined as; missing completely at random (MCAR), when 
loss to follow-up is not related to any patient characteristics, missing at random (MAR), 
when loss to follow-up Is dependent on patient characteristics for which Information Is 
available, and missing not at random (MNAR), where loss to follow-up depends on 
information that Is not observed even after conditioning on the observed data. Most of 
the techniques for dealing with missing data assume MAR, and use available 
Information to impute missing data. In other words prognostiC models are used to 
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predict, and eventually impute, the missing value. m In the context of TBI if an early 
disability outcome adds predictive Information, to the already known predictors of 
unfavourable outcome at six months, It would be useful for using in Imputation 
methods when dealing with loss to follow-up. 
Finally, most of TBI related death occurs during hospitalisation. So from the patient 
. and relative perspectives, the most Important prognostiC Information, after hospital 
discharge, is related to long term dlsabllity.126 An early and valid predictor of long term 
disability, available at hospital discharge, could be a useful tool for the communication 
among doctors and patients about long term prognosis. 
The CRASH trial presents an opportunity to evaluate the predictive validity of an early 
disability outcome measure, the Modified Oxford Handicap Scale (mOHS), which was 
completed at hospital discharge, and the GOS which was completed at six months after 
hospital discharge. 
The aim of this chapter was to analyze the association between the mOHS and GOS at 
six months. The three specific objectives were 
1) Evaluate the potential uses of the mOHS for Informing DMC 
2) Evaluate the potential use of the mOHS for dealing with loss to follow-up 
3) Evaluate the potential use of the mOHS for communicating with patients and 
relatives at hospital discharge. 
6.2 Methods 
6.2.1 The sample of patients 
Of 10,008 study partiCipants enrolled In the CRASH trial, 99 (1%) had missing data on 
the mOHS, 418 (4.2%) had missing data on the GOS at six months, and 36 (0.3%) 
had missing data for both mOHS and GOS. A further 8 patients were excluded from 
analysis as they had a Glasgow Coma Scale (GCS) score of 15 at randomisation. In 
total 9,447 patients (94, 4%) were available for this analysis. For objective one I used 
all the patients from the sample, while for objectives two and three I based my 
analysis only on survivors at hospital discharge. 
6.2.2 Exposure 
Modified Oxford Handicap Scale (m OHS) 
The mOHS Is the result of various modifications of previous disability scales. In table 
6.1 it is shown that the original source was the Rankln Scale (RS). The RS was 
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developed in Scotland In 1957 to describe recovery in stroke patients at hospital 
discharge.127 In 1988, as part of a study of aspirin in stroke, it was modified and 
renamed to Modified Rankin Scale (mRS). An additional grade (0 no symptoms) was 
added.128 In 1989 the mRS was modified for a study of stroke patients in the 
community, and renamed Oxford Handicap Scale (OHS).129 All three scales have been 
used in different settings, at different times, and administered in a variety of ways.130 
The last column of table 6.1 displays the six categories of the mOHS used in the 
CRASH trial. In relation to the OHS, moderate handicap and moderately severe 
handicap were combined in one, and a further category, death, was added. 
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Table 6-1 Comparison of disability scales 
Modified Oxford 
Modified Rankin Scale 
Oxford Handicap Scale Handicap Scale 
Rankin Scale 1957 1989 as used in the CRASH 
1988 
trial 
No symptoms at all No symptoms No symptoms 
No significant disability : No sign ificant disability 
Minor symptoms that do 
able to carry out all despite symptoms : able 
not interfere with Minor symptoms 
usual duties to carry out all usual 
duties and activities 
lifestyle 
Slight disability: unable 
Minor handicap, 
Sl ight disability : unable symptoms that lead to 
to carry out some 
to carry out all prev ious some restriction in 
previous activities but Some restriction in 
activities but able to lifestyle but do not 
able to look after own lifestyle but independent 
look after own affairs interfere with the 
affairs without 
without assistance patient's capacity to look 
assistance 
after himself 
Moderate handicap, 
Moderate disability: Moderate disability : symptoms that 
requiring some help, but requiring some help, but sig nificantly restrict 
able to walk without able to walk without lifestyle and prevent 
assistance assistance totally independent 
Dependent but not 
existence 
requiring constant 
Moderately severe Moderately severe Moderately severe 
attention 
disability : unable to walk disability : unable to walk handicap, symptoms that 
without aSSistance, and without aSSistance, and clearly prevent 
unable to attend to own unable to attend to own independent existence 
bodi ly needs without bodily needs without though not needing 
assistance assistance constant attention 
Severe disability : Severe disability : 
Severe handicap, totally 
bedridden, incontinent bedridden, incontinent 
dependent patient Fully dependant requiring 
and requiring constant and requiring constant 
requiring constant attention day and night 
nursing care and nursing care and 
attention night and day 
attention attention 
Death 
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6.2.3 Other variables considered in the analysis 
The variables that have been reported to be associated with six month unfavourable 
outcome (as measured with the GOS) in Chapter 4 were also included in some of the 
analysis reported in this chapter. These variables were: age, Glasgow Coma Scale 
(GCS) at randomisation, pupil reactivity, whether the patient sustained a major extra 
cranial injury and computerised tomography (CT) scan results (petechial 
haemorrhages, obliteration of the third ventricle, midline shift, subarachnoid 
haemorrhage and non evacuated haematomas).131 I also analysed income region, high 
income countries (HIC) or low & middle income countries (LMIC), as a potential effect 
modifier of the association between mOHS and GOS. All these variables were defined 
as referred in Chapter 4. 
6.2.4 Outcome 
Unfavourable outcome at six months 
This outcome was defined using the GOS, which was assessed at six months with a 
validated questionnaire that was mailed to patients or their carers, administered by 
telephone interview, or undertaken during a home visit or hospital apPOintment 
(Appendix 4.1).102 GOS was dichotomised as for the analysis in the CRASH trial into 
favourable outcome (good recovery or moderate disability) and unfavourable outcome 
(severe disability or death). I created two further dichotomies: good recovery versus 
other outcomes, and survival versus death. 
6.2.5 Analysis 
I estimated the association between mOHS and 6 month unfavourable outcome 
according to income regions, and conducted a likelihood ratio test to evaluate the 
presence of interaction between Income and mOHS. For descriptive purposes I 
performed a cross-tabulation between the OHS and GOS categories. 
6.2.5.1 Use of the mOHS to Inform DMC 
I evaluated the relationship between mOHS and GOS. Their relation was assessed with 
the Spearman rank correlation coefficient. The validity of all the possible disability 
dichotomies of the mOHS for predicting unfavourable outcome measured with GOS at 
six months was assessed by calculating their sensitivity and speclficity. 
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6.2.5.2 Use of the mOHS for dealing with loss to follow-up 
Because the problem of loss to follow-up occurs after hospitalisation, I conducted this 
analysis only among survivors at hospital discharge. I first fitted a logistic regression 
model to predict unfavourable outcome as defined by GOS (severe disability or death) 
including all the variables which have been already reported to be predictors in 
Chapter 4. This model included age, GCS, pupil reactivity, whether the patient 
sustained a major extra cranial injury and CT scan variables (petechial haemorrhages, 
obliteration of the third ventricle, midline shift, subarachnoid haemorrhage and non 
evacuated haematomas). I then fitted a second model which also Included mOHS. For 
each model I analy~ed its discrimination using the c statistic. For descriptive purposes I 
also reported the crude and adjusted odds ratio for GOS at six months for each of the 
categories of the mOHS. 
6.2.5.3 Use of the mOHS for communicating with relatives and patients 
Among survivors at hospital discharge I estimated the positive predictive value (with 
95% confidence intervals) of each mOHS category for three different outcome defined 
by GOS at six months (good recovery, good recovery or moderate disability and 
survival). 
6.3 Results 
There was not strong evidence of an interaction between mOHS and Income region to 
predict six months unfavourable outcome (p=0.12), so the analysis was performed for 
patients from both HIC and LMIC. 
6.3.1 General characteristics of the population 
Table 6.2 shows a cross tabulation between mOHS at 14 days and GOS at six months 
for the sample Included In the analysis. At 14 days 1,092 (11%) were fully dependent, 
and 1,948 (21%) patients had died. A total of 4,869 patients (50%) were discharged 
with no or minor symptoms, and 1,538 (16%) were with some restriction or dependent 
but without need of constant care. 
At six months, 1,208 (13%) patients were severely disabled, and 2,317 (24%) patients 
had died, while 5,922 (63%) reported to have a good recovery or to be moderately 
disabled. 
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Table 6-2 Cross tabulation between mOHS and GOS 
Glasgow Outcome Scale at six months 
Modified Oxford Handicap Good Moderate Severe 
Death Total 
Scale at 14 days recovery disability disability 
n 0/0 n 0/0 n 0/0 n 0/0 N 
No symptoms 1,910 79 : 334 14 150 6 17 1 : 2,411 
Minor symptoms ; 1,646 67 537 22 233 9 42 2 : 2,458 
Some restriction in lifestyle 354 46 : 246 32 147 19 : 20 3 767 
but independent 
Dependent but not requiring 232 30 273 35 22 1 29 : 45 6 771 
constant attention 
Fully dependent requiring 148 14 : 242 
attention day & night 
22 457 4 2 : 245 22 : 1,092 
Dead 0 0 0 o o 0 1 948 100 : 1948 
Total 4,290 46 : 1,632 17 : 1,208 13 : 2317 24 : 9,477 
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6.3.2 Use of the mOHS Scale to inform DMC 
For evaluating the potential role of the mOHS to inform DMC I analysed the correlation 
among mOHS and GOS and the validity of the different possible dichotomies. The 
mOHS at 14 days and GOS at six months were highly correlated (Spearman rank 
correlation coefficient 0.75). Four dichotomies of disability for the mOHS were 
considered (Table 6.3). The first separated patients with no symptoms from the rest, 
the second considered patients with no or minor symptoms in the baseline group, the 
third included patients with no symptoms, minor symptoms or with some restriction 
(but independent) as the baseline group . Finally the forth dichotomy separated 
patients who were full y dependent or dead, from the rest . 
Table 6-3 Dichotomies of the mOHS 
A B C D 
No Symptoms No No No No 
- -- - ------- . 
Minor Symptoms Yes No No No 
--------- _.-
Some restriction in lifestyle but Yes Yes No No independent 
-------.-- -
Dependent but not requiring constant Yes Yes Yes No 
attention 
----------- -
Fully dependent requiring attention day Yes 
and night Yes Yes Yes 
Dead Yes Yes Yes Yes 
Table 6.4 shows the validity measures for each dichotomy in relation to unfavourable 
outcome as defined by the GOS (severe disability or death). As expected there was a 
trade-off between sensitivity and specificity. The increase in specificity was obtained at 
expense of a decrease in sensitivity 
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Table 6-4 Validity of the mOHS dichotomies for unfavourable 
outcome 
mOHS dichotomy Sensitivity Specificity 
A 95.3 37.9 
B 87.5 74.8 
C 82.7 84.9 
D 75.2 93.4 
6.3 .3 Use of the mOHS for dealing with loss to follow-up 
For evaluating the potential role of the mOHS for dealing with loss to follow-up I 
analysed the incremental predictive ability of the mOHS to the other known predictors 
of unfavourable outcome at six months. 
The c statistic, for predicting unfavourable outcome at six months, for the model 
including age, GCS, pupil reactivity, major extra cranial injury and CT scan variables 
was 0.78 (95% Cl 0.77 -0.80). The c statistic for the model including the previous 
variables plus the mOHS was 0.83 (95% Cl 0.82-0.84). There was strong evidence 
that the discrimination of the model including mOHS was superior to the one without it 
(p <0.001) . The c statistic for mOHS alone was 0.77 (0.78 -0.79). 
In table 6.5 it can be seen that in the crude analysis there was a strong association 
between the mOHS and six months unfavourable outcome, as measured with GOS. 
After adjusting for the other predictors, although there was an attenuation in the effect 
measures, there was still strong evidence of an association between mOHS and GOS. 
Patients who were fully dependent at hospital discharge were thirteen times more 
likely to have an unfavourable outcome at six months, in comparison with those 
patients who were discharged without symptoms. There were no changes in the 
estimates when adjusted for treatment. Figure 6.1 shows that after adjustment there 
was a linear relationship among mOHS and unfavourable outcome. 
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Table 6-5 Crude and adjusted association between mOHS and unfavourable outcome 
Crude Adjusted~ 
95% Cl 95% Cl 
mOHS OR OR 
Lower Upper Lower Upper 
No symptoms 1.0 1.0 
Minor symptoms 1.7 1.4 2 .1 1.6 1.3 2.0 
Some restriction 
in lifestyle but 3.7 3.0 4.7 2.7 2.1 3 .5 
independent 
Dependent but 
not requiring 
constant 7.1 5.7 B.B 4 .7 3 . 7 6 .0 
attention 
Fully dependent 
requiring 24 .1 19.8 29.4 13.3 lOA 16.9 
attention day & 
night 
¥Adjusted by GCS, pupil reactivity, major extra -cranial injury ,age and plus er findings (petechial haemorrhages, obliteration of the third ventricle or 
basal cisterns, subarachnoid bleed, midline shift, non evacuated haematoma) 
137 
Figure 6-1 Relationship between mOHS and unfavourable outcome 
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6.3.4 Use of the mOHS for communicating with relatives and patients 
For evaluating the potential use of the mOHS for communicating with relatives and . 
patients I analysed the predictive ability of each category of the mOHS for different 
. relevant outcomes as defined by GOS at six months. Table 6.6 shows the prediction of 
different disability status, measured with the GOS at six months, according to mOHS 
categories. For example, a patient who was fully dependent at hospital discharge, had 
a probability of approximately 13% of good recovery, 36% of good recovery or 
moderate disability, and 78% of survival at six months. 
139 
Table 6-6 Prediction of GOS according to mOHS categories 
Good recovery or 
Good recovery Moderate disability Survival 
95% CI 95% CI 95%CI 
OHS 0/ 0 Lower Upper 0/0 Lower Upper 0/0 Lower Upper 
No symptoms 79 .2 77.6 80.8 93.1 92.1 94. 1 99 .3 99.0 99.6 
Minor symptoms 67 .0 65.1 68.8 88.8 8 7.6 90.1 98 .3 97.8 98.8 
Some restriction 
in lifestyle but 4 6. 1 42.6 49.7 78 .2 75.3 81.2 9 7 .4 96.3 98.6 
independent 
Dependent but 
not requ iring 
constant 30.1 26.8 33.3 65.5 62.1 68. 9 94.2 92.5 95.8 
attention 
Fully dependent 
requ iring 13.6 11 .5 15.6 35.S 32 .9 38 .6 77.6 75.1 80.0 
attention day & 
night 
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6.4 Discussion 
6.4.1 Principal findings 
I found that the mOHS was highly correlated with GOS at six months. 
Among the different dichotomies of the mOHS explored, the dichotomy that considered 
patients as dead or fully dependent (dichotomy D) was the one with the highest 
specificity in comparison with unfavourable outcome defined by the GOS. 
The mOHS showed to add predictive information to the prognostic models for 
unfavourable outcome at six months which included age GCS, pupil reactivity, major 
extra cranial injury and CT scan variables. 
I reported the predictive ability of the mOHS for different GOS categories at six months 
in a way that could be easily communicate to relatives and patients. 
6.4.2 Comparison with other studies 
The incidence of unfavourable GOS outcome at six months in the CRASH trial cohort 
was lower (37%) than the one reported in the IMPACT study (48%).104 However, 
unlike the CRASH trial, the IMPACT study included only moderate and severe cases. 
The mOHS was first used in the CRASH trial, so this is the first study reporting on the 
predictive validity of this scale ,in relation to GOS at six months. However, a previous 
study reported a good agreement between the Modified Rankin Scale (the scale from 
which the OHS was derived) and the GOS in a trial of stroke patients.m 
6.4.3 Strengths and weaknesses of the study 
To my knowledge this is the first study that evaluated the predictive validity of a 
simple scale for disability at hospital discharge In TBI patients. The main strengths of 
our study Include the large sample size, which ensures precision in our estimates and 
provides some information in an area which is virtually unexplored. 
However, I acknowledge that there are some limitations. Because the main objective 
of the correlation analysis was to evaluate the usefulness of mOHS when GOS Is not 
available, I used all the mOHS categories for this analysis, Including dead patients. 
But, It is self evident that as the GOS also Included dead patients this means that a 
large part of the high correlation observed might be explained by the correlation 
between this category. I repeated the correlation analysis excluding dead patients and 
the Spearman rank correlation coefficient was lower (0.43). This result confirms that in 
terms of disability both scales are not highly correlated. Nevertheless, it is Important to 
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stress that the purpose of this analysis was to evaluate if the early use of the mOHS 
was a practical way to tackle the problem of missing GOS data In the context of RCT of 
TBI patients, and not to evaluate if the scales were correlated In term of disability. In 
fact this finding is not surprising as the scales measure different aspects of disability. 
The mOHS is a very rough scale of disability at the moment of hospital discharge, 
while the GOS measures more subtle levels of functional and psychosocial disability 
when the patients Is already back In his/her usual social life, six months after hospital 
discharge. This difference explains why for example 20% of patients discharged with 
no symptoms according to the mOHS where conSidered with disability when evaluated 
with the GOS six months later. 
The measurement of the mOHS was not conducted with a structured Interview and the 
Inter rater reliability was not assessed. Nevertheless, a good Inter-observer reliability 
has been reported for the original OHS (weighted kappa of 0.72) .129 Furthermore, it is 
possible that some of the investigators who completed the early disability scale also 
completed the GOS questionnaire at 6 months. However, it is unlikely they would 
remember the mOHS result at hospital discharge when completing the GOS 
questionnaire after six months, and furthermore, there are no clear parallel categories 
in the two forms completed. 
In addition, the results of the validity of the mOHS to predict GOS at six months 
reported in this chapter were not externally validated in a different sample of patients. 
Unfortunately, at the time of writing this thesis there is not a TBI patient sample with 
availability of mOHS data at hospital discharge which could be used for validation 
purposes. 
6.4.4 Implications 
6.4.4.1 Use of the mOHS Scale to inform DMC 
DMC dealing with trials of TBI patients usually have data on in-hospital mortality and 
six months GOS for interim analysis. The data for the latter lags behind and is not 
available for all the patients Included. The findings from this chapter In relation to the 
high correlation and validity of the mOHS in comparison with GOS, suggest that the 
mOHS have a potential role providing some additional useful data to the DMC. Among 
the different dichotomies, the one that categorises patients as fully dependent or dead 
against the other categories (dichotomy D) had the higher speclficlty (93.4%), and 
would be the most useful for interim analysis. In my opinion, the additional Information 
provided by the mOHS should only be used for safety rather than for efficacy. I would 
not recommend to claim efficacy for an Intervention based only on the early disability 
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outcome. According to the results from this chapter there are some changes In the 
disability status after hospital discharge and It would not be appropriate to assume 
that the effect on disability at hospital discharge reflects exactly the long term effect. 
However, it is possible that DMC could use mOHS for suspending a trial for safety 
reasons while awaiting the six months disability outcome for all the patients. 
6.4.4.2 Use of the mOHS for dealing with loss to follow-up 
Loss to follow-up is a common problem in RCT involving TBI patients. Ideally trials 
should be designed and carried out in such a way to minimise loss to follow-up, but 
sometimes missing data on outcomes is unavoidable. Different strategies are used to 
deal with missing data. Some' of these strategies, like the parametric imputation 
method, use predictions based on statistical models fitted with variables associated 
with the missing variable. 133 The evidence that the mOHS adds predictive Information 
to the other predictors already identified in this thesis suggests that mOHS is a good 
candidate to be used for such techniques when GOS Is missing. Furthermore, as the 
mOHS is simple to obtain, its application Is very practical In the context of clinical 
trials. 
6.4.4.3 Use of the mOHS for communicating with relatives and patients 
Finally, the positive predictive value of the different categories of mOHS to predict GOS 
at six months could be potentially useful for Informing patients and relatives and give 
doctors a simple way to estimate prognosis at hospital discharge. From the patient and 
relative perspective it might be important to know that approximately lout of 10 
patients who were discharged as fully dependent had a good recovery by six months. 
It could be argued that a prognostic model Including all the predictors has a better 
performance, as measured with the c statistiC, however a simple scale of disability has 
the advantage that it might be easier to use. First, because It uses data available at 
that moment and doctors don't need to rely on admission variables, such as GCS, pupil 
reactivity or CT scans results that could not be easily available at hospital discharge. 
Also it might be easier to remember because of Its face value, as It predicts disability 
at six months based on another disability scale. 
6.4.5 Future research 
The association between mOHS and GOS, and the predictive validity of the mOHS 
should be examined In new cohorts of patients In order to confirm these findings. 
Ideally, new studies should Include measurement of the mOHS at hospital discharge 
and also at 6 months. The analysis of the correlation of the mOHS at these two 
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different pOints in time could further Inform about the usefulness of the mOHS when 
there is loss to follow-up of patients In RCT of TBI patients. 
Simulation studies could evaluate the use of the mOHS for dealing with loss to follow 
up and its potential use for interim analysis. 
Further studies should also explore the needs of prognosis In relation to disability from 
the patients' and relatives' perspectives, and should also evaluate the feasibility and 
practicality of the use of the mOHS for communication with them at hospital discharge. 
Finally, new scales capturing more complex domains of disability, such as cognitive 
function should be devised and evaluated In future studies. 
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Chapter 7 Conclusions 
7.1 Principal Findings 
This thesis has shown that doctors consider prognostic Information to be very 
important in the clinical management of patients with TBI, such as when deciding on 
medical treatment, surgery or withdrawing medical care. However, only a minority of 
clinicians think that they currently predict accurately, and most of them believe that a 
more accurate way of making prognosis, such as a prognostic model, would change 
the way they treat patients and communicate with patients and relatives. 12o 
A systematic review, reported in this theSiS, found that although prognostic models for 
TBI were frequently published, these have many limitations. Most models were 
developed on small samples, many were methodologically flawed, and few were 
validated in external populations. Few were presented in a clinically practical way, nor 
were they developed in populations from low and middle Income countries, where most 
trauma occurs. 114 
In this thesis I also reported the development and validation of prognostic models 
using data from the CRASH trlal.117 These models, derived from a cohort of 10,008 
patients with TBI , overcame many of the limitations from previous prognostic models. 
Two types of models were derived: one using only clinical and demographic variables 
(age, GCS, pupil reactivity, and extracranlal Injury), and the other using the previous 
variables plus er scan results (petechial haemorrhages, obliteration of the third 
ventricle, midline shift, subarachnoid haemorrhage and non evacuated haematomas). 
The outcomes predicted in the models were mortality at 14 days and unfavourable 
outcome at six months, as defined by the GOS. Because some Interactions were 
Identified among predictors and outcomes by Income region, different models were 
developed for HIC and LMIC. All of the models showed good Internal validity. The 
models for HIC were validated in an external sample and showed good discrimination 
and calibration. An important finding was that GCS, measured as a continuous 
variable, had a good discriminative ability, similar to the one reported for the models In 
LMIC. In HIC, GCS showed lower discrimination. One hypothesis for this difference Is 
that in HIC pre-hospltal care Is more common, so when patients arrive they are 
already sedated and so GCS does not only reflect TBI severity but also medical 
sedation. Intracranial bleeding (IB) was shown to be a strong predictor. Because of 
lack of data collected In the CRASH Trial I could not explore further the relationship 
between size if IB and poor outcome. But using a different dataset I explored this 
relationship, see appendix 6. 
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All the models developed are available in a web based calculator. Because Internet 
availability is unlikely in the emergency department in LMIC, a paper based score was 
also developed for this setting. In this thesis I showed that this paper based score, 
named "CRASH score card", was considered practical by doctors, and was used 
correctly by most of them. 
I also showed that the mOHS, which is a simple disability scale obtained at hospital 
discharge, was strongly correlated with GOS at six months.134 The mOHS dichotomy 
that showed the highest specificity in relation to the GOS was the one that separates 
patients dead or fully dependent from the rest (dichotomy D). It was shown that the 
mOHS adds predictive information to the prognostic models reported in Chapter 4. The 
predictive value of each Modified Oxford Handicap Scale (mOHS) category for three 
different outcomes at six months, according to GOS, was also reported. 
7.2 Comparison with other studies 
7.2.1 Doctors' perception about the importance of prognosis for TBI patients 
There have been very few studies assessing the importance of prognosis from the 
perspective of physicians in the context of the care of patients. To the best of my 
knowledge the only previous study in the context of TBI patients was a survey 
conducted more than 20 years ago in a sample of a similar size as the one reported In 
this thesis.85 This survey found similar results, most of the respondents thought that 
prognosis was a frequent practice, and that statistical prediction would Improve the 
way they make predictions. 
7.2.2 Systematic review of prognostic models for TBI 
Previous to the publication of the systematic review reported in Chapter 3, only one 
systematic review had been published addressing the same question. This systematic 
review was more limited as it only included models with early indicators that predict 
mortality or unfavourable outcome defined by GOS in moderate or severe TBI.83 The 
authors found 10 prognostic models and did not attempt to carry out a critical 
appraisal of the models. They evaluated their performance in an external cohort and 
reported that calibration and discrimination was worse than the original measures 
reported. The authors' conclusion emphasized the need for external validation. 
Subsequent to the publication of the systematic review reported in this thesis, a new 
systematiC review was published which was also focused on the methodological 
appraisal of existing models.99 They found 31 models and their conclusions were 
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similar to those reported in this thesis, the most common predictors Included were 
GCS, age and pupil reactivity, models were derived from small samples, they were 
rarely validated, and they do not report adequate measures of performance. 
7.2.3 Prognostic models for TBI patients 
The prognostic models reported in Chapter 4 of this thesis differ from the prognostic 
models included in the systematic review In different ways: Firstly, specific models 
were derived for HIC and LMIC patients. Secondly,' they were derived from the largest 
dataset of TBI patients, so the predictions are more precise. Thirdly, they were 
validated in a large dataset, and finally the models are available both as a web based 
calculator, and as a paper based score, for which practicality and acceptability was 
formally evaluated. To the best of my knowledge, this the first time that the 
presentation of a prognostic model for TBI patients has been evaluated by physicians. 
Subsequent to the publication of the prognostic models reported in this thesis, the 
investigators from the. IMPACT study developed and published similar prognostic 
models for six months mortality and unfavourable outcome.115 Both, the IMPACT study 
and the models reported in this thesis, used large datasets, adequate methodology 
(e.g. discussion of the rationale of the predictors, clear definition of variables, correct 
strategy to build multivariable analysis, adequate handling of missing data). 
Furthermore, both studies reported important aspects such as characteristics of the 
sample, performance of the models so that physicians can make an informed judgment 
about the applicability in their own settings. The IMPACT "core" model and the CRASH 
"basic" model were very similar. Both CT models included subarachnoid haemorrhage 
as a predictor. Importantly, for both studies, an Internal and external validation was 
performed. Finally, both studies made the models easily available with a web based 
calculator and in a simple paper based format. However, one of the strengths of the 
models I developed in this thesis Is that the CRASH models were derived, not only 
from patients from HIC, but also from patients from LMIC. Another Important 
difference is that the CRASH models were derived from a more recent period (1999-
2004) in comparison with the IMPACT models (1984-1997), and that the CRASH 
dataset had very few missing variables, while for the IMPACT models Imputation 
methods were necessary to handle missing data. Another difference was that, unlike 
for the IMPACT chart scores, the practicality of the CRASH Score Card was formally 
evaluated. On the other hand some of the IMPACT models Included more variables that 
have been shown to be strong predictors (I.e. hypotension, hypoxia, haemoglobin and 
glycaemia). Although their added advantage to the more simple models Is limited, It Is 
possible that they add clinical credibility for physicians. Finally, for both studies the 
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discrimination was acceptable when evaluated In the external database but calibration 
was poor when tested with the Hosmer-Lemeshow test. 
7.2.4 Use of the Modified Oxford Handicap Scale 
Because the CRASH trial was the first to used the mOHS at hospital discharge, no 
previous study has assessed its relationship with disability at six months. The only 
study that compared one of the scales from which the mOHS was derived (the Modified 
Rankin Scale) also showed good agreement with the Glasgow Outcome Scale.132 
7.3 Strengths and weaknesses 
7.3.1 Doctors' perception of the Importance of prognosis for TBI patients 
Among the strengths of the survey reported in Chapter 2 of this thesis, it can be 
mentioned that it Included mainly doctors from LMIC where most of the trauma occurs. 
However, the survey has some limitations. For example, it was a small convenience 
sample from a selected group of doctors who participated In the CRASH trial. It Is also 
possible that because respondents were aware of the intention of developing 
prognostic models with the CRASH data, they responded more positively about the 
need for prognostic models, than what they really believe (desirability bias). 
7.3.2 Systematic review 
The systematic review reported in Chapter 3 had several strengths: the Inclusion 
criteria were broad, so studies including patients with all the spectra m of severity and 
predicting all types of outcomes were selected, and a thorough methodological 
description was conducted. However, It was not free of limitations, only studies from 
1990 were included and some prognostic models could have been missed. Finally, 
systematic reviews of prognostic models are still In their Infancy, and therefore there 
are still many methodological challenges, such as, valid search strategies, accepted 
risk of bias framework, or statistical methods to synthesize the results from the 
included studies. 
7.3.3 Prognostic models 
The prognostic models reported In Chapter 4 of this thesis, have many strengths. A 
large inception cohort of patients was used to develop the models; there was a 
prospective and standardized way of collecting exposures and outcomes, and very low 
loss to follow-up and missing data. One of Its major strengths Is that, as far as I am 
aware, It Is the first time prognostic models for patients with TBI from LMIC have been 
developed from a large sample and using adequate methodology. Prognostic models 
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for HIC were externally validated and showed an acceptable discrimination. Another 
strength is that the models are available to clinicians in a web based calculator and as 
a practical paper based score to predict 14 day mortality In low & middle Income 
countries. 
Among the limitations of the prognostic models reported in this thesis is that they were 
derived from a clinical trial and this could Influence the judgment about its external 
validity for some of the users. Some strong predictors were not available, such as 
hypotension and hypoxia. It has been shown that these variables do not add much 
discriminative ability once age, GCS, and pupil reactivity are already In the models. 
However, the clinical acceptability of the models could be influenced by this omission, 
as doctors have expressed their belief that hypotension and hypoxia are important 
predictors. Finally the prognostic models for LMIC were not validated in an external 
cohort of patients. 
7.3.4 Modified Oxford Handicap Scale 
The main strength of the analysis reported in this thesis in relation to the predictive 
ability of the mOHS is that it provides a simple and useful tool in an area largely 
unexplored. The substantial number of patients included in the analysis is a further 
strength. Nevertheless, there are limitations, the mOHS was not used in a structured 
way. In addition, it is possible that some of the investigators who completed the early 
disability scale also completed the GOS questionnaire at 6 months. However, it is 
unlikely they would remember the mOHS result at hospital discharge when completing 
the GOS questionnaire after six months, and furthermore, there are no clear parallel 
categories in the two forms completed. 
7.4 Implications 
7.4.1 Prognostic models 
I developed user-friendly and practical prognostic models which showed good 
performance in internal and external validation and that can be used In the clinical 
setting. 
Although external validity is always a matter of judgement, the fact that these were 
the first models to be developed from a large sample of patients from LMIC, makes 
them more likely to be relevant for this setting. 
According to the results of this thesis, when externally evaluated, the models showed 
better discrimination than calibration. The relevance of the different components of 
accuracy will vary according to the setting where the prognostic model is applied. For 
example, In a setting where physicians need to allocate limited resources they might 
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be more interested in discrimination. While in other settings, where physicians use the 
model to inform patients and relatives, calibration might be more relevant. 
However, two important questions should be answered to establish the clinical 
usefulness of these models. The first question is: Do these prognostic models add 
predictive capacity to clinical prediction? 
In the survey reported in Chapter 2, the doctors Identified as Important predictors the 
variables that were subsequently included into the models. In addition, they reported 
that they frequently use the GC5 to assess prognosis. In LMIC I found that the GC5 
had a very Similar discriminative ability In comparison to the models I developed. So, it 
is possible that doctors, who are already using the main predictors Included in the 
model, can discriminate as accurately as the models reported in this thesis. However, 
it is not clear how doctors combine the difference predictors and transform them into 
probabilities. There is no recommendation on how to do this, and it is likely that there 
is a great variability in this process. 
The second question' is related to the previous one: If the use of the prognostic models 
adds to clinical prediction, does this have an impact on TBI patients' outcomes? 
This question remains unanswered. The main challenge to answer this question is that, 
currently, there is no evidence from randomised trials of effective interventions for the 
management of TBI patients.61 Hopefully, in the future, trials will provide evidence of 
effective interventions for these patients. Randomised clinical trials will provide the 
relative effect of treatment, and with the baseline risk estimated with the prognostic 
models, specific individual recommendations will be able to be derived. This approach 
is useful for clinical practice, so that for any speCific patient, one can judge the absolute 
benefit of a treatment (set against the absolute risk of side effects) and decide whether 
the treatment Is indicated for that particular patient. m 
The hypothetical scenario presented below exemplifies the potential usefulness of this 
approach for the management of patients with TBI. One of the potential targets of 
treatment for TBI patients is lB. As shown In appendix 6 there Is evidence that the 
larger the IB the worse the outcome. There is also some evidence that IB progress 
within the first 24-48 hours, so haemostatic drugs administered in the first hours after 
a TBI could potentially be effective In reducing the progression of IB and therefore 
could be clinically useful. However, as there Is yet no empirical evidence of this 
potential effect, I will assume the following facts for this example: 
Tranexamic acid (TXA), a haemostatic, reduces mortality In TBI patients with a relative 
risk of 0.9 (in comparison to placebo), which Is constant for patients with different 
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baseline risk. Deep venous thrombosis (DVT) is an adverse event associated with TXA 
which is observed in 0.8% of patients, and which is constant for all patients. Table 8 .1 
shows the baseline absolute risk of death, the relative risk of death associated with the 
use of TXA, the absolute risk reduction of death for patients treated with TXA, the 
absolute risk of DVT for patients treated with TXA. For clarity, I also present the 
absolute risk of death and DVT per 1,000 patients treated with TXA. Although the 
judgment about whether or not to use the intervention will depend on different 
circumstances, such as costs, resource constraints and patient values, it is likely that 
for patients with a higher baseline risk the intervention will be recommended, while in 
the low risk group, adverse events might offset the potential benefit . It is important to 
remember that there are two general assumptions that might not hold for all the 
situations and should be confirmed for this approach. The first assumption is that the 
relative reduction of the outcome we want to reduce with the treatment (in this case 
death) is constant for patients with different baseline risk (no evidence of 
interaction).The second assumption is that the adverse event rate (in this case DVT) is 
also constant for all the groups. 
Table 7-1 Risks associated with TXA 
Lives DVT 
saved events 
Baseline Relative Absolute Absolute per per 
risk of risk of risk risk of 1,000 1,000 
death death reduction DVT patients patients 
1% 0.9 0.1% 0.8% 1 8 
30% 0.9 3% 0 .8 % 30 8 
70% 0.9 7% 0 .8% 70 8 
Unfortunately, the current state of knowledge in TBl does not allow to use this 
approach. In a hypothetical future with evidence of effectiveness (and harms) of 
interventions, such an approach could be taken . Meanwhile, even in the absence of 
evidence of effective interventions, physicians still make routine clinical management 
decisions based on their own idiosyncratic way of estimating prognosis. But it is likely 
that the use of prognostic information differs by setting . For example, in the focus 
groups reported in Chapter 5, one of the respondents from Peru mentioned that 
prognostic models would be useful to define the need for intensive care because they 
had very limited resources. The photograph shown in figure 8.1, taken from an 
emergency department in Peru, speaks for itself about the need to make triage 
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decisions, and the potential use of an accurate prognostic model, in the context of 
limited resources. 
Figure 7-1 Emergency department in a hospital in Peru 
Facilities in most high income countries are much more widely available, and the use of 
prognostic information is likely to have different implications. So, as the use of 
prognostic information has different uses in different settings, it is quite difficult to 
assess the overall impact of prognostic models, even if they add to clinical prediction. 
However, it could be argued that if prognostic models are more predictive than clinical 
prediction, they would allow physicians to make better informed decisions . It is also 
possible that the existence of formal tools to assess prognosis will encourage 
physicians to discuss more frequently with patients and relatives about prognosis, and 
perhaps will enhance shared decision making. Ultimately, in my opinion, even 
discussing about prognostic models could make doctors more aware of how much 
prognosis is neglected in clinical practice. Prognosis is generally implicit, non 
systematic and not evidence based, something that nowadays would be unacceptable 
in the context of diagnosis and therapy practice .28 
The prognostic models developed and validated in this thesis represent a step forward, 
as they provide a valid and practical tool for those doctors who are willing to explicitly 
use prognostic information in the context of the management of patients with TB!. This 
implication is backed up by the fact that a recent review article about the management 
of TB! patients published in Lancet Neurology referred to the models included in this 
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thesis as overcoming the limitations, and with greater validity and' generalizability in 
comparison with previous models.4 
Another potential use of prognostic models is in the design and analysis of clinical 
trials. In this thesis I concentrate on prognostic models in the context of clinical 
practice, but there is a large bibliography in relation to the use of prognostic models 
for research. For example, prognostic models could be used to select patients to be 
included in a trial, excluding those patients with very low or very high risk and less 
likely to benefit from any treatment. In addition, some authors suggest that 
adjustment by prognostic models could enhance the precision of the estimates 
increasing the power of clinical trials. 136,137 If these findings are confirmed, it is 
possible that simple pre-specified prognostic models, including the widely accepted 
three predictors (age, GCS and pupil reactivity), could be used when analysing clinical 
trials in TBI. However, if predictors are well balanced among treatment arms, it is 
unlikely that adjusted estimates will differ from the crude estimates. Furthermore, any 
increase in precision should be judged against the drawback of reporting a measure 
(adjusted odds ratio) which, possibly, would be more difficult to interpret and might 
have less acceptance by physicians. 
7.4.2 Modified Oxford Handicap Scale. 
If the findings of the association between the mOHS and the GOS are replicated in a 
different population, then the mOHS could be used to inform interim analysis in 
randomised clinical trials in TBI patients. It could be a useful tool with which provide 
early data on disability while awaiting the six months data on GOS. The mOHS could 
also help tackling the problem of loss to follow-up by being used in imputation 
techniques for dealing with missing data. The fact that this scale is very simple is a 
further advantage as it can be easily collected at hospital discharge. Finally, it could 
also be used as a simple tool to inform patients and relatives about their prognosis at 
hospital discharge. 
7.5 Future research 
7.5.1 Prognostic models 
There are two main aspects that should be further explored in relation to the 
prognostic models reported in this thesis, their validity and their clinical usefulness. 
Validity should be evaluated in other populations, particularly the models from LMIC 
which were not externally validated. The models could subsequently be updated with 
the data of the new patients in the validation study. Two simple methods can be used 
to update the calibration of the models. The first is to adjust the Intercept of the model 
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according to the incidence of the outcome in the new population. The second named 
"logistic recalibration" adjusts the regression coefficients if there is evidence of 
overfitting in the development study.138 To update the discrimination, other methods 
referred as "model revision methods" could be used.138 These include re-estimating the 
regression coefficient for some predictors for which the strength of the association is 
different from the original setting, or adding new predictors not included In the origi nal 
models. 
As discussed above, to determine whether the models are clinically useful there are 
two further questions that should be answered. First, do prognostic model add to 
clinical prediction? The predictive ability of physicians with and without the model 
should be compared in future studies. One difficulty in designing these studies will be 
related to the metrics used to compare their performance. The setting and purpose of 
the prediction will define the relative importance of the accuracy component to be 
evaluated (discrimination or calibration). An additional difficulty is related to the fact 
that although statistical "significance" can be defined for both components, clinical 
"significance" is not easy to define. There are some standard definitions for the c 
statistic as "very good" "good" "acceptable" "poor" but these definitions are arbitrary. 
The calibration measurement is not without difficulties either. In general, it is 
estimated graphically, and statements as "there is evidence of good calibration" are 
always a matter for judgment. The statistical test to evaluate calibration, Hosmer 
Lemeshow test, has also some drawbacks. If the sample is too large the test could be 
"statistically significant" but the difference detected among "observed" and "predicted" 
might not be clinically meaningful. Furthermore, it compares deciles of risk, a concept 
that is not very meaningful to doctors. 
New eVidence about effective treatments may in the future provide meaningful 
threshold of probabilities for which speCific interventions are recommended, and more 
useful metrlcs, such as net reclasslficqtion improvement, could be reported. 
In this scenario, In addition, studies to answer the second important question "Do 
prognostic models improve patients' outcomes?" would be feasible to conduct. Once 
effective interventions become available according to the estimated risk, then impact 
analysis through cluster randomised clinical trials could be conducted. Some could 
argue that randomised clinical trials should be conducted even in the absence of 
effective interventions according to baseline risk. But, in my opinion, the problem with 
this approach is that the "intervention" (I.e. the use of prognostic models) has a 
complex causal pathway between its Implementation and patients' outcomes. It is 
likely that the "uptake" of prognostic models, its interpretation, and the decisions 
made according to the risk estimated will differ from one setting to another. Because 
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there are no clear recommendations according to baseline risk, the use of prognostic 
information implies different actions in different settings, so the effect of the 
"prognostic model strategy" is likely to differ according to the setting. If a randomised 
clinical trial Is conducted to evaluate the impact of prognostic models in TBI it should 
report, not only the main clinical outcomes, mortality and disability, but it should also 
report the effect on intermediate steps, and different outcomes according to the 
setting's priorities (e.g. physician's or patient's satisfaction, cost, etc). This approach 
would allow a better understanding of the impact of the use of prognostiC model in TBI 
in different settings. 
7.S.2 Modified Oxford Handicap Scale 
The simple disability scale at hospital discharge showed good correlation and predictive 
ability In relation to unfavourable outcome, as defined by the GOS. Future research 
could validate these findings and formally assess the potential use of this scale to 
tackle the problem of loss to follow-up in trials including TBI patients. Simulation 
studies using different techniques such as multiple imputation could evaluate this 
apP!'"Oach. In addition the potential use of this scale as an early outcome for interim 
analysis for these trials could also be assessed through simulation studies. Finally, 
future studies could also explore, the practicality and acceptability of using the mOHS 
when communicating with patients at hospital discharge. 
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Appendix 2.1 
Survey of CRASH trial collaborators' 
beliefs, behaviours and attitudes in relation to 
prognosis for head injury patients 
INSTRUCTIONS 
We intend to develop a useful clinical prognostic model for head injury patients. Your answers will 
be very helpful for this. There are no right or wrong answers. 
Please add any other comments on the blank page at the end 
A. What you think about prognosis in your practice 
Please say how much you agree or disagree with the following statements 
For each question, tick one box IiI 
1) I currently assess prognosis for 
head injury patients accurately 
2) Assessing prognosis with an 
accurate prognostic model 
would change the way I 
manage head injury patients 
3) AsseSSing prognosis with an 
accurate prognostic model 
would change the way I tell the 
prognosis to a patient or relative 
Totally 
disagree 
0 
o 
o 
Disagree Unsure 
0 0 
o o 
o o 
Agree 
0 
o 
o 
Totally 
agree 
0 
o 
o 
B. What you do in relation to prognosis In your practice 
For each question, tick one box IiI 
184 
4) Do you use a specific score to 
assess prognosis for head 
injury patients? 
Please specify the names of the 
scores you use: 
Always 
o 
5) Do you record the prognosis for 
head injury patients in their 0 
clinical notes? 
185 
Usually Sometimes 
o o 
o o 
Almost 
Never 
o 
o 
Never 
o 
o 
c. What you would like from a prognosis model 
6) Which outcomes do you consider most Important to predict accurately in head Injury patients? 
For each outcome, tick one box 1iI 
In-hospital death 
6 month death 
Need for surgery 
Need for Intensive Care Unit 
Days of stay in hospital 
Very 
important 
o 
o 
o 
o 
o 
Major disability (e.g. Persistent Vegetative State or 0 
severely disabled - conscious but dependent) 
Minor disability (i.e. independent but disabled) o 
Need for rehabilitation o 
Other (please specify) ................................... . o 
Other (please specify)...... ...... ......... ...... ...... ... . 0 
................................................................... 
7) Which of the following ways of expressing prognosis are useful to you? 
For each option, tick one box (if 
186 
Important Not important 
o o 
o o 
o o 
o o 
o o 
o o 
o o 
o o 
o o 
o o 
Very useful Useful Not useful 
As a percentage (e.g. 90% of survivors at 1 
week) 0 0 0 
Qualitatively (e.g. excellent, good, etc) 0 0 0 
As survival time (e.g. days, weeks, months, 
years) 0 0 0 
Other (please, specify} ................................. 0 0 0 
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8) For which situations do you think an accurate prognosis is important? 
For each situation, tick one box Ii:1 
Very Important Not important 
important 
To decide which patients should receive treatment 
0 0 0 (e.g. hyperventilation, barbiturates, mannitol) 
To decide in which patients treatment should be 0 0 0 
withdrawn 
To decide in which patients CT scan should be 0 0 0 
done 
To decide in which patients intracranial pressure 0 0 0 
should be monitored 
To decide which patients need Intensive Care Unit 0 0 0 
To decide which patients need rehabilitation 0 0 0 
To decide which patients need surgery 0 0 0 
To decide which patients need decompressive 0 0 0 
craniotomy 
To give counselling to patients ancl/or relatives 0 0 0 
Please specify any other important uses that you would have for accurate prognostic 
information in the management of head injury patients: 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 11 •••••••••••••••••••••••••• ·., •• •• ••• • ••••••••••••• , • 
........................................................................................................................... 
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 11 •••••••••••••••••••• ···············,··· ••••••••••••••• 
188 
9) Please specify the most important uses of accurate prognostic information: 
1 
2 
3 
10) Which 3 variables do you consider to be most important for making prognosis for head 
injury patients? 
1 
2 
3 
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11) Which variables do you consider to be important for making prognosis for head injury patients? 
For each variable, tick one box ~ 
Very important Important Not important 
Age 0 0 0 
Gender 0 0 0 
Cause of injury 0 0 0 
Presence of major extracranial injury 0 0 0 
Time since injury to hospital arrival 0 0 0 
Total GCS 0 0 0 
Eye component of the GCS 0 0 0 
Motor component of the GCS 0 0 0 
Verbal component of the GCS 0 0 0 
Pupil reactions 0 0 0 
Presence of complications 0 0 0 
Wound infection 0 0 0 
Gastrointestinal bleeding 0 0 0 
Seizures 0 0 0 
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Pneumonia 0 0 0 
Abnormal CT scan 0 0 0 
One or more petechial haemorrhages within 0 0 0 
the brain 
Obliteration of the third ventricle or basal 0 0 0 
cisterns 
Subarachnoid bleed 0 0 0 
Midline shift over 5mm 0 0 0 
Non evacuated haematoma 0 0 0 
Evacuated haematoma 0 0 0 
Cortical Contusion 0 0 0 
Other, please specify: ............................ 0 0 0 
To help us interpret the results, please answer these 
questions. 
12) What is your age? __ _ 13) What is your gender? 0 Female 0 Male 
14) What is your primary specialty in medicine? 
o Orthopaedic & Trauma 
o Emergency Medicine 
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D Anaesthesiology 
D Intensive Care 
D Neurological Surgery 
D General Surgery 
D Other (please specify) ...... ......................................... . 
15) In which region of the world is your hospital located? 
D Australia & New Zealand . 
D Caribbean 
D East Asia & Pacific 
D Eastern Europe & Central Asia 
D Latin America 
D Middle East & North Africa 
D North America 
o South & Southeast Asia 
o Sub-Saharan Africa 
o Western Europe 
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16) Does your hospital have? 
(Tick aI/ that apply) 
o Intensive Care Unit 
o Computed Tomography 
o Neurosurgery Service 
Any other comment: 
Thank you very much for your collaboration I 
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Appendix 3.1 
Electronic bibliographical data bases and search strategies for the 
systematic review 
Database (time period or version) Search Strategy 
Medline(PUBMED version) [brain Injuries OR traumatic brain Injury 
limit to 1990 - 2005 OR craniocerebral trauma] OR [ "brain 
injuries" OR "Traumatic brain Injury" OR 
"brain Trauma" OR "brain Trauma" Field: 
Embase(OVID version): 
yr=1990-2005 
Title] AND [ braln[tl] OR braln*[tl] OR 
coma[tl] OR consclous*[tl] OR 
cranlo*[tl] OR skull[tl]] AND ["Case-
Control Studles"[MeSH] OR "Cohort 
Studles"[MeSH] OR "Follow-Up 
Studles"[MeSH] OR 
predlct* Field: Title] 
prognos* OR 
1. traumatic brain Injury .mp. or exp 
traumatic brain Injury I or exp 
*traumatlc brain Injury I or brain 
Injur$.tl. 2. (braln$ or brain$ or coma$ 
or consclous$ or cranio$ or skull$).tl. 3. 
1 and 2 
4. (prognos$ or predlct$).mp. 5. 3 and 4 
6. case control study.mp. or (cohort 
study or cohort analysls).mp. or exp 
follow up/ or exp case control study/ or 
follow up.mp. or systematic revlew.mp. 
or trlal.mp. or randoml$.mp. 7. 5 and 6 
8. limit 7 to 
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Appendix 3.3 
Characteristics of the models included in the systematic review 
Study Author Year of Age Severity Objective Outcome Hult/varlab/e N ° of patients 
number publication group analysis Included 
1 chol 1991 nr severe develop GOS CART 555 
2 feldman 1991 nr al validate mortality na 479 
2 fe ldman 1991 nr aN valida te mortality na 131 
3 benzer 1991 all severe validate mortality na 421 
4 zagara 1991 adul ts severe validate mortalit y na 76 
5 vllalta 1992 all severe develop mortality logist ic 173 
6 ross 1992 all se vere validate GOS nD 503 
7 fearnslde 1993 all severe develop mortal ity logistic 315 
7 fearnslde 1993 all severe develop functl onal logistic 315 
8 walder 1995 adults severe validate GOS na 109 
9 temkln 1995 nr all develop fun ctional CART 448 
9 temkln 1995 nr all develop fun ctional CART 448 
9 temk ln 1995 nr all develop fun ctional CART 448 
9 temkln 1995 nr all develop fun ctl onal CART 448 
9 temk ln 1995 nr all develop fun cti onal CART 448 
9 temk in 1995 nr all develop functlonal CART 448 
10 cooke 1995 nr severe validate GOS na 131 
11 mamelak 1996 all severe develop GOS l ogist ic 672 
12 combes 1996 nr severe develop GOS logist ic 198 
13 zafonte 1996 adults all validate functi onal nu 501 
14 lang 1997 all severe develop mortality logist ic 799 
14 lang 1997 all severe develop mortal ity logist ic 799 
14 lang 1997 all severe develop mortality neura l network 799 
14 lang 1997 all severe develop mortality neura l ne twork 799 
15 cho 1997 adu lts all validate mortality na 200 
15 cho 1997 adu lts all validate mortality nu 200 
15 cho 1997 adu lts all validate mortality na 200 
15 cho 1997 adults all validate fun ctional na 200 
15 cho 1997 adu lts all validate mortalit y na 200 
15 cho 1997 adu lts all validate mortal ity na 200 
15 cho 1997 adults all validate mortal ity na 200 
15 cho 1997 adul ts all validate fun ctional na 200 
16 alvarez 1998 adults all validate mortal ity na 247 
16 alvarez 1998 adults all validate mortality nil 247 
16 alvarez 1998 adults all validate mortality na 247 
16 alvarez 1998 adul ts all valida te mortallty_ na 247 
17 l al 1998 adu lts severe validate GOS na 70 
severe and 
18 slgnorlnl 1999 adu lts moderate develop mortal ity logistic 110 
severe and 
19 slgnorlnl 1999 adu lts moderate develop mortal ity I oo_lstIc 372 
20 nlssen 1999 all all validate GOS na 324 
sa kella rop ou I 0 
21 s 1999 nr IV develop GOS bayeslan 525 
22 stuss 2000 adults all develop functional CART 187 
22 stuss 2000 adults all develop functional welbu ll regression 187 
23 sustlc 2000 adults all devel_op mortality no 41 
23 sustlc 2000 adults all devel~ mortality no 4:3 
24 m ukhe rjee 2000 all severe develop GOS logistIC 103 
25 slma 2000 children IV develop er s~n lesion neura l ne twork 
--1Sl 
25 slma 2000 children IV develop er scan lesion logistIC ~ 
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Study Author Year of Age Severity Object i ve Outcome H ul tlvllrl"bl. N ° o( plltlents 
number publication group anll l ysls In lud d 
IIn r dlscrlmln nt 
26 ashwal 2000 children nr develop functional analysis 27 
linear discriminant 
26 ashwal 2000 children nr develop functional !n8lysls 26 
27 lannoo 2000 adu lts severe develop GOS logistic 78 
27 lannoo 2000 adu lts severe develop mortality logiStiC 158 
28 vath 2000 nr severe develop GOS neura l network 95 
28 vath 2000 nr severe develop GOS neura l network 9S 
28 vath 2000 nr severe develop GOS neural network 95 
28 vath 2000 nr severe develop GOS neural network 95 
29 wagner 2000 adu lts all validate functional nu 378 
29 wagner 2000 adults all validate functional ne 378 
29 wagner 2000 adults all validate functional na 378 
29 wagner 2000 adu lts all validate functional na 378 
29 wagner 2000 adults all validate functional na 378 
29 wagner 2000 adu lts all validate functional na 378 
29 wagner 2000 adults all validate functional na 378 
29 wagner 2000 adu lts all validate functional na 378 
30 wagner 2000 adults all validate functional na 378 
30 wagner 2000 adu lts all validate functional na 378 
linear discriminant 
31 adachl 2000 all nr nr GOS analysis 63 
32 schaan 2001 all nr develop GOS not clear 554 
33 schrelber 2002 adults severe develop mortality logistic 368 
34 ratanalert 2002 all severe develop GOS logistic 337 
35 andrews 2002 all all develop GOS CART 124 
35 andrews 2002 all all develop GOS CART 124 
35 andrews 2002 all all develop GOS CART 124 
36 heard 2002 children nr validate mortality na 119 
37 pll lal 2003 adults severe develop GOS 100lstlc 289 
38 tender 2003 all mild develop GOS no 255 
discriminant 
39 brenner 2003 children severe develop functional _a_~81Ysls 22 
linear discriminant 
39 brenner 2003 children severe develop functional ana lysis 22 
diSCriminant 
39 brenner 2003 children severe develop functional analysis 22 
40 cassldl 2003 children all develop functional logistic 3491 
41 bush 2003 adults all validate functional ~ 294 
42 rovllas 2004 adults severe develop GOS CART 345 
43 Ibailez 2004 adults mild develop eT scan lesion log istic 1101 
43 Ibaiiez 2004 adults mild develop eT scan lesion logistic 1101 
43 Ibaiiez 2004 adults mild develop eT scan lesion CART 1101 
43 Ibailez 2004 adu lts mild develop eT scan lesion CART 1101 
severe and 
44 demetrlades 2004 all moderate validate mortality ~ 7764 
45 fabrrl 2004 adults mild develop eT scan le~lon logistic 5578 
neurosurglc I 
45 fabrrl 2004 adu lts mild develop Intervention logistic 5578 
45 fabrrl 2004 adults mild develop GOS log istic 5578 
46 carter 2005 children severe develop GOS ne 102 
47 levln 2005 adults mild develop functional logistic 129 
48 eftekhar 2005 adults all develop mortality 100lstlc 1271 
48 eftekhar 2005 adults all develop mortftllty neural network 1271 
severe and 
49 hsu 2005 all moderate develop GOS neurel netwol It 3345 
50 wechsler 2005 children all develop functional 10glslIC 44 39 
50 wechsler 2005 children all develop functional loglltlc 4439 
severe ana 
51 poon 2005 nr moderate develop GOS logiStiC 68 
severe nd n urosurg le I 
52 hukkelhoven 2005 nr moderate develop Intervention logistic 27,S 
severe and 
52 hukkelhoven 2005 nr moderate develop raised IPC logistic 27~ 
severe and 
53 hukkelhoven 2005 nr moderate develop GOS logiStiC 2269 
severe and 
53 hukkelhoven 2005 nr moderate develop mortality IOlllttlc 2269 
.~UU 
Appendix 4.1 
Questionnaire for six months follow-up to assess 
Glasgow Outcome Scale 
INTERNATIONAL STUDY OF RECOVERY AFTER HEAD INJURY 
These questions are about changes in your lifestyle since your inj ury. They can be answered by 
you, a relative or friend, or by yo u both together . If you have any quesMns about thi s form, please 
contact Phi l Edwards on 020 7958 8112. Please answer each questi on below by ticking one box 
which is true for you 
Your answers will help us Improve the care of people following a head Injury. 
Please "'1"'"" IIIed oul "', I,m,. o Patlenl alone o - , t1end or carer alone o Patlenl a'1d reta"'e, I1end or car .. klget1er 
1. At present, where do you live most of the time? 
o n"""tore o /nhospitat 0 n r .. /denial care 
2. As a result of your injury, do you now need help in the home? 
O No 
O Yes. I need sorre hepil he 
tore, bul nol every day. 
o Yes. I need hep il he "' .... 
every day. 
D l need~il"""' .... , bulnol 
because 01 .... "icry 
3. As a result of your Injury, do you now need help to shop? 
O No 
D yes. I need some hop,bul can 
go n .... local shops on my"""'. 
o Yes I need help n shop e_ 
locally. or cannolshop alal 
D I need hep n shop, bul nol 
becaUSe 01 .... n)cry 
4. As a result of your Injury, do you now need help to travel? 
O No 
D Yes I need sorre hop, bul can 
raYe! locally on my 0UI1 (e.g. by 
IIrangng a taxi) . 
D Yes. I need help n U'o'8l n Ineed~ll t .... " . bul nol 
even locally, or I cannot becaUSe 01 .... "icry. 
Uyetalat l 
5. As a result of your Injury, has there been a change In your ability to work? 
(or to study If you were a student; or to look after your family) 
n No Ves. I sIll work, bul al a re<l.Jced [J Uyallllly 10-'<1, o leyet (e.g. a ch!I"ge t an ~Hl rre I:> D Yes I am t.nabte 1:>-'< al resl1ckld, bul nol because 01 parl-Ume, or a 'Ml;Je" 1eY .. 01 presert. 
.... /n,..-y, or I havo relred 
responsib lily) 
6. As a result of your injUry, has there been a change In your ability 
to take part in social and leisure activities outside home? 
U No 
uy ablly I:> take parI Is o Yes I take part a bll less, bul al leaS! o Ves. ltal<eparl rrllr:nlelS, [l rBSl1cled b some 0,,", 
haI as 01'En. or do I'd take parI al atl reason, not because 01 .... 
iVy· 
7, As a result of your Injury, are there now problems In 
how you get on with friends or relatives? 
DNo o Ves. There ere octastonat LJ Yes There or. tequert or [ J There ere I"obiems b some ~ reascn, not because of problem. (less I1an once a week). ronstanlpr ctll8ms 
..../nklV. 
Thank you lor your help Please relum thIS form I1lhe envelope plovlded 10 Or lan Roberts, 
Inlemabonal Sludy 01 Recovery after Head Inlury, LSHTM, U ..... erslly 01 London, Keppel Sheet London WC I E 7HT 
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Appendix 4.2 
CRASB EARLY OUTCOME FORM ,---- --, Complete at discharge, death in hospital, I Attach I or 14 days after injury whichever occurs first I t reatment I 
Please PRINT clearly and a n swe r EVERY question I pack label here 
1. Hospital name 
2. Patient details o r attach a label with these d etails (fo r 6-month follow-up) 
Family name: 
Given name(s): 
Sex: M 
Add ress: 
Postcode: 
3. Cause of injury: 
F Date of Birth: 
Road traffic accident 
Patient identification no. [If apP"'I""'It) 
NHS number (if appropriate) 
(day/monthlyear) 
Telephone: 
Fall> 2 metres Other: 
4. Outcome (please comp let e questio ns a,b,c and d) 
a. Death Transferred to other Discharged to rehabilitation 
in hospital acute <afe hospital centre or nursing home 
b . Date of death, transfer or dis<harge: 
If t ransferred give consultant name/department, and name of hospital 
c. 
Discharged 
home 
L ______ .J 
St ili in th is 
hospital now 
TIck ,I' one box that best describes the pat ient's head injury·related symptoms now (i.e. at t4 days or prior discharge): 
d. No 
'¥"'ptoms 
Minor 
symptoms 
Dependen~ but not 
requlflng constant anfllUon 
fully depeflden~ rtqUonng 
.tten.1on day MId night 
Dud 
~ 
Q 
VI 
~ 
m 
Z 
m 
o 
Cl 
m 
VI 
l> 
Z 
o 
\11 
m 
> ,... 
~ 
o 
Cl 
m 
~ 
I 
m 
;a 
OLD- - - - - - - - - - - - - - - - - - - - r- - - - - - - - - - - - - - - - - - - -FOLD 
5. Management and complications 6. Head cr scan Yes No If No go to section 7 
(p lease tick .I ONE box on EACH line) 
v". No 
Admit ted to Intensive Care Unit 
If Ves, please write numb~r of days in ICU 
Seizure 
Haematemesls or melaena requiring transfusion 
Wound infection with pus 
Pneumonia treated wi th antibiotics 
Other treatment with antibiotics 
Neurosurgical operation 
Major eXl racranial injury 
7. Trial treatment a) Loading dose: Ves 
Da te of first TIme 
head Cl s<an: I I (24 hrclock) 
Result : (please .I t ick all that apply) 
No 
Midline shift >Smm 
Intracranial ha matoma 
- evacuated 
Intracranial haematoma 
- non-evacuated 
One or more pe t~t"lal ha morrhages w.thln 
the brain 
~~~~,~ c8ra~~Pe~ 
Subarachnoid bleed 
Normal scan 
b) Hours of maintenance dose: hours (1-48) 
Sections 8 and 9 are only requ ired if the pat ient is alive 
8. Reliable contact (Next o f kin o r fr iend) 9. Family doctor 
Name: Name: 
Address: Address: 
Post code: Post code: 
Tel: Tel : 
10. Person completing form (please PRINT): 
Name: Posit ion: Date: 
When complete fold form as indicated, stick together and post to: 
CRASH Co-ordinating Centre, FREEPOST, LON14211, London WC1 N 1 BR OR FAX +44 (0)20 1299 4663 
CRASWOCIlI lOI 
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eT Scan Guidance 
Case 2 Acute subdural haematoma demonstrating midline shift 
Midline shift> Smm 
Intracranial haematoma - non-evacuated 
Cortical contusion> lcm in diameter 
Obliteration of the 3rd ventricle 
•• 
Case 3 Acute subdural haematoma 
Intracranial haematoma - non-evacuated 
Case 4 Acute extradural haematoma 
Intracranial haematoma - non-evacuated 
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appendix 4.3 continuation 
Case 5 Diffuse axonal injury 
One or more petechial haemorrhages within the brain 
Case 6 Cerebral contusion 
Cortical contusion > lcm in diameter 
Obliteration of the third ventricle :The third ventricle is demonstrated well in Case One -
Normal Scan. Here you can see that it is effectively a small cleft with in the brain. If t here is any 
pressure, or swelling of the brain , th is is one of the first structures to disappear on the scan, as 
the walls of the cleft are pushed against each other. It is a sign of increased pressure within the 
head and can either result from a blood clot pressing on the brain, or of swelling of the brain 
itself. 
Midline shift - Greater than Smm : If you look at Case Two, you will see that we have drawn 
the midline using a series of yellow dots . You can do the same thing by using a ruler and joining 
the falx cerebri anteriorly and posteriorly, as labelled in Case One. The third ventricle and the 
septum between the frontal horns of the lateral ventricle should not deviate from the midline at 
all, although there may be slight variations less than Smm . You can use the sca le to t he right 
hand side of each scan to work out if the shift is greater than Smm . 
Intracranial haematoma - Evacuated Often, when you look at a post operative scan , there is 
still residual blood clot. Even though an extradural , or subdural haematoma has been removed, 
one will often see evidence of a blood clot post operatively, wh ich is hopefully much smaller and 
not causing pressure on the brain . It does, however, indicate that there has been evacuation of 
a significant intracranial haematoma . These cases should be classi fi ed as "Intracrania l 
haematoma - Evacuated" 
Intracranial haematoma -Non-evacuated:This refers to blood clot lying either on the surface 
of the brain in the extradural, or subdural space, or, indeed, to haematomas wi t hin the bra in 
substance itself. If these have not been removed surgica lly, then t hey should be classi fi ed as 
non-evacuated . 
One, or more petechial haemorrhages within the brain: This refers to very small 
haemorrhages seen as small, wh ite dots on the scan. Th ey usually occur at the interface 
between grey and white matter (See Case Five) . Other class ical sites are the dorsolateral 
quadrant of the midbrain and also the corpus callosum . They are an ind icator of diffuse axonal 
injury, which is a form of severe primary injury to th e bra in . This usually ca rries qu ite a poor 
prognosis . 
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Score and f igure 
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2 
o 
'CT cl sifi lion I - no .isible inlrxrnnial p;1lhlo@ on CT fio:art; " - midlfle shin 0-5 PlOl, III - cl ~rn 
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Coloured chart 
Cardiovascular Disease Risk Prediction Chart for Pr imary Prevention 
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Appendix 5.2 
Survey about the CRASH score for prognosis In traumatic head Injury 
Instructions 
The CRASH score was developed to estimate prognosis for traumatic head Injury patients. We want it In a 
practical format so it can be used in the clinical setting. Your answers will help this. 
First some things about you 
1) Your age D 
2) Your specialty in medicine 
4) In which country is your hospital located? 
5) About how many patients with head injury do you treat per month? 
Please estimate the CRASH score and probability of death at 14 days for the following patient. 
(Using the CRASH SCore provided) 
Male aged 52 years old who had a road traffic crash; on physical examination the total Glasgow Coma Scale 
is 10 and both pupils are reactive. The er scan shows midline shift of 8 mm. The patient does not have a 
major extra crania/Injury. 
7) What is the CRASH score for this patient? 
6) What is the probability of death at 14 days? 
SO that we know your opinion about the practicality of the CRASH score Card, please say how 
much you agree or disagree with the following statement (tick one box) 
"The format of the CRASH score Is practical for use In the clinical setting" 
Totally 
Agree Unsure Disagree 
Totally 
agree disagree 
0 0 0 0 0 
Finally write any suggestion you have to Improve the CRASH score. 
Thank you very much for your collaborationl 
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Appendix 6 
Prognosis of size of intracranial bleeding in patients with TBI 
Introduction 
Intracranial bleeding (IB) is a common and serious consequence of traumatic brain 
injury (TBI). In the CRASH trial 56% of the patients had at least one IB.63 
IB can be classified according to the location into epidural haemorrhage (EOH), 
subdural haemorrhage (SOH), intraparenchymal haemorrhage (IPH), and subarachnoid 
haemorrhage (SAH). 
A review by the Brain Trauma Foundation found that all types of IB are associated with 
a worse prognosis, with increased in-hospital mortality and disability at six months.139 
In the multivariable analysis reported in Chapter 4 I found that in the CRASH trial SAH 
and non evacuated haematoma were independently associated with a worse outcome 
at 2 weeks and six months.117 
Among all the variables identified in the prognostic models IB is one of the few that 
could be "etiologically" related with the outcome. Furthermore, the increasingly 
recognized fact that IB "evolves" in the first hours after a TBI makes it a potential 
target for interventions. Studies involving repeated CT scanning of patients with TBI 
have found that intracranial bleeding can develop or expand in the first 24-72 hours 
after injury. Oertel and colleagues found that among patients who had their first scan 
within 2 hours of injury, 49% had radiological evidence of progressive bleeding within 
24 hours. 140 More recently Narayan and collaborators showed that approximately 50% 
of IPH expand in the first 72 hours after a TBI.64 Evidence that IB can enlarge following 
TBI has generated interest in potential therapeutic approaches, such as haemostatic 
drugs, that could prevent or decrease the growth of IB.64 If IB enlarges after hospital 
admission, and larger bleeds have a worse prognosis, this would strengthen the 
therapeutic rationale for agents to prevent an increase In the extent of bleeding. 
Although there have been some studies on the association between size of IB and 
prognosis, the empirical evidence Is limited, most studies having small sample sizes 
and restricted populations.74-77 Many of these studies were conducted in one centre 
and a limited set of data were collected; this explains why, although biologically 
plausible, there Is still uncertainty regarding the strength and characteristics of the 
aSSOCiation between size of IB and mortality in TBI patients. 
The CRASH trial did not collect data about the different types and size of IB to study 
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this relationship. Therefore, to further explore this topic I contacted the Trauma Audit 
& Research Network (TARN), a large European trauma registry, which has detailed 
data on EDH, SDH, and IPH, and I set up a collaboration. I designed and wrote the full 
extent of the study included in this appendix. Because of confidentiality aspects 
associated with the database a statistician from TARN conducted the analysis. 
The aim of this chapter was to evaluate the association between the size of IB (EDH, 
SDH and IPH) and mortality and haematoma evacuation In patients with TBI. 
Methods: 
c" 
Sample 
TARN was established in 1989 to benchmark and improve hospital trauma care (using 
case fatality measures). Membership is voluntary and' includes 60% of hospitals 
receiving trauma patients in England and Wales and some hospitals in European 
centres. Data are collected on patients who arrive at hospital alive and meet any of the 
subsequent criteria: 
- Death from injury at any point during admission 
- - Stay in hospital for longer than 3 days 
- Require Intensive or high dependency care 
- Require Inter - hospital transfer for specialist care. 
Patients with isolated closed limb Injuries are excluded, as are patients over 65 years 
with isolated fracture neck of femur or pubic ramus fracture. Data are collated by 
trained staff in participating hospitals and submitted via the TARN Electronic Data 
Collection and Reporting (EDCR) system (ref www.tarn.ac.uk). Each submission is 
checked for conSistency and accuracy by trained coders at the University of 
Manchester. All Injuries are coded using the Abbreviated Injury Scale (AIS) 1998 
Dictionary which allocates each Injury a severity code between 1 (minimal) and 6 
(maximal).141 AIS severity coding Is derived from the precise Injury descriptions given 
by imaging, operative and post mortem reports. 
For this study adult patients, hospitalized between 2001 ~nd 2008, with a Glasgow 
Coma Score (GCS) less than 15 at presentation or any head Injury with AIS severity 
code 3 and above were selected. 
Variables 
Main Exposures 
The extent of Intracranial bleeding was determined from the AIS code. 141 IB was coded 
as epidural (EDH), subdural (SDH), and Intraparenchymal (IPH). Each type was coded 
as absent, present small, present large or present size unspecified, referred as "no 
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further specification" (NFS) in this paper. There are differences In the volume of blood 
that attract "small/large" codes depending on the site of bleeding. (Appendix 6.1) 
There was no data about the size of subarachnoid haemorrhage (SAH). 
Potential confounders 
Potential confounders of the relationship between size of bleeding and patient outcome 
were selected for the multivariable analysis. These variables were: age, GCS, SAH, 
brain contusions, brain swelling, petechial haemorrhages, presence of other brain 
injuries (skull fractures and any brain lesion no further specified), presence of 
extracranial injuries (AIS with severity score >2), and whether or not the patient has 
been treated at a neurosurgical unit (NSU). These variables have previously been 
reported to be associated with poor outcome. 65,115,117,142 
Outcome 
The main outcome was in hospital mortality. 1 also explored the association between 
size of bleeding and evacuation of haematoma. 
Other variables 
Other variables reported for descriptive purposes of the sample were: gender, cause of 
injury (road traffic crash, fall <2 m, fall> 2 m) and Injury Severity Score (155). 155 is 
a summary of the overall severity of anatomical injury for each patlent.143 It has an 
ordinal scale from 1-75 and is derived from the AIS severity scores for each injury. 
Analysis 
Analysis of Age and GCS 
To determine the functional form of the predictors age and GCS in the model, 
fractional polynomials, quadratic and cubic spline and Lowess smoothing were 
explored. 
Conceptual framework of the multivarlable analysis 
Deciding which variables should be considered confounders and which should be 
considered mediators that are on the causal pathway between bleeding and outcome 
requires a conceptual framework. 1 could consider as confounders all variables shown 
to be associated with poor prognosis in TBI such as age, severity of the TBI (as defined 
by GCS), and other CT scan abnormalities. However, some of these variables (I.e .. 
brain swelling and GCS) might be on the causal pathway between bleeding and patient 
outcome. Adjusting for these variables would attenuate a true association between 
bleeding and outcome. Because of the uncertainty In determining which factors are 
confounders and which are on the causal pathway, I analysed the data from two 
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conceptual frameworks in the hope that the two different analyses would provide a 
better understanding of the association between IB and outcome. The first includes all 
potential confounders, the second excludes brain swelling and GCS as these variables 
could be on the causal pathway between IB and patient outcome. 
Statistical approach for the multivariable analysis 
Firstly I reported the crude association for each of the exposures of Interest. Secondly 
for the adjusted models all the potential confounding variables were entered into a 
multivariable logistic regression to analyse their relationship with the outcome. All the 
exposures and the potential confounders for which there was strong evidence for a 
relationship with mortality (p <0.05), were retained in the adjusted models. 
An initial analysis considered no bleeding as the baseline category. Because I was 
interested in quantifying the mortality risk associated with large, as opposed to small 
IB, I also conducted a second analysis evaluating the effect of IB size on mortality 
using small IB as the baseline. 
Results 
General characteristics 
Between 2001 and 2008 18,055 adult patients meeting study Inclusion criteria 
presented to TARN hospitals. In 2,507 (14%) patients the outcome was unknown, In 
1,586 (9%) patients, the GCS was missing. The remaining 13,962 (77%) were used 
for this study. 
Table A6.1 describes the characteristics of the study population. Almost three quarters 
of the patients were male. The median age was 41 years old, the median GCS was 13 
and the median ISS was 18. The most common mechanism of Injury was road traffic 
crashes and in-hospital mortality was 22%. About 46% of patients had some type of 
lB. SDH was the most common type, present In 30% of the patients. EDH, IPH and 
SAH were present In 22% each. The size of IB (either large or small) was reported In 
30% of patients with EOH, In 53% with SOH, and in 27% of patients with IPH. Patients 
with IB were generally older, had more severe TBI (as defined by GCS), and had 
higher In-hospital mortality. Among the different types of IB, patients with EOH were 
the youngest, and those with SAH had the highest In-hospital mortality. Patients with 
IPH were less frequently hospitalized In services with neurosurgery units (NSU). 
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Table A6-1 Characteristics of the population 
All patients EDH SDH IPH SAH No bleeding 
N(%) 13962 (100%) 3140 (22.5%) 4204 (30 .1%) 2990 (21.8%) 3025 (21.7%) 7517 (53.8%) 
NFS 2,185 (70%) 1985 (47% ) 2193 (73%) 
Small NA 536 ( 17%) 1168 (28% ) 321(11%) NA NA 
Large 419 (13% 1051 (25%) 476 (16%) 
Median Age 40 .7 43.4 48.9 47.1 46 .6 37.8 
Male 10229 (73. 3%) 2352 (74.9%) 3050 (72 .5%) 2187 (73.1%) 2257 (74.6%) 5456 (72.6%) 
Female 3733 (26.7%) 788 (25.1%) 1154 (27.5%) 803 (26.9%) 768 (25.4% ) 2061 (27.4%) 
Median GCS 13 11 10 11 8 14 
Median ISS 18 25 25 25 25 13 
RTC 6 125 (43 .9%) 1053 (33.5%) 1337 (3 1.8%) 1025 (34.3%) 1299 (42 .9%) 3756 (50.0%) 
Fall more> 2m 231 2 (1 6 .6%) 753 (24 .0%) 1026 (24.4%) 690 (23.1%) 715 (23 .6%) 892 (11.9%) 
Fall <2m 2706 ( 19.4%) 720 (22.9%) 1119 (26.6%) 763 (25.5%) 561 (1 8.5%) 1238 (16.5%) 
Other 2819 (20.2%) 614 (19.6%) 722 (17 .2%) 512 (17.1%) 450 (1 4.9% ) 1631 (21.7%) 
NSU 6055 (43 .4%) 1617 (51.5%) 2 160 (51.4%) 1356 (45.4%) 1599 (52 .9%) 2704 (36.0%) 
Mortality 3065 (22 .0%) 869 (27.7%) 1380 (32 .8%) 950 (31.8%) 1222 (40 .4%) 1098 (14.6%) 
NA: Not appl icable NFS: No furthe r specified GCS : Glasgow coma scale ISS : Injury severity score RTC : Road traffic crash NSU: Neurosurgica l unit EDH: Epidural 
haemorrhage SDH : Subdural haemorrhage IPH: Intracerebral haemorrhage SAH Subarachnoid haemorrhage 
2 14 
Relationship between age and GCS with mortality 
Figures A6.1 and A6.2 show the fit of the three functional forms to the observed data. 
It can be seen that fractional polynomials (FP) fit the data well for both age and GCS, 
therefore they were included in this wa y in the analysis . For age the optimal fun ctional 
form was the sum of square root age and age, for GCS it was the sum of inverse GCS 
cubed and GCS. 
Figure A6-1 Functional form for age in TARN 
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In-hospital Mortality 
Ta ble A6.2 shows the crude and adjusted effect (odds ratio) for mortality of the 
different types and sizes of lB . 
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Crude analysis 
IS either coded as large or NFS In all locations were associated with an Increased risk 
of mortality In comparison with no bleeding. Large SOH and large IPH were associated 
with a worse prognosis, with an odds ratio (OR) for mortality of 6.30 (95% Cl 5.50-
7.21) and OR 4.19 (95% Cl 3.46-5.06) respectively. Small SOH were the only small 
lesions associated with an increase in mortality. 
Adjusted analysis 
There was strong evidence of an association with mortality for all the potential 
confounder variables (age, GCS, presence of extracranlal Injury, treatment at a NSU, 
brain contusion, brain swelling, petechial haemorrhages, SAH and other brain Injuries) 
so they were all included In the multlvariable model. 
After adjustment for confounding variables, large IS Irrespective of location was 
associated with an Increased risk of mortality. The odds ratio for large SOH was halved 
after adjustment, 3.36 (95% Cl: 2.76-4.08), the odds ratio for large IPH was slightly 
attenuated, 3.10 (95% Cl: 2.38-4.03) and the association between large EOH and 
mortality remained virtually unchanged, 1.85(95% Cl: 1.36-2.51). After excluding GCS 
and brain swelling from the multlvariable analysis (model 2), there was still strong 
evidence of an association between large IS and mortality, with values for the OR that 
were more extreme than those reported In model 1. 
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Table A6-2 Association between haemorrhage size and mortality 
Type of IB Size 
No EOH 
Epidural 
NFS 
haemorrhage 
Small (EOH) 
Large 
No SOH 
Subdural 
NFS 
haemorrhage 
Small (SOH) 
Large 
NoIPH 
Intraparenchymal 
NFS 
haemorrhage 
Small (IPH) 
Large 
Crude odds ratio 
1 
1.77 (1.60-1.96) 
0.57 (0.43-0.74) 
1.61(1.29-2.01) 
1 
1.75 (1.57-1.96) 
1.31 (1.13-1.53) 
6.30 (5.50-7.21) 
1 
1.79 (1.61-1.98) 
0.88 (0.65-1.19 ) 
4.19 (3.46-5.06 ) 
Adjusted odds ratio Adjusted odds ratio 
(mode/l t) (model 2*) 
1 1 
1.28 (0 .84-1.93) 1.27 (0.89-1.83) 
0.67 (0.47-0.95) 0.61 (0.45-0.83) 
1.85 (1.36-2.51) 2.11 (1.62-2.75) 
1 
0.98 (0.71-1.35) 
0.99 (0.81-1.22) 
3.36 (2.76-4.08) 
1 
1.13 (0.75-1.69) 
0.89 (0 .61-1.30) 
3.10 (2.38-4.04) 
1 
1.05 (0 .80-1.40) 
1.21 (1.02-1.44) 
7.09 (6.01-8.37) 
1 
1.40 (0 .98-1.99) 
0.83 (0.60-1.15) 
3.45 (2.74-4.33) 
Variables included in the model: 
t Model 1: Age, GCS, NSU, EDH, SDH, IPH, Bra in contUSion , Swelling , Petechial, SAH, Other brain injuries, Extracrania1 injuries. 
:l: Model 2 : Age, NSU, EDH, SDH, IPH, Bra in contusion, Petechial, Penetrating, SAH, Other brain inju ries, Extracranial injuries . 
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Evacuation of haematoma 
Table A6.3 shows the crude and adjusted effect (odds ratio) for haematoma evacuation 
of the different types, and size, of lB. 
Crude analysis 
IB from all the locations and from all the categories (large, small and NFS) were 
associated with an Increased risk of evacuation, except for small IPH. EOH and SOH 
showed the largest odds ratio (22.6 and 13.7 respectively). 
Adjusted analysis 
After adjusting for all the potential confounding variables, there was an Increased risk 
of haematoma evacuation for both SOH and EOH. The magnitude of the association 
was larger for large haematomas, intermediate for those coded as NFS and smallest 
for the small ones. The odds ratio for large EOH and SOH were, respectively, 25.58 
{95% CI:18.80-34.81} and 15.47 (95% Cl: 11.88-20.13). After multivarlate analysis 
none of the categories of IPH remained positively associated with evacuation. Similar 
results were obtained when excluding GCS and brain swelling from the multlvarlable 
adjustment. 
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Table A6-3 Association between haemorrhage size and haematoma evacuation 
Type of 18 
Epidural 
haemorrhage 
(EDH) 
Subdural 
haemorrhage 
(SDH) 
Intraparenchymal 
haemorrhage 
(IPH) 
Size 
No EDH 
NFS 
Small 
Large 
NoSDH 
NFS 
Small 
Large 
No IPH 
NFS 
Small 
Large 
Crude odds ratio 
1 
4.69 (4.02-5.49) 
3.96 (2.98-5.20) 
22.56 (18.05-28.16) 
1 
6.43 (5.40 -7.65) 
3.96 (3.14-4.98) 
13.70 (11.40-16.47) 
1 
3.54 (3.07-4.08) 
0.82 (0.44-1.40) 
1.91 (1.36-2.63) 
Adjusted odds ratio 
(modellt) 
1 
2.78 (1.75-4.44) 
2.99 (2.15-4.20) 
25.58 (18.80-34 .81) 
1 
5.58 (3.78-8.25) 
3 .29 (2.50-4.33) 
15.47 (1 1.88-20.13) 
1 
0.58 0.36-0.95) 
0.617 (0 .31-1.22 ) 
0.91 (0.57-1.44) 
Variables included in the model : 
Adjusted odds ratio 
(model 2:1) 
1 
2.95 (1.85-4.70) 
3.08 (2.22-4.27) 
28.87 (21.27-39.20) 
1 
5.77 (3.91-8.50) 
3.59 (2.73-4.72) 
19.40 (15.07-24.97) 
1 
0.58 (0.36-0 .95) 
0.66 (0.34-1.29) 
1.04 (0 .66-1.63) 
t Model 1: Age, GCS, NSU, EDH,SDH,IPH, Brain contusion, Swelling, Petechial, SAH, Other bra in injuries, Extracranial injuries. 
:j: Model 2 : Age, NSU, EOH, SOH, IPH, Brain contus ion, Petechial, SAH, Other brain injuries, Extracranial injuries . 
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Comparison between large and small haemorrhages 
In table A6.4 it is shown that large 16, wherever the location, were associated with an 
increased risk of mortality in comparison with small 16 lesions. After adjusting for 
potential confounders, (model 1) the odds ratio for mortality was 2.86 (95% Cl: 1.86-
4.38) for large EOH, 3.41 (95% Cl: 2.68-4.33) for large SOH and 3.47 (95% Cl: 2.26-
5.33) for large IPH. Patients with EOH coded as NFS had an odds ratio for mortality of 
1.89 (95% Cl: 1.20-2.99) in comparison with those with small EOH. Patients with no 
EOH showed an Increase risk in comparison with those patients with a small EOH. 
There was no strong evidence of Increased risk of mortality for those patients with SOH 
or IPH coded as NFS when compared with patients with corresponding lesions coded as 
small. 
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Table A6-4 Comparison between large and small haemorrhages 
Type of IB 
Epidural 
haemorrhage 
(EDH) 
Subdural 
haemorrhage 
(SDH) 
Intraparenchymal 
haemorrhage 
(IPH) 
Size 
Small 
No EOH 
NFS 
Large 
Small 
No SOH 
NFS 
Large 
Small 
NoIPH 
NFS 
Large 
Adjusted odds ratio t 
1 
1.49 (1.05 - 2 .12) 
1.89 (1.20 -2.99) 
2 .86 (1.86 - 4 .38) 
1 
1.07 (0 .85 - 1.35) 
0 .99 (0 .72 - 1.37) 
3.41 (2 .68 - 4 .33) 
1 
1.23 (0 .84 - 1.80) 
1.39 (0 .84 - 2.28) 
3.47 (2.26 - 5.33) 
Variab les included in the model : t Age, GCS, NSU, EOH, SOH, IPH, 
Brain contusion, Swell ing, Petechia l, SAH, Other brain, Extracranial injuries. 
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Discussion 
General findings 
This analysis of over 13,000 patients with TBI showed that patients with a large EOH, 
SOH or IPH have a substantially higher mortality than patients with either no bleeding 
or a small bleed in the same location. Even after adjusting for other potential 
confounding variables, such as age, GCS, extracranial injuries and Cl findings, large 
bleeds substantially Increased the probability of death. Patients with large IPH or large 
SOH had more than a threefold Increase in mortality odds in comparison with patients 
with small IB in the same location, while large EOH showed more than a doubling in 
mortality odds in comparison with patients with small EOH. Small IBs were not 
associated with an increase In mortality after adjustment for other potentially 
confounding variables. Patients with IB coded as NFS had generally a risk which was 
intermediate between that reported for patients with large IB and the one reported for 
patients with small lB. Patients with no EOH had a higher risk of mortality In 
comparison with patients small EOH. This finding although counterlntultive has been 
previously reported. 104 In the analysis reported in this appendix I adjusted for other 
type of IB as I considered them potential confounders. However, because of the large 
amount of misSing data in relation to size of IB it is very likely that there Is residual 
confounding. This means that those patients coded as no EOH could stili have some 
type of IB not recorded In the TARN database. Other explanations for this paradoxical 
finding could be related to other potential confounders not recorded In the TARN 
database. For, example the presence of small EPH could be related to a certain 
mechanism of TBI which has a better prognosis than the mechanism seen In patients 
who do not have an EPH, such as those with diffuse axonal Injury, a Cl scan result not 
recorded In this dataset. 
Comparison with previous studies 
These results are conSistent, but more preCise, than those of previous studies showing 
that IB Is associated with Increased mortality. There has not been any systematiC 
review describing the association between size of IB and prognosis In TBI but a 
comprehensive review has been reported In the Guideline for the Surgical Management 
of Traumatic Brain InJury".112 In this guideline bleeding size is taken Into account to 
recommend surgical evacuation. However, the evidence presented In the guideline Is 
very limited. For EOH they reported 18 studies with a median of 67 patients Included In 
each (range: 11 to 200), seven of the studies evaluated the effect of size, and only 
three reported a positive association between size and poor outcome. In relation to 
SOH there were 21 studies and the median number of patients was also 67 (range 15· 
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211), five reported on the effect of size, and only two reported a positive association 
between size and poor outcome. For IPH 51 studies were reported, with a median of 
35 patients included (range 8-1,107), and only five reported a positive association 
between size and poor outcome. 
Strengths and weaknesses 
The strength of this analysis is that it included more than 13,000 patients with 
traumatic brain injury, and so the precision of the estimates of the risk aSSOCiated with 
IS is high. I also adjusted for most of the relevant potential confounding variables. 
One limitation of this analysis is that for a large proportion of patients it was not 
reported whether their IS was small or large. These patients, with IS size coded as 
NFS, presented intermediate risk between patients with small and large lesions. The 
large proportion of patients with missing data on size of bleeding makes the results 
presented in this appendix of limited value and further studies with more complete 
data should be carried out to confirm the reported associations. 
Another limitation is the potential of residual confounding. Although I adjusted for 
known confounders, it is possible that some of them were measured In a limited way 
or other confounding variables may have remained unaccounted for. For example, I did 
not have information on pupil reactivity which has been shown to be an Important 
prognostic factor. A further limitation is that I had no continuous measurements of the 
size of the bleeding, nor did I analyse the timing of the CT scan. 
Finally, 23% of the patients who fulfilled the Inclusion criteria were excluded because 
either their outcome was unknown or there was lack of data on GCS. This Is a potential 
cause of selection bias and could have Influenced the effect estimates obtained In this 
study. Selection bias In this context would have occurred If the relationship between 
size of IS and mortality In the excluded patients was different from the one observed In 
the sample analysed. Although there are no evident reasons for such a difference this 
cannot be ruled out and should be considered as a limitation of this study. 
Implications of this study 
Patients with TSI and large Intracranial bleeds have a substantially worse outcome 
than patients with either no bleeding or a small bleed. There Is evidence from other 
studies that bleeds enlarge In the first 24-72 hours after Injury. This raises the 
possibility that Interventions· to prevent the enlargement of Intracranial bleeds could 
Improve patient outcome. 
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Future research 
However, it is possible that some of the Increased risk of death associated with having 
large rather than small IS found In this study Is due to bias or confounding. Therefore, 
the effect on mortality of Interventions that reduce the extent of Intracranial bleeding 
would need to be established in randomlsed controlled trials. 
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Appendix 6.1 
AIS 1990 revision, update 1998 
Small EDH 
Cerebellum S ·30ee 
Cerebrum S sOmls 
Small SDH 
Cerebellum S 30ec 
Cerebrum S sOee 
Small IPH 
Cerebellum (Slscc; or 3em diameter) 
Cerebral S 30ce; S 4cm diameter 
Large EDH 
Cerebellum >30cc, > 2cm diameter/ thick, massive / extenSive, bilateral 
Bilateral cerebral 
Cerebral> 50 cc, > lcm thick, massive / extensive 
Large SDH 
Cerebellar> 30cc, > 2cm dlameter/ thick, massive /extenslve, bilateral 
Bilateral cerebral 
Cerebral > 50 cc, > lcm thick, massive / extensive 
Large IPH 
Cerebellar> lscc; >3cm diameter, bilateral 
Bilateral cerebral 
Cerebral> 30cc / 4cm diameter 
EDH NFS 
Epidural haematoma (haemorrhage) to cerebellum not further specified 
Cerebrum epidural I haematoma/haemorrhage not further specified, 
SDH NFS 
Cerebellar subdural haematoma not further specified 
Cerebrum subdural haematoma not further specified 
IPH NFS 
Intracerebellar Including petechial and subcortical haematoma (haemorrhage) not 
further specified 
Cerebrum intracerebral haematoma not further specified 
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Introduction 
Head injury is an important cause of death and disability world-
wide with most of the burden in low- and middle-income coun-
tries. Accurate information on prognosis has the potential to 
improve clinical decisions in patients with head injury [1]. Prog-
nostic models are statistical models that combine two or more 
items of patient data to predict clinical outcome. Some studies 
have shown that correctly interpreted prognostic models can be 
more reliable than clinical judgement [2]. We conducted a survey 
among doctors who routinely treat patients with head injury to 
assess their needs in relation to prognostic information. 
Participants, methods and results 
The sampling frame for the survey was all doctors participating in 
the final results meeting of a large-scale international multi-centre 
clinical trial in head injury [3]. Of the 67 doctors attending, 60 
completed the study questionnaire. Prior to the meeting, the crite-
rion and face validity of the questionnaire was assessed in a 
convenience sample of doctors treating head injury (not included 
in the final sample). The questionnaire was translated into Spanish 
for the one quarter of respondents who were Spanish speakers. The 
main specialities of the respondents were intensive care (34% of 
respondents) and neurosurgery (32%). Most doctors worked in 
low- and middle-income countries: 25% from Latin America and 
the Caribbean, 20% from Africa, 19% from Southeast Asia and 9% 
from Eastern Europe and Central Asia; while 27% were from 
Western Europe. Most worked in hospitals with intensive care, 
computed tomography and neurosurgical facilities. 
The outcome considered most important to predict was in-
hospital mortality (73%); the most favoured way of expressing the 
prognosis was probability of the outcome (97%) followed by a 
qualitative scale (82%) or as survival time (77%). 
The majority (85%) reported routinely using a score to assess 
prognosis, of which the summated Glasgow Coma Scale was the 
most popular used by three quarters of the doctors. In relation to 
individual prognostic variables, 80% of doctors felt that the motor 
component of the Glasgow Coma Scale was very important. Other 
variables identified as very important were pupil\ary reaction 
(80%) and a midline shift greater than 5 mm on the CT scan 
(88%). 
Although most doctors routinely used a score to assess progno-
sis, only 37% agreed that they currently assess prognosis accu-
rately. The majority (67%) reported that a more accurate 
prognostic model would change the way that they manage patients 
and the way that they currently tell the prognosis to a patient's 
relative (88%), Accurate prognostic information was considered to 
be very important for a number of clinical decisions, including the 
need to undertake a decompressive craniotomy, who should 
receive intensive care, and in which patients treatment should be 
withdrawn (see Table I). 
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Table 1 Doctors' opinions in relation to the situations for which accurate prognostic information is important (n. 60) 
Situations 
To decide which patients need decompressive craniotomy 
To decide which patients need intensive Care Unit 
To decide which patients should receive treatment 
(e.g. hyperventilation. barbiturates. mannitol) 
To give counselling to patients and/or relatives 
To decide in which patients treatment should be withdrawn 
To decide in which patients intracranial pressure should be monitored 
To decide which patients need surgery 
To decide in which patients CT scan should be done 
To decide which patients need rehabilitation 
Comments 
Doctors around the world make important decisions about the care 
of patients with head injury, including the decision to withdraw 
care, based on judgments about prognosis. More widespread use of 
accurate methods of assessing prognosis such as statistical progno-
sis models may improve clinical management in head injury. 
A key strength of our survey is that it includes doctors treating 
head-injured patients from diverse regions of the world, mainly 
from developing countries, where the major burden of head injury 
occurs. The response rate was high at 90%. 
A previous survey of 59 neurosurgeons [4] showed that two-
thirds of them thought that computer predictions would be helpful 
in the clinical management of patients with head injury. Twenty 
years later, it appears that there is still demand for accurate prog-
nostic information. Although there has been a systematic review of 
individual prognostic factors in head injury [5], such an approach 
is lacking for prognostic models. A systematic and critical appraisal 
of existing prognostic models would enable doctors to know which 
of the available models are accurate and clinically useful. 
C 2007 The Authors. Joumal compilation C 2007 Blackwell Publishing Ltd 
Very important (%) Important (%) Not important (%) 
61 27 12 
60 26 14 
55 26 19 
54 37 9 
52 34 14 
50 40 10 
49 32 19 
19 49 32 
14 53 33 
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Abstract 
Background: Traumatic brain injury (TBI) is a leading cause of death and disability world-wide. 
The ability to accurately predict patient outcome after TBI has an Important role In clinical practice 
and research. Prognostic models are statistical models that combine two or more Items of patient 
data to predict clinical outcome. They may Improve predictions In TBI patients. Multiple prognostiC 
models for TBI have accumulated for decades but none of them Is widely used In clinical practice. 
The objective of this systematic review Is to critically assess existing prognostic models for TBI 
Methods: Studies that combine at least two variables to predict any outcome In patients with TBI 
were searched in PUBMED and EMBASE. Two reviewers Independently examined titles, abstracts 
and assessed whether each met the pre-defined Inclusion criteria. 
Results: A total of 53 reports Including 102 models were Identified. Almost half (47%) were 
derived from adult patients. Three quarters of the models Included less than 500 patients. Most of 
the models (93%) were from high Income countries populatlons. Logistic regression was the most 
common analytical strategy to derived models (47%). In relation to the quality of the derivation 
models (n:66), only 15% reported less than 10% pf loss to follow-up, 68% did not Justify the 
rationale to Include the predictors, I I % conducted an external validation and only 19% of the 
logistiC models presented the results In a clinically user-friendly way 
Conclusion: Prognostic models are frequently published but they are developed from small 
samples of patients, their methodological quality Is poor and they are rarely validated on external 
populations. Furthermore, they are not clinically practical as they are not presented to physicians 
In a user-friendly way. Finally because only a few are developed using populatlons from low and 
middle Income countries, where most of trauma occurs, the generallzability to these settln, Is 
limited. 
Background 
Traumatic brain injury (TBI) is a leading cause of death 
and disability worldwide. Every year, an estimated 1.5 
million people die and hundreds of miIlions require 
emergency treatment after a TBI. Fatality rates and disabil-
ity rates vary depending on the severity and mechanisms 
of the TBI but unfavourable outcomes (death, vegetative 
state and severe disability) following TBI can be higher 
than 20%11,2). 
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Physicians routinely make diagnostic and therapeutic 
decisions based on the patient's prognosis. Furthermore, 
prognostic information is also important in the counsel-
ling of patients and relatives in this critical scenario. Nev-
ertheless in general, physicians believe that their 
predictions are inaccurate. A survey of doctors about prog-
nosis in TBI found that only 37% thought that they cur-
rently assess prognosis accuratelY(3). 
Prognostic models are statistical models that combine two 
or more items of patient data to predict clinical outcome. 
They may improve predictions in TBI patients. Some stud-
ies have shown that they are more reliable than what doc-
tors can foretell (4). A study conducted with TBI patients 
demonstrated that the introduction of a computer-based 
outcome prediction influenced patient management, with 
a higher use of resources in those patients with better 
prognosis (5). 
Prognostic models could also be used in the design and 
analysis ofRandomized Controlled Trials (RCTs). RCTs in 
TBI patients face many difficulties. Trauma is one of the 
most neglected research topics worldwide with a paucity 
of resources invested in RCTs [6]. Furthermore, unfamili-
arity with issues of informed consent in unconscious 
patients pose further obstacles in this clinical setting (7). 
Because of these barriers RCT in TBI are generally under-
powered. A review of published RCTs in this area found 
that the average size was 82 participants per trial and no 
trial was large enough to detect reliably a S% absolute 
reduction in risk (8). Prognostic models have been pro-
posed as a way to improve the power in TBI and stroke 
clinical trials [9,10]. With one such approach TBI patients' 
outcomes are defined taking account their baseline prog-
nosis, instead of using the usual Glasgow Outcome Scale 
dichotomized in favourable or unfavourable. 
Prognostic models can also assist in clinical audit by 
allowing adjustment for case-mix (11,12]. 
Multiple prognostic models for TBI have accumulated for 
decades but none of them is widely used in clinical prac-
tice. For a prognostic model to be clinically useful it 
should fulfil two requirements: it must be clinically valid 
and methodologically valid (13). Systematic reviews of 
prognostic models in different areas of medical care have 
shown that models often fail in these two aspects [14,15). 
Previous reviews of prognostic studies in TBI have only 
focused on individual predictors or have been restricted to 
prognostic models of some type of traumatic brain injury 
or outcome. So far, there has not been any comprehensive 
systematic review of prognostic models in traumatic brain 
injury [16,17). It has then become increasingly important 
to identify and evaluate prognostic models in TBI 
patients. 
http:/twww.biomedcentral.comI1472-694716138 
Objective 
Our objectives were 
(a) identify prognostic models in traumatic brain injury 
(b) describe their characteristics 
(c) investigate their quality and 
(d) described the models that were validated in an exter-
nal population. 
Methods 
TYfHI of studle. 
We included studies that gave an overall prognostic esti-
mation combining the predictive information from at 
least two variables. Studies could develop new prognostic 
models (derivation studies) or evaluate previous ones 
(validation studies). Studies conducted prior to 1990 were 
excluded because patient management and diagnostic 
techniques may have changed since this time. Studies that 
investigate more than one variable but do not combine 
them for obtaining a prediction were excluded. 
Type of expo.ure. 
Only variables that were collected before hospital dis-
charge were considered as predictors. Glasgow Coma 
Scale (GCS) was considered as one predictor variable. 
TYfHI of partIcipants 
Patients of any age with any type or severity of traumatic 
brain injury. 
TYfHI of outcome mea.ure. 
Studies that predict any outcome in traumatic brain injury 
patient (i.e. neurological impairment, disability, survival, 
etc.). There was no time restriction for the evaluation of 
the outcomes. 
Search .trateD for Identification of studle. C ... Additional fI'. '1 
The reference lists of included studies were inspected for 
further possible studies meeting the inclusion criteria. A 
forward search (citing references in the Web of Knowl-
edge) was conducted with selected seminal papers and 
some of the citing papers, not found by the database 
search, were inspected for relevance and possible inclu-
sion. All records were converted into an Endnote data-
base. 
Trial Identification and selection 
Two reviewers (PP & PE) independently examined titles, 
abstracts and keywords of records from electronic data-
bases, for eligibility. The full text of all potentially relevant 
records was obtained and two reviewers (PP & PE) inde-
Page 2 of 10 
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pendently assessed whether each met the pre-defin d 
inclusion criteria. Disagreement was resolved by a third 
reviewer CIR). 
Quality assessment 
Quality assessment scores for controlled dinical trials and 
diagnostic studies have been criticized 118,191. The main 
problem with quality scores is to determine the weight 
that each item should provide to the overall score. The 
abundance of quality scores shows that there is no con-
sensus on this issue. Instead, a component approach 
appraisa l allows one to evaluate each methodologi al 
aspect. Depending on the question and the study design 
some components may be more relevan t than others (e.g. 
with a surgical intervention blinding of the patient and 
caregiver would be unachievable) 
In studies of prognostic models in particular, although 
diverse quality assessment cri teria have been proposed, 
there is none widely accepted 114,20-22). We analyzed the 
quali ty of the prognostic models included in this system-
atic review considering two main domains: 
a) Internal validity. This refers to the systemati ITor of 
the study and is rela ted to study de ign, variables and 
analysis strategy. 
b) External validity or generalizability. This refers to the 
extrapolation of the study to other settings. For making 
judgments about generalisabil ity it is important to con-
sider the characteristics of the sample from which th 
model was derived, the clear presentation of the results 
and finally the model should, ideally, be evaluated (vali -
dated) in a different sample from the original. 
Taking into account these two domain ,18 qu stions wer 
considered for each of the models in lud d 1 Addi-
tional file 2). 
We restricted the quality assessment to th derivation 
studies. 
Performance of models externally validated 
We reported the performance of mod Is that were vali-
dated in an externa l sample. W consid r d as externally 
validated those models that wer reported by the author 
as evaluated in a different cohort of TB I pati nts from th 
derivation set. 
Data extraction 
One reviewer (PP) extracted the information from each 
study for assessing the quality of r porting in ad1 of th 
questions. 
http://www.blomedcentrl .com/14 72-694 7/6/38 
Results 
A total of 3354 r ord w r id ntin d. ACt r r < ding 11 
th r ords 92 r ports w r id ntifi d and r ,d in full. 
Thirty nin w r exdud d for th ~ 11 win 
analyz d individual pr di tor but did not ombin th m 
in a singl s or, iglu did not in lud in-hospital pr di -
tors, six indud d pati nts without tr um ti br, in injury, 
five w r not original r earch ( .g. di us ion, I tt r) and 
in two th obj tiv was not t valu t pr gno i in TBI 
pati nts. (Figur 1) 
The r maining 5 r ports d rib d 102 progn ti mod-
els [s Additional file I. 
General characteristics of the prognostic mod Is [see 
AddItIonal file 4} 
Population induded 
Almo t half (47%) of th mod I w r d riv d from an 
adu lt population, 12% w r d riv d fr m a hild popula-
tion while 2 1 % w r d riv d from a popul tion 1.h t 
in lud d both adu lts and childr n . In 21 % of th m d I 
it was not I arly r port d from whid1 popul tion th y 
wer d rived. 
In r lation to th v rity of lh TBI studi d, forty fiv 
mod Is (44%) in lud d , 11 gr d of v riry, thirty on 
(30%) in lud d s v r TBl, nin (9%) m d rat or s v r 
TBI, nin (9%) mild TBI nd in ight (8%) th s v rity of 
TBT wa not I arly report d. 
Figure I 
J 11 (),./~ UNu/''l J IHlh\'4/IMtI ",...,lIc Id" 
• 8 JiJ 1t.}I ININJ I" IN. ",W' ,.,.tJ"'hI~ 
• 6 btrl"tlNl !H,'I ",. k UIfo.H41 TBI 
• j .. N fHU urlsiltu/ f ,.,,(It 
• 1 I1t4 uhjrtthw ~d "d/M rM lu" or 
,,,,-,IUid,, U I"" ',.rut", ,... .. 401 
ofll of I'tporl.llarlwdrd: 53 
Study selection process for th syst m tic r vi w of prog-
nostic models in head injury. 
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A median of319 patients (range 22-7764 patients) were 
included per model. Three quarters included less than 500 
patients. 
A total of ninety five models (930/0) included populations 
from high income countries, five (50/0) included popula-
tions from middle income countries and in two (20/0) the 
population was from a low income country. 
Objectives 
Most of the models reported (65%), were derived for the 
first time (derivation models) while in 35% the models 
reported were validating pre-existing models (validation 
models). The majority of the validation models (29 out of 
35) validated general trauma score. The remaining 6 mod-
els validated specific TBI prognostic score. One validation 
model was reported as a letter and information was lim-
ited. Three models validated prognostic scores that were 
developed before 1990. 
Variables Included as predictors 
A total of 89 variables were included in the prognostic 
models. A mean of 5 variables were included in each 
model (range 2 to 13). GCS was the most common pre-
dictor included in the models,(50%) followed by age 
(46%) and pupil reactivity (26%). Overall clinical varia-
bles were included in 66% of the models, demographic 
variables were included as predictors in 50% of the mod-
els, er scan predictors were used in 190/0 of the models 
and 7% included variables related to characteristics of the 
injury. In 7% of the models other predictors were 
included (e.g. other complementary tests or existing 
scores). 
Outcomes 
Mortality was the main outcome in 30% of the models 
and GOS in 28%. Other functional outcomes were 
reported in 31 % of the models. The presence of a er scan 
lesion was the main outcome in 7%, the need of neurosur-
gical intervention in 2% and raised intracranial pressure 
in 1%. 
Analysis 
In the multivariate analysis for the development of prog-
nostic models (n:66) logistic regression was used in 31 
( 4 7%) models. Regression tree analysis was reported in 14 
(21%) and neural networks in nine (13%). Other meth-
ods of analysis were performed in nine (14%) models 
while in one (2%) it was not clear and in three (5%) no 
multivariable analysis was performed. 
Quality assessment (table I J 
We restricted the quality assessment to the 66 derivation 
models. Some of the quality assessment items could only 
be applied to logistic regression models. 
http://www.biomedcentral.comI1472-694716138 
InternGl validity 
In over half of the models loss to follow-up was not 
reported;15% reported an adequate loss to follow-up (less 
than 100/0). 
Most of the models (68%) did not include a discussion 
about the rationale to include the predictors in the model. 
A detailed description of the measurement of the predic-
tors was absent in 82% of the models. In one third of the 
models the validity of the outcome measures was not 
reported. 
In relation to the analysis of those that used multivariate 
logistic regression, stepwise was the most common 
approach (81%). Interactions were examined in 13% of 
the models. Predictor variables were analyzed as continu-
ous in 19% of the models. A third (29%) of the models 
included at least 10 events per variable analyzed as predic-
tor. The most common strategy to handle missing data 
was exclusion of observations (550/0). 
External Validity 
The sample was described in almost all the models (830/0). 
The procedure to obtain the score was explained in 
approximately half of the models (56%), however in 
those that used logistic regression only 19% included a 
user-friendly presentation. 
In relation to the performance of the models, discrimina-
tion was reported in 580/0 of the models through the area 
under the receive operator curve (A.U.R.O.C.), 44% of 
which included the respective confidence interval. Cali-
bration was reported with the Homer-Lemeshow test in 
27% of the models. Almost half the models(56%) 
reported their overall accuracy. 
Less than half of the models (38%) were validated, of 
which 11 % were validated in an external population. 
None of the models was evaluated prospectively in a ran-
domized clinical trial to assess the effect in clinical prac-
tice. 
aescrlpt/on of externally validated models 
Seven models were developed and also reported an exter-
nal validation (table 2). Two other models were valida-
tion of pre-existing models. 
PilIai et al. developed a prognostic model to predict unfa-
vourable outcome (death or vegetative state) at one 
month (23). They developed the model in a cohort of289 
patients and validated the model in 26 patients from the 
same centre. The predictor variables were oculocephalic 
reflex, motor score of the GCS and midline shift score. In 
the validation set they reported sensitivity (750/0), specifi-
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Table I: Quality assessment of prognostic models 
INTERNAL VALIDITY All models Loflstlc ""/'Inion OI/Ier anottm 
N:66 N:JI N:3S 
STUDV 
Loss to follow-up 
<10% 10 (15%) 5 (16%) 5 (14%) 
>10% 19 (29%) 7 (23%) 12 (34%) 
Not reported 37 (5''') 19(61%) 18 (52%) 
VARIABLES 
Discussion about predictors 
Yes 21(32") 11 (35") 10(2'%) 
No 45(68") 20 (65") 25 (71%) 
Description of measurement of predictors 
Yes 12 (18") 8 (26") 3 (9%) 
No 54 (82%) 23(74") 32(91") 
Validity of outcome reported 
Yes 31 (47%) 14 (45%) 17(4''') 
No 20 (30%) 7 (23") 13 (37%) 
Not applicable 15(23%) 10 (32") 5 (14%) 
Handling of missing data 
Estimated statistically 4 (''') 4 (13") 0 
Excluded 36(55") 16(52") 20 (57%) 
Not reported 26(39%) 11 (35%) 15 (43%) 
ANALYSIS 
MultiYariable analysis Stepwise 
Baclcwards 12 (39%) NlA 
Forwards 3 (IOX) 
Noc specified 10 (32%) 
Noc reported 5 (16") 
Other I (3") 
Interactions examined 
Yes 4 (13") 
Not reported 27(87%) 
Handling of predictors variables 
Continuous 6(19%) 
Categorical 16 (52") 
Not clear 9 (29%) 
More chan 10 evenU per variable 
Yes 9(29%) 
No 16 (52") 
Not reported 6(19%) 
EXTERNAL VALIDITY All models I.o&istlc regression Oth,ranalysll 
Description of the sample 
Yes SS (83") 28 (90%) 27 (77") 
No 11(17%) 3 (IOX) 8 (23") 
Presentallon of the prognostic mod.1 
Normogram I (I") I (3") 0 
Simplified score 8 (12%) 4 (13") 4 (11") 
Figure Il (2OX) I (3") 12 (34") 
Regression fannull is (23") 12(39%) 3(9%) 
Not explained 29 (44") 13(42") 16 (46") 
r 
EXTERNAL VALIDITY AI models Loptlc ""/'Inion OIhe,a~ 
N:66 N:31 N:3S 
Perfonnance reported A.U.C (Dllcrimlnatlon) 
Yes 18 (58%) NA 
No 13(42") 
C.I. presented 8 out of 18 (44") 
H.L (Calibration) 
Ye. 7 (23") NA 
No 23(74") 
Other I (3%) 
Overall accuracy 
Ye. 37 (56") 15 (*") 22 (63") 
No 29 (44") 16 (52") 13 (17%) 
Validation 
Yes 25 (38%) 17 (55") 8 (23") 
External 7 (/I") 7 (23") 0 
No 41 (62") 14 (45") 27 (77%) 
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'& Author Derivation sample Validation sample Predictors Outcomes Performance in the Presentation of a <0 a. 
~ validation sample simplified score CD co 0>0 
N as "" 
..... 
Il.!! 
~ 'U 
..... 
... 
E PiIIai et aL 208 patients from India with severe TBI 26 patients from the same centre l-oculocephalic reflex Dead! or vegetative state Sensitivity (7S%~ No ~ 2-motorGCS Specificity (67% (; ~ 3-mid1ine shift co PPV 50% ~ 
! .Q 
-
~ C Signorini et aI 3n patients from Scotland with 520 patients from the same centre I-GCS Survival at I year A.U.R.O.C (0.835) Nomogram co ~ moderate and severe TBI 2..JSS Error rate (15.2%) 8-
"0 3-pupils reactivity and So CD Brier score (0.1160) 
E +haematoma (CT scan) Hosmer-Lemeshow 
0 (p < 0.001) 
i Signorini ec aI 110 patients from Scotland with 140 patients from the same centre I-GCS Survival at I year Not reported No moderate and severe TBI 2..JSS 
t 3-pupi1s reactivity and +haematoma (CT scan) §..ICP measures 
HukkeIhoven et aL 114 patients from Netherlands with ISO patients from the same centre l-age Raised ICP A.U.R.O.C. (0.50) No 
moderate and severe TBI 2-m0t0rGCS Hosmer-l.emeshow 
)..pupils reactivity (p = 0.18) 
4-pupiIIary size 
~tension 
IX) HukkeIhoven ec aL 275 patients from Netherlands with 2SO patients from the same centre l-age Surgical removable lesions A.U.R.O.c. (0.67) No CO') 
ID moderate and severe TBI 2-cause of injury Hosmer-l.emeshow J-pupiIs reactivity (p = 0.01) 
8 4-pupiIIary size 
0 ~sion 
N 
01 
~ HukkeIhoven ec aL 2269 patients from 2 U"iaIs in high income 796 patients from Europe l-age Deadl or disability at 6 A.U.R.O.c. (0.83) Score chart ~ counIries with moderate and severe TBI 2-rnotorGCS months Hosmer-l.emeshow 
c: ~xiareaaivity (p = 0.05) 
.Q 
~ 7-subanochnoid haemorrhage 
"0 
C 
-~ HukkeIhoven ec aL 2269 patients from 2 U"iaIs in high income 796 patients from Europe and 74& l-age Deadl at 6 months A.U.R.O.c. (0.87/0.89) Score chart counIries with moderate and severe TBI from the United States 2-.orGCS HOSI1*"-l.emeshow 
-
~ reactivity (p = 0."21<0.001) ~ ~~ S 
iD 7-subanochnoid haemorrhage 
.s.! 
~ 
0 
~ (Q 
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city (67%), predictive value of unfavourable outcome 
(50%), predictive value of favourable outcome (86%), 
percentage offalse optimistic results (25%), and percent-
age of false pessimistic results (33%). They did not report 
the model's performance measured in the derivation set. 
Confidence intervals of the estimates were not reported. 
Although the authors reported how to calculate the pre-
diction score, they did not present it in a user-friendly 
fashion. 
Signorini et al. developed two prognostic models, for one 
they used only clinical variables and for the other they 
added variables on secondary insults. (24,25] In both 
models the outcome was survival at 1 year. The first model 
was validated in 520 patients who attended the same cen-
tre. The predictors were age, GCS, ISS, pupils reactivity 
and presence of haematoma on the er scan. They 
reported measures of discrimination: A.U.R.O.C. (0.835), 
error rate (15.2%) and calibration: brier score (0.1160), 
Hosmer-Lemeshow (p < 0.0001). They included a graph 
with the 95% confidence interval of the calibration of the 
model. The second model was validated in 140 patients 
who attended the same centre. The predictor variables 
were the same as the first model plus ICP measures. 
Although they mentioned that brier score, error rate, 
A.U.R.O.C were higher than the original dataset they did 
not report the actual estimates. They reported a normo-
gram to predict probability of survival that is user-friendly 
for physicians. 
Hukkelhoven et al. reported four different models 
(26,27). The outcomes were: raised intracranial pressure 
(ICP), surgically removable lesions (SRL), unfavourable 
outcome (death, vegetative state or severe disability) and 
mortality at six months. For the validation of the first two 
outcomes they use an historical (previous) sample of 205 
patients from the same centre. The predictors for ICP were 
age, motor score, pupil size, pupillary reactivity, hypoten-
sion and ISS. For SRL the predictors were the same except 
for motor score which was not, and cause of injury that 
was added. For unfavourable outcome they used one data-
base and for mortality two databases, none of these data-
bases were related with the popUlation of the derivation 
set. The predictor variables were age, gender, cause of 
injury, pupil reactivity, hypotension, hypoxia, er classifi-
cation and traumatic subarchnoid haemorrhage They 
reported the models discrimination: A.ll.R.O.C. of 0.50 
(95% Cl 0.41-0.58), 0.67 (95% Cl 0.60-0.75) and 0.83 
(95% Cl 0.80-0.86) for ICP, SRL, unfavourable outcome 
and mortality respectively. They also reported the model 
calibration: Hosmer-Lemeshow goodness of fit test of 
0.18, 0.01,0.05 and 0.42 «0.001), for ICP, SRL, unfa-
vourable outcome and mortality respectively (the calibra-
tion of the mortality model was validated in two different 
http://www.blomedcentral.comI1472-694716138 
databases). They presented the model as a score chart to 
facilitate its use in clinical practice. 
Bush et al. validated a model previously developed by the 
same group (28]. Their model was intended to allow bet-
ter understanding of factors influencing functional out-
comes and was not intended to predict individual 
outcomes. It was not clearly reported whether the patients 
came from the same original population. They used path 
analysis to evaluate the predictors (functional status, 
injury severity and cognitive status) on functional out-
comes (disability rating scale, community integration 
questionnaire and return to employment). The reported 
difference indexes of goodness of fit that showed that the 
originally model fitted better than the validation model. 
They did not report any discrimination measures. 
Benzer et al. validated a model that used an existing scale, 
although they did not provide details of when and how it 
was developed (29]. They did not use any kind of muIti-
variable analysis. The used a score based in the following 
variables : reaction to acoustic stimuli, reaction to pain, 
body posture, eye opening, pupil size, pupil response to 
light, position and movements of eyeballs and oral 
automatisms to predict mortality at 21 days. They did not 
report any performance measure, but just the chi square 
test for survival of those with low versus high score. They 
presented the score in a user-friendly way. 
Discussion 
This systematic review shows that although publications 
of prognostic models for TBI patients are very frequent 
their quality is relatively poor. In addition they are rarely 
validated on external populations or presented to physi-
cians in a friendly way. Furthermore, only a few are devel-
oped using populations from low and middle income 
countries where most trauma occurs. 
Patients from all severity spectra were investigated but 
prognostic models for moderate and severe TBI patients 
were more frequent. It is noteworthy that only 2% of the 
models included patients from low income countries tak-
ing into account that 90% of trauma occur in these coun-
tries. Although biologically prognostic factors should be 
the same worldwide, is reasonable to consider that the 
strength of the association could differ depending on the 
medical care received. This difference could affect the 
accuracy of the prognostic models in different settings. 
Although there is no data about this, an ongoing project 
analysing the MRC CRASH Trial Cohort is exploring this 
issue. 
GCS, age and pupil reactivity were the most common var-
iables analyzed as predictors whereas, G.O.S. and mortal-
ity were the most common outcomes investigated. 
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Multiple logistic regression was the multivariable analysis 
most frequently used. 
We found several limitations in the quality of the models. 
The majority did not include a thorough discussion of the 
rationale for including the predictor variables. Only a 
minority had a loss to follow-up ofless than 10%. This is 
potentially an important limitation as the loss to follow-
up could be related to prognosis and this could lead to 
biased results. Furthermore only four models handle 
appropriately the missing data with statistical imputation. 
In relation to the multivariable analysis, automatic proce-
dures (stepwise) were quite common in logistic regres-
sion. There is no agreement in relation to the 
appropriateness of this strategy. This is shown, for exam-
, pie, in conflict recommendations in quality assessment 
for prognostic studies; while in one study the use of step-
. wise was considered as good quality in other it was con-
sidered as an indicator of a fatal flaw (30). One of the 
limitations we found was that most of the studies did not 
explicitly consider clinical criteria to enter the variables in 
the model beyond the automatic procedures. Interactions 
were hardly ever explored although this is strongly recom-
mended in multivariable analysis (31). Another common 
weakness in the logistic regression models was the lack of 
power of the models, as only one third included at least 
10 events per variable. It has been proposed that this is the 
minimum ratio of events to variables which is large 
enough to allow an adequate precision of the estimates 
(31). 
We did not attempt to obtain an overall quality assess-
ment and instead we evaluated its different components, 
this approach makes a cross comparison between differ-
ent analytical strategies difficult because, for example 
many of the criteria only apply to logistic regression anal-
ysis. 
It is also important to report how well the model works 
and for this performance measures should be reported. 
Remarkably only two thirds reported a measure of dis-
crimination and only one fifth a measure of calibration. 
This is of particular concern considering that calibration is 
the most important performance measure for the applica-
tion of the models in clinical practice (32). Even when a 
discrimination measure was reported, less than half pre-
sented confidence intervals to provide readers an estima-
tion of the precision. 
For a model to be generalizable to other populations it is 
very important to conduct an external validation (32). 
Only seven models (three reports) developed and vali-
dated a model but in only one of them the validation was 
performed on patients of a different centre. Those models 
that considered mortality as an outcome found A.U.R.O.C 
http:/twww.biomedcentral.comI1472-694716138 
that were higher than 0.70 which is considered as excel-
lent discrimination. However the discrimination for the 
other outcomes were not as good. Furthermore, the cali-
bration measures were low in all the outcomes consid-
ered. 
Finally, to be useful, the method to estimate prognosis 
should be clearly reported and, to be clinically practical, 
they should be user-friendly. In only half of the models 
was it clearly explained how to obtain the prognostic score 
and in only one tenth was it reported in such a way that 
could be easily applicable in a clinical setting. 
From all of the models found in our systematic review we 
consider that those developed by Hukkelhoven et al. and 
Signorini et al. are the most clinical useful for patients 
from high income countries with moderate and severe 
TBI, as they fulfilled the majority of the methodological 
requirements and showed an acceptable performance in 
the external validation, furthermore they are available in 
a user-friendly way (27,25). 
We acknowledge some limitations in our study. Firstly, we 
only included studies that explicitly combined at least two 
predictors, in doing so we could have missed some reports 
that used multivariable to analyze individual predictors 
and did not report in the abstract the overall estimation 
although they included the estimate in the full report. Sec-
ondly, we did not include studies that assessed clinical 
predictor rules for which although they considered more 
than one variable they did not combine them. We consid-
ered that the methodological framework to assess such 
studies is fundamentally different from prognostic mod-
els. Thirdly, we restricted our search to 1990 onwards so, 
we could have missed some relevant prognostic models 
published prior to that date. However because of changes 
in management and diagnostic technology in recent years 
we doubt that prognostic models previous to 1990 could 
be useful for the current medical care of TBI patients. 
Finally, another limitation of this paper is that we did not 
describe the time of prediction assessment of the prognos-
tic models. Although we acknowledge that this informa-
tion can be clinically very useful unfortunately this data 
was seldom available in the reports. 
To our knowledge there has been only one previous sys-
tematic review of prognostic models in TBI (17). They 
found 10 reports, all of which were identified in our sys-
tematic review. They validated four of these reports (6 
models) in four series of patients. Discrimina-
tion(A.U.R.O.C.) in the validation series ranged from 0.70 
to 0.80. On the other hand calibration was poor. They 
concluded that large sample sizes and refitting of the orig-
inal model coefficients are related with a better perform-
ance ofthe models. Unlike ours this systematic review was 
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restricted to models that use baseline characteristics to 
predict mortality or unfavourable outcome (defined by 
G.O.S.) in moderate and severe TBI patients. Furthermore 
the search strategy was not specified. 
Systematic reviews of prognostic models for other diseases 
have found similar results to ours. For example Counsel et 
al. conducted a systematic review of prognostic models in 
patients with acute stroke (14). They found 83 prognostic 
models but they concluded that none of them has been 
sufficiently well developed and validated. 
Conclusion 
This systematic review describes the limitations of pub-
lished prognostic models in TBI and most importantly 
inform researchers who are involved in the development 
of prognostic models in TBI. Future studies should con-
sider the following issues to develop valid prognostic 
models: thorough discussion with physicians of potential 
predictors that are "clinically relevant", clear description 
of the measurement and validity of variables included in 
the model, large sample size to ensure precise estimates, 
adequate handling of continuous variables and missing 
data, assessment of interaction in the multivariable analy-
sis, clear description of the calculation of the prognostic 
score, external validation and adequate report of model 
performance measures, such that physicians can interpret 
their accuracy. It should also be encouraged that more 
studies include population from low and middle income 
countries where most of the burden ofTBI occurs. Finally, 
for prognostic models to be clinical useful they should be 
presented in user-friendly way to be easily applied in the 
clinical scenario. 
Competing Interests 
The author(s) declare that they have no competing inter-
ests. 
Authors' contributions 
PP, IR and PE developed the protocol and conducted the 
SR. RW conducted the searching. PP conducted the analy-
sis. All the authors read and approved the final manu-
script. 
Additional material 
Additional File 1 
Electronic lribliographical databases and search strategies. This tab16 
describe the databases and search strategies used in the s)l5tematic review. 
Click here for file 
[http://www.biomedcentral.com/content!supplementary/14 72-
6947-6-38-Sl.doc) 
http://www.biomedcentral.coml1472-694716138 
Additional File 2 
Quality assessment of prognostic models. This document describ, th' dif-
ferent items analysed for the quality assessment. 
Click here for file 
[http://www.biomedcentral.com/content/supplementary/1472-
6947-6-38-S2.doc) 
Additional File 3 
Studies included in rhe s)l5tematic review. List of references of included 
studies in th, systematic review 
Click here for file 
[http://www.biomedcentral.com/content/supplementary/14 72· 
6947-6-38-S3.doc) 
Additional File 4 
General Characteristics of the models. This tabl, describe th, characterise 
tics of the included models in rhe systematic review 
Click here for file 
Ihttp://www.biomedcentral.com/content!supplementary/1472· 
6947-6-38-S4.pdf) 
Acknowledgements 
pp and RW were funded by the Cochrane Injurl .. Group. IR and PE were 
funded by the London School of Hygiene a Tropical Medicine. 
References 
I. Bruns J Jr, Hauser WA: Th •• pld.mlololY of traumadc braIn 
Injury: a review. Eplleps/o 2003. «(Suppl 10):2-10. 
2. Flemlnpr S. Ponsford J: Lon, t.rm outcome after traum.dc 
brain Injury. BM] 2005.3]1(7530):1419-20. 
3. Pere! pwJ. Ravl R. Shakur H, et al.: Pro,nosls followln, h.ad 
Injury: a .urv.y of docton from d.veloplnl and developed 
countries. ]EeP In preas. 
4. Lee KL. Pryor DB. Harrell FE Jr. et aL: Predlctlnl outcom. In cor-
on.ry dls ••••• Statl.tlc.I models vanu. expert cllnlcl.n .. Am 
] Med 1986.80(4):553-60. 
5. Murray LS, Telsdale GM, Murray GO. et aL: Doe. pradlctlon of 
outcome alter patl.nt manal.mentl Lall(et 1993. 
34 I (8859): 1487-91. 
6. Rob.ru I. Shakur H. Edwards P. et al.: Trauma e.r. re ... rch .nd 
the war on unc.rtalnty. BM] 2005, 3]1(7525):1094·6. 
7. Coats TJ, Shakur H: Con .. nt In eme"l.ncy re.e.rch: new rea-
ulatlon.. Etne,., Med] 2005, 11( I 0):683-5. 
8. Olcklnson K, Bunn F, Wentz R, er cL: Slz •• nd quality of ran-
doml.ed controlled trl.l. In head Injury: revl.w of publl.h.d 
studl.s. BM] lOOO.1l0(7245):1308-11. 
9. Murray GO, Barer 0, Chol S. et al.: De.I,n .nd analysis of ph ••• 
1\1 trial. with ord.red outcom. sc.lell the concept of the 
.Ildln. dichotomy. ] Neurollauma 2005. 11(5):511.7. 
10. Young fB. Lees KR. Weir CJ: Improvln, trIal powar throu,h u .. 
of pro.nosl.-adju.ted end polnta. Stroke 2005, 36(3):597·60 I. 
11. Aitmln OG: System.tlc reviews In h.alth carat System.dc 
revl.ws of .valu.tlon. of pro,no.tle varl.bl... BM] 2001, 
313(7306):22 .... 228. 
12. Lecky f, Woodford M. Yates DW: Trend. In treum. cara In Ina-
I.nd and Wale. 1989-91. UK Trauma Audit and R •••• rch 
N.twork. Lall(et 2000. 355(9117):1771·5. 
13. Altman DG. Royston P: What do w. mean by v.lldatln,. Prol' 
nottlc mod.1f Stat Med 2000. 19(4):453-73. 
14. Counsell C. Oennll M: System.tlc revl.w of propo.dc model. 
In p.tlent. with .cute .trok.. Cerebrovasc 01. 200 I, 
12(3): I 59·70. 
IS. Jacob M. Lewsey JO, Sharpln C, et al.: Systemadc revl.w .nd val. 
Id.tlon of pro,nostlc models In liver transpl.ntetlon. Liver 
TronspllOOS, 11 (7):81 .... 25. 
Page 9 of 10 
(pege number not for cllltion PUI'pOHII) 
BMC Medicallnformatics and Decision Making 2006, 6:38 
16. Brain Trauma Foundation (U.S.) MoNS: Management and prognosis of 
seyere traumatic brain injury. New YotIc 2000. 
17. Hukkelhoven CW, Rampen AJ. Maas AI. et aL: Some prognostic 
models for traumatic brain injury were not valid. J aln ~ide­
mio/2006. 59(2): 132 .... 3. 
18. Junl P. Altman OG. Egger M: Systematic reviews In health care: 
Assessing the quality of controlled clinical trials. BM) 2001, 
323(7303):42-6. 
19. Whiting P. Harbord R. Kleijnen J: No role for quality score. In sys-
tematic reviews of diagnostic accuracy studies. BMC Med Res 
Merhodo/200S.5:19. 
20. Laupacis A. Sekar N. StielllG: Clinical prediction rules. A review 
and suggested modifications of methodological standards. 
JAMA 1997.277(6):488-94. 
21. Stiell IG. Wells GA: Methodologlc standards for the develop-
ment of clinical decision rules In emergency medicine. Ann 
Emerr Med 1999.33(4):437-47. 
22. Wasson JH. Sox HC. Nelf RK. et al.: Clinical prediction rules. 
Application. and methodological standards. N Engl) Med 1985. 
313(13):793-9. 
23. Pillai SV. Kollurl VR. Praharaj SS: Outcome prediction model for 
.evere diffuse brain InJuries: development and evaluation. 
Neurol India 2003. 51 (3):345-9. 
24. Signorini OF. Andrews PJ. Jones PA, et al.: Predlctlng.urvlval using 
.Imple clinical variables: a case study In traumatic brain 
Injury. J Neurol Neurosurr Psychiatry 1999. 66( I ):20-5. 
25. Signorinl OF. Andrews PJ. Jones PA, et al.: Addlngln.ult to Injury: 
the prognostic value of early secondary Insults for .urvlval 
after traumatic brain Injury. ) Neurol Neurosurr Psychiatry 1999. 
66( I ):26-31. . 
26. Hukkelhoven CW. Steyerberg EW. Habbema JO. et oL: Admission 
of patients with severe and moderate traumatic brain Injury . 
to specialized ICU facilities: a search for triage criteria. Inten-
slye Core Med 200S. 31(6):799-806. 
27. Hukkelhoven CW. Steyerberg EW. Habbema JO. et aL: Predicting 
outcome after traumatic brain injury: development and val-
Idation of a prognostic score based on admission character-
Istics. ) Neurotrouma 2005. 22(10):1025-39. ' 
28. Bush BA. Novack TA. Malee JF. et 0/.: Validation of a model for 
evaluating outcome after traumatic brain Injury. Arch Phys 
Med Rehabil 2003.84(12):1803-7. 
29. Benzer A. Mitterschlffthaler G. Marosl M. et 01.: Prediction of non-
survival after trauma: Innsbruck Coma Scale. Lancet 1991. 
338(8773):977-8. 
30. Hayden lA. Cote P. Bombardier C: Evaluation of the quality of 
prognosl. studies In sy.tematlc review.. Ann Intern Med 2006. 
144(6):427-37. 
31. Concato J. Feinstein AR, Holford TR: The Risk of Determining 
Risk with Multlvarlable Models. Ann Intern Med 1993. 
118(3):201-210. 
32. Justice AC. Covinsky KE. Berlin JA: Assesslnl the lenerallzablllty 
ofprolnostic Information. Ann Intern Med 1999, 130(6):515-24. 
Pre-publication history 
The pre-publication history for this paper can be accessed 
here: 
http',IIwwwbiomedcentral comJ1472-6947J6J38,1prepub 
http://www.biomedcentral.comI1472-694716138 
Publish with BloMed Central and every 
scientist can read your work free of charge 
"BloMed Central will be the most Significant development for 
disseminating the ,.sults of blomed/c.' ,.surc h In our lifetime. " 
Sir Paul Nurse, Cancer Research Ut( 
Your research papers will be: 
" Ivailable free of charge to the entire blomedlc.1 community 
• peer reviewed and published Immediately upon .cceptance 
• cited In PubMed and althlved on PubMed Centr.1 
• youn - you keep the copyright 
Submit your manuscript h.,.: 0 BloMedcentral 
http11www.blomtck ... tr.l.com/Info..publllhln~.IdY .• 1P 
Page 10 of 10 
(PI{1II number not fbr eIt.1Ion purpoaH) 
BM 
Data supplement 
References 
Rapid responses 
Email alerting 
service 
Notes 
Downloaded from bmj.com on 12 February 2008 
Predicting 'outcome after traumatic brain Injury: 
practical prognostic models based on large 
cohort of International patients 
MRC CRASH Trial Collaborators 
BMJ published online 12 Feb 2008; 
doi:10.1136/bmj.39461.643438.25 
Updated information and services can be found at: 
http://bmj.comlcgilcontentJfull/bmj.39461.643438.25v1 
These include: 
Web extra: Table A" 
http://bmj.com/cgllcontentlfuIUbmj.39461.643438.2510C1 
This article cites 19 articles, 6 of which can be accessed free at: 
http://bmj.com/cgllcontentJfuIUbmj.39461.643438.25v1#BIBL 
1 on line articles that cite this article can be accessed at: 
http://bmj.comlcgllcontentJfull/bmj.39461.643438.25v1#otherarticles 
You can respond to this article at: 
http://bmJ.com/cglleletter-aubmltlbmJ.39461.643438.26v1 
Receive free email alerts when new articles cite this article - sign up in the 
box at the top left of the article 
To order reprints follow the "Request Permissions" link in the navigation box 
To subscribe to BMJ go to: 
http://resources.bmJ.com/bmj/subscrlbera 
BM] 
London School of Hygiene and 
Tropical Medicine. London 
WC1B 3DP 
eorrespondeoce to: P A PereI 
PabIo.pereI@ishtm.ac.uk 
doi:l0.1136/bmi.39461.643438.25 
BMJ I ONLINE FIRST I bmj.com 
Downloaded from bmj.com on 12 February 2008 
RESEARCH 
Predicting outcome after traumatic brain injury: practical 
prognostic models based on large cohort of international 
patients 
MRC CRASH Trial Collaborators 
ABSTRACT 
Objective To develop and validate practical prognostic 
models for death at 14 days and for death or severe 
disability six months after traumatic brain injury. 
Design Multivarlable logistic regression to select 
variables that were independently associated with two 
patient outcomes. Two models designed: 'basic' model 
(demographic and clinical variables only) and 'cr model 
(basic model plus results of computed tomography). The 
models were subsequently developed for high and low-
middle income countries separately. 
Setting Medical Research Council (MRC) CRASH Trial. 
Subjects 10008 patients with traumatic brain Injury. 
Models externally validated In a cohort of 8509. 
Results The basic model Included four predictors: age, 
Glasgow coma scale, pupil reactivity, and the presence of 
major extracraniallnjury. The CT model also Included the 
presence of petechial haemorrhages, obliteration of the 
third ventricle or basal cisterns, subarachnoid bleeding, 
midline shift, and non-evacuated haematoma. In the 
derivation sample the models showed excellent 
discrimination (C statistic above 0.80). The models 
showed good calibration graphically. The Hosmer-
Lemeshow test also Indicated good calibration, except for 
the CT model in low-middle Income countries. External 
validation for unfavourable outcome at six months In high 
Income countries showed that basic and CT models had 
good discrimination (C statistic 0.77 for both models) but 
poorer calibration. 
Conclusion Simple prognostic models can be used to 
obtain valid predictions of relevant outcomes In patients 
with traumatic brain Injury. 
INTRODUCTION 
Traumatic brain injury is a leading cause of death and 
disability worldwide. Every year, about 1.5 million 
affected people die and several millions receive 
emergency treatment.12 Most of the burden (90%) is 
in low and middle income countries. a 
Clinicians treating patients often make therapeutic 
decisions based on their assessment of prognosis. 
According to a 2005 survey, 80% of doctors believed 
that an accurate assessment of prognosis was important 
when they made decisions about the use of specific 
methods of treatment such as hyperventilation, barbi-
turates, or mannitol. 4 A similar proportion considered 
that this was important in deciding whether or not to 
withdraw treatment. Assessment of prognosis was also 
deemed important for counselling patients and rela-
tives. Only a third of doctors, however, thought that 
they accurately assessed prognosis.4 
Prognostic models are statistical models that com-
bine data from patients to predict outcome and are 
likely to be more accurate than simple clinical 
predictions.s The use of computer based prediction of 
outcome in patients with traumatic brain injury 
increases the use of certain therapeutic interventions 
in those predicted to have a good outcome and reduces 
their use in those predicted to have a poor outcome.' 
Many prognostic models have been reported but 
none are widely used. A recent systematic review offers 
possible explanations.7 Most models were developed 
on small samples, most were methodologically flawed, 
and few were validated in external populations. Few 
were presented in a clinically practical way, nor were 
they developed in populations from low and middle 
income countries, where most trauma occurs. 
The Medical Research Council (MRC) CRASH 
(corticosteroid randomisation after significant head 
injury) trial is the largest clinical trial conducted in 
patients with traumatic brain injury and presents a 
unique opportunity to develop a prognostic model.lII 
The trial prospectively included patients within eight 
hours of the injury, used standardised definitions of 
variables, and achieved almost complete follow-up at 
six months. Furthermore, the large sample size 
guarantees precise and valid predictions. The high 
recruitment of patients from low and middle income 
countries means that models developed with these data 
are relevant to these settings. 
We have developed and validated prognostic 
models for death at 14 days and death and disability 
at six months in patients with traumatic brain injury. 
METHODS 
Patimt.t-The study cohort was all 10 008 patients 
enrolled in the trial. Adults with traumatic brain injury, 
who had a score on the Glasgow coma scale of 14 or 
PIlI 1 or 10 
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Fig 11 Relation between age and mortality at 14 days 
less, and who were within eight hours of injury, were 
eligible for inclusion in the trial. 
Outcomes-Death of a patient was recorded on an 
early outcome form that was completed at hospital 
discharge, death, or 14 days after randomisation 
(whichever occurred first). Unfavourable outcome 
(death or severe disability) at six months was defined 
with the Glasgow outcome scale (see box). The scale 
comprises five categories: death, vegetative tate, 
severe disabil ity, moderate di ability and good recov-
ery. For the purpose of this analYSiS, we dichotomised 
outcomes into favourable (moderate disability or good 
recovery) and unfavourable (dead, vegetative state, or 
severe disability). 10 
PrognostiC variables-For the prognostic model we 
con ideredage, sex, cause of injury, time from injury to 
randomisation, Glasgow coma score at randomisation, 
pupil reactivity, results of computed tomography, 
whether the patient had su tained a major extracranial 
injury, and level of income in country (high or low-
middle income countries, as defined by the World 
Bank) ( ee table A on bmj .com). I I We adjusted analyses 
for treatment within the trial as this was related to 
outcome, and we did not find interaction between 
treatment and the potential predictors.89 
Analysis-Most of the variable collected in the 
CRASH trial have been previously as ociated with 
progno is in traumatic brain injury, so we includ d all 
of them in a first multivariable logistic regres ion 
analysis.12 We excluded variables that were not 
significant at 5% level. We quantified each variable 's 
predictive contribution by its z core (the model 
coefficient divided by its tandard error). We xplored 
Category and definition on Glasgow outcome scale 
• Good recovery: able to return to work or school 
• Moderate disability: able to live independently; unable to return to work or school 
• Severe disability: able to follow commands/unable to live independently 
• Persistent vegetative state: unable to interact with environment; unresponsive 
• Dead 
page 2 of 10 
linearity between age and mortality at 14 days and 
Glasgow coma score and mortality at 14 day . Int r-
actions between country in om level and all tlle other 
predictors were evaluated with a likelihood ratio test. 
Becaus there were few data missing, we performed a 
complete case analysis . 
PrognostiC models-We developed different models 
for each of the two outcome: a basic model, which 
included only clinical and demographiC variable , and 
a eT model, which also included re ults of computed 
tomography. 
Perfonnance a/the model-W e as ess d p rformance of 
the models in terms of calibration and di crimination . 
Calibration was assessed graphically and Witll the 
Hosmer-Lemeshow test. Di crimination was asses ed 
with the C statistic {an equivalent concept to area under 
the receiver operator characteristic urve). 13 
intemal validatio7 The internal validi ty of the fin al 
model was asse s d by the bootstrap rc-sampling 
technique. Regres ion model were e timated in lOO 
models. For each of 100 bootstrap ample we refitted 
and tested the model on the original sample to obtain 
an estimate of predictive a curacy corrected for bias. 
This howed no overoptimism in any of the final 
model's predictive stati ti s. 
Extemal validation- A good prognostic model 
hould be gcn ralisable to populations different to 
those in which it was derived. I ' We externally validated 
the models in an external cohort of 8509 patients with 
moderate and s vere traumatic brain injury from 11 
tudies conducted in high income ountri (the 
IMPA T (international mi ion for progno is and 
clinical trial) dataset). 15 
Score development-We cl veloped a clinical core 
based on regre ion coeffi i nts. A web based version 
of the model wa developed to be acc ssibl to 
clinicians int rnationally. 
t 
7 6 4 3 
Glassow (om a l ale 
No of 1499 1498 962 748 690 633 709 946 677 478 455 667 
pati ents 
No of 51 76 65 62 108 113 152 241 231 232 275 342 
deaths 
Fig 21 Relation between Glasgow coma scale and mortality at 
14 days 
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RESULTS 
General characteristics 
Table 1 shows the characteristics of the patients. More 
of the patients were men (8 1 %) and more came from 
low-middle income countries (75%). More than half 
(58%) of participants were included within three hours 
Table 11 General characteristics of study population 
Low-middle 
income High income 
Total (n=10 countries (n=7 countries (n=2 
008) 526) 482) P value' 
Age (years): 
<20 12.3 12.5 11.8 
20-24 17.0 17.8 14.4 
25-29 13.0 13.5 11.2 
30-34 10.7 10.9 10.1 
35-44 17.9 18.5 15.9 
45-54 12.5 12.3 13.3 
"55 16.7 14.5 23.4 
Mean (SO) 37 (17.1) 35.8 (16) 40.6 (19.4) <0.001 
Sex: 
Female 19.0 18.3 21.1 
Male 81.0 81.7 78.9 0.002 
Hours since iniury: 
<I 26.8 24.0 35 .2 
1-3 31.0 30.1 33.7 
)3 42.3 45.9 31.1 
Mean (SO) 3.4 (2.7) 3.6 (2 .8) 2.8 (2.0) <0.001 
Cause of head injury: 
Road traffic crash 65.1 69.9 50.2 
Fall )2 meters 13.3 11.1 20.0 <0.001 
Other 21.7 19.0 29.8 
Total Glasgow coma score: 
Mild (13-14) 30.2 29.4 32.6 
Moderate (9-12) 30.4 32.6 23.6 <0.001 
Severe (3-8) 39.5 38.0 43.8 
Pupil reactivity: 
80th reactive 82.8 83.5 80.7 
One reactive 6.3 6.2 6.3 
None reactive 8.2 8.0 9.1 <0.001 
Unable to assess 2.7 2.3 3.9 
~--
Major extra cranial injury: 
No 77.3 77.3 77.5 
Yes 22.7 22.7 22.5 0.801 
c;;;;;;;ted tomography: 
No scan 21.1 24 .0 12.0 <0.001 
-Normal scan 22.8 20.0 30.2 <0.001 
Petechial haemorrhages 28.7 28.7 28.7 0.970 
Obliteration of 3rd ventricle 23.4 28.6 9.6 <0.001 
or basal cisterns 
Subarachnoid bleed 31.6 33.5 26.4 <0.001 
Midline shift 14.6 15.9 11.1 <0.001 
Non-evacuated haematoma 27.1 27.3 26.5 0.475 
Evacuated haemaloma 12.7 14.4 7.9 <0.001 
Outcomes: 
Mo rtality at 14 days 19.5 20.7 16.0 <0.001 
Death or severe disab ility at 37.2 36.8 38.5 0.150 
6 months 
.p va lue for comparison between low-middle income countries and high Income countries. 
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of injury. Road traffic rash s wer th mo t omm on 
cause of injury (65%) and 79% of th parli ipants 
underwent computed tomography . total o f 1948 
patients (19%) died in the first two w ks, 2323 pati nts 
(240/0) were d ad atsix month , and 3556 pati nt (37%) 
were dead or sever Iy depend nt at si month . 
Th relation betwe n ag and th log odds of death 
within J 4 days showed no asso iation until th ag of 40 
and a tin ar increase aft rwards. Th r lation betw n 
Glasgow coma core and mortality at 14 days was 
reasonably lin ar and we th refor in lud d the oma 
score as a co ntinuous variable (fig I and 2). Th 
relation with unfavourabl outcome at i month 
showed similar pattem s. 
Low-middle v high income countries 
In compari on with pati nt from high incom 
countrie , those from low-middle in ome ountries 
were you ng r, more likely to be male, w re r cruited 
later, had less sev re traumati brain injury (as d fin d 
by Glasgow oma ore and pupil r a tivity), and more 
often had abnormal r suits on omput d tomography . 
Road traffic crash were a more common eau of 
traumatic brain injury. Although pati nts from low-
middle in ome countrie xperie n d high r mortality 
at 14 day (odd ratio 1.94, 95% onfid n e int rval 
1.64 to 2.30), th re was no ignil'i ant di~ r n e in 
unfavourabl outcom at i months. 
There w r Significant int ra tions betw n th 
country ' income level and . v ral pr di tors. nd so 
w d veloped two mod Is, n C r low-middl in om 
countries and anoth r for high in om ountri . Id r 
age was a trong r pr di tor o f 14 da mortalit in high 
inco me ountri (int ractio n P<O.OOI), and low I' 
Glasgow oma cor was a strong r pr di lor in low-
middle in ome countri (int Ta tion 1'=0.003). blit-
eration of th third venlri I and a non- va uat cl 
haemato ma wer both as 0 iat d with, high r risk in 
high in om ountri (int ra ti n P<O.OO I and 
P=0.03, resp tiv I ). 
r: b, i and T 
Iti n 
ventri I hift w r str ng ( 
pag 3 of 10 
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Fig 3 1 Calibration of basic models using expected and observed 
probabilities of mortality at 14 days (top) and death or severe 
disability at six months (bottom) in patient with traumatic brain 
injury according to income level of country. P value is for 
Hosmer-Lemeshow test 
predictors of mortali ty at 14 days, and non-evacuated 
haematoma was the stronge t predictor of unfavour-
able outcome at six months. 
Perfonnance a/mode All mod Is howed cellent 
discrimination, with C statisti s over 0.80 (tab I 2 and 
3). Calibration in all models was adequate and ix out of 
the eight models had good calibration when valuat d 
with the Hosmer-Leme how test (figs 3 and 4) . 
Clinical score-Individual s ores and th ir resp tive 
probability of outco me can be obtained fTom our web 
based calculator (www.crash2.1shtm .ac.ukl). By enter-
ing the values of the predi tors, we can obtain th e 
expected risk of death at 14 day and of death or sev re 
disability at six months. Figure 5 shows a ampl 
screen hot of the prediction fOT a 26 y aT o ld patient 
from a low and middle income country (Argentina), 
with a Glasgow coma sco re of I I, one pupil reactive, 
and absence of a major extra cranial injury. According 
to the basic model this patien t has a probabili ty o f death 
at 14 days of 10% and a 23.9% risk of death or s v re 
disabili ty at six months. A good agreement is evident 
between ob erved and predicted outcome by the web 
calculator (figs 3 and 4). 
Extental validatiol Because an external ohort of 
patients from low-middle income ountries was not 
available, we validated the models in patients from 
high income countries only. T he IMPA T dataset 
used for the validation did not include mortality at 
14 days and so we could validate only model for 
unfavourable ou tco me at six months. W validat d the 
basic model with the variables age, Glasgow co ma 
score, and pupil reactivity. We did not in lude the 
variable "major xtracrani al injury" as it was not 
avai lable in th validation sample. For the T models, 
we add d obliteration of the third ventricl or basal 
cisterns, subarachnoid bleeding, midline shift, and 
non-evacuated ha matoma to the basi mod I. imi-
larly, we exclud d th variable "pete hial haemor-
rhages" as this was not availabl in th va lidation 
Table 21 Multivariable basic predictive models (excluding data from computed tomography*). Flgures are odds ratios (95% 
confidence intervals) with z scores 
Mortality at 14 days Death or severe disability at 6 months 
High Income countries Low-middle Income High Income countries Low-middle Income 
Prognostic variables (n=2294) countries (n=7412) (n=2185) countries (n=7119) 
Aget 1.72 (1.62 to 1.83). 1.4 7 (1.40 to 1.54). 1.73 (1.64 to 1.B2). 1.70 (1.63 to 1.77). 
14.08 14.10 15.99 IB .58 
GCS:j: 1.24 (1.19 to 1.29), 1.39 (1.35 to 1.42). 1.22 (1.18 to 1.25). 1.42 (1.39 to 1.45). 
10.22 25.60 12.B4 30.64 
Pupi l reactivity: 
Both 1 1 1.00 
One 2.57 (1.65 to 4.00). 4.17 1.91 (1 .53 to 2.39). 5.69 2.43 (1.62 to 3.66). 4.26 2.01 (1.59 to 2.56). 
5.81 
None 5.49 (3.70 to 8.15) . 8.45 3.92 (3 .14 to 4.90), 3.28 (2 .20 to 4.89). 5.85 4.54 (3.38 to 6.11). 
12.07 10.03 
Major extracranial injUlY: 
No 1 1 1 1.00 
Yes 1.53 (1.11 to 2.09), 2.62 1.15 (0.99 to 1.34), 1.78 1.62 (1.26 to 2.07). 3.82 1.73 (1.51 to 1.99). 
7.76 
C statistic 0.86 0.84 0.81 0.84 
GCS=Glasgow coma scale. 
'Includes age. GCS. sex. hours since Injury. cause of injury. pupil reactivity. and presence of major exl,acranlal Injury. 
tPer 10 year Increase afte r 40 yea rs. 
tPer decrease of each value of GCS. 
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Fig 41 Calibration of computed tomography models using 
expected and observed probabilities of morta lity at 14 days 
(top) and death or severe disability at six months (bottom) in 
patient with traumatic brain injury according to income level of 
country. P value is for Hosmer-l emeshow test 
sample. For the validation process we first ran th e e 
models in the CRASH trial cohort and we then applied 
thecorrespondingcoeffi i nt inthe validation ampl . 
Although discrimination was, as e pected, low r than 
in the original data, it was still quite good for both th 
basic and CT models ( tatistic 0.77 for both mod I ). 
The calibration was excellent for the T model but 
poorer for th e basi model (figs 6 and 7). 
DISCUSSION 
We have develop d w b bas d prognostic model fo r 
predicting two clinical ly rei vant outcomes in patient 
with traum atic brain injury using variables that are 
available at the bedside. The model have xcellent 
discrimination and good fi t with both internal and 
external validation. We have reported on difference in 
outcomes and on the strength of predictors of ou t-
comes, according to whether patients are from high or 
low-middle incom countries. 
Older age, low lasgow coma sco re, abs nt pupil 
reactivi ty, and the presen e of major extra raniaJ 
injury predict poor prognosi . All of these variables 
have been previou Iy identifi ed as prognostic factors 
for poor outcome in traumatic brain injury. 12 Glasgow 
coma score showed a cl ar linear re latio n with 
mortali ty. Our finding that mortali ty in pati nt with 
Glasgow oma score of 3 was lower than in patients 
wi th a score of 4 may be because scores of s dated 
pati ents a re re ported as 3. Increasing ag was 
associated with worse out omes but thi asso iation 
was apparent only after age 40. similar threshold has 
b en reported elsewhere. ' 6 ' 7 Plau ible explanation for 
thi include xtracranial omorbidities, hange in 
brain pia ticity, or differences in linical management 
a sociated wi th in rea ing ag . T he pr s n of 
"obliteration of th ird v ntri le or basal istern " on 
Table 31 Multivari able predictive models with computed tomography" . Figures are odds ratios (95% confidence intervals) with z scores 
Mortality at 14 days Death or severe disabili ty at 6 months 
Low-middle Income 
Prognostic variables High Income countries (n=2030) countries (n=5635) High Income countries (n=1955) 
Aget 1.73 (1.62 to 1.84), 13.33 1.46 (1.39 to 1.54), 12.54 1.73 (1.63 to 1.83), 14.94 
GCSt 1.18 (1.12 to 1.23), 6.87 1.27 (1.24 to 1.31), 16.68 1.18 (1.14 to 1.22),9.83 
Pupil reactivity: 
Both 1 
One 2.00 (1.25 to 3.20), 2.88 1.45 (1.14 to 1.86), 2.97 2.12 (1.39 to 3.24), 3.47 
None 4.00 (2 .58 to 6.20) . 6.21 3.12 (2.46 to 3.97), 9.3 1 2.83 (1.84 to 4.35),4.73 
Major extracranial injury: 
No 1 1 1 
Yes 1.53 (1.10 to 2.13), 2.53 1.08 (0.91 to 1.28), 0.89 1.55 (1.20 to 1.99), 3.37 
Findings on computed tomography: 
Petechial haemorrhages 1.15 (0.83 to 1.59),0.84 1.26 (1.07 to 1.47), 2.82 1.21 (0.95 to 1.55). 1.56 
Obliteration of 3rd ventricle or 4.46 (2.97 to 6.68),7 .23 1.99 (1.69 to 2.35) , 8.25 2.21 (1.49 to 3.30). 3.95 
basal cistems 
Subarachnoid bleed 1.48 (1.09 to 2.02) . 2.51 1.33 (1.14 to 1.55), 3.60 1.62 (1.26 to 2.08). 3.79 
Midline shift 2.77 (1 .82 to 4.21), 4.77 1.78 (1 .44 to 2.21) . 5.35 1.93 (1.30 to 2.87) , 3.24 
Non-evacuated haematoma 2.06 (1.49 to 2.84), 4.40 1.48 (1.24 to 1.76), 4.43 1.72 (1.33 to 2.22), 4.15 
C statistic 0.88 0.84 0.83 
GCS=Glasgow coma scale. 
·Includes age. GCS, pupil reactivity, presence of major extra crania l Injury, and all find ings on computed lomography. 
t Per 10 year increase after 40 years. 
tPer decrease of eac . .::h ...:.v:::al:::ue::....::.:of...:.G:..:C:::.S ~ _______________ _ 
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Low-middle Income countries 
(n=5 394) 
1.72 (1.64 to 1.81). 17.74 
1.34 (1.30 to 1.37). 22.)2 
1.00 
1.54 (1.20 to 1.99).3.35 
3.56 (2 .60 to 4.87),7.92 
1.00 
1.61 (1.38 to 1.88), 6.03 
1.b9 (1.29 to 1.73), 5.33 
1.53 (1.3 1 to 1.79).5.30 
1.20 (1.04 to 1.39). 2.49 
1.86 (1.48 to 2.3 2),5 .42 
1.68 (1.43 to 1.97), 6.34 
0.84 
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Fig 51 Screenshot of web based calculator available at www.crash2.tshtm.ac.uk/. If CT scan 
available box is ticked, calculator displays additional CT variables 
page 6 of 10 
computed tomography was associated with the worst 
prognosis at 14 days. This is supported by rec nt 
findings that absence of basal cisterns is the strongest 
predictor of six month mortality. IS We also found- as 
previously reported- the independ nt prognosti 
value of traumatic subarachnoid haemorrhage. 19 
Patients from low-middle income countries had 
worse early prognosis than those from high income 
countries. Regional differences in outcome aft r 
traumatic brain injury have previou ly b en report d 
between Europe and North America, but the differenc 
in mortality between low-middle and high income 
countries has not been explored.20 
The strength of asso iation between some predictors 
and outcomes differed by region . A low Glasgow oma 
score had an even wors prognosis in patients from 
low-middle income countri s compared wilh pati nts 
from high income countries. This might relate to 
quality of care or it cou ld be that low Glasgow coma 
score in high income countries is associated with 
greater use of sedation, rather than to severity of 
traumatic brain injury. Increasing age had a worse 
prognosis in high income countri s compared with 
low-middle income ountries. This is becau e of even 
lower risks at younger ages in high income countri s, 
while both have imilar risks at old r ages. Regarding 
computed tomography, some abnormal findings w r 
stronger predictors in high in ome counlri s. This 
could be be ause of better technology and th refore 
more accurate diagnosis with comput d tomography. 
A systemali revi w id ntifi d ov r 100 prognosti 
models for pati nls with traumati brain injury, but 
methodologi al quality was adequate in only a f W .7 As 
with our mod Is, two of the mor m thodologically 
robust mod Is how d similarly good discrimination 
but worse calibration .'721 Th y too in lud d lasgow 
coma score, age, pupil reactivity, and results of 
computed tomography as predi tors, but, unlike our 
models, th y did not include the presence of major 
extracranial injury, and non ofth m includ d patienls 
from low-middl in ome counlri s. 
Strengths and weakness of the study 
Our study's strength are th us of a well d cribed 
cohort of patients, prospective and standardis d 
collection of data on prognosti factors low loss to 
follow-up, and the us of a validat d outcome m asure 
at a fixed time after the injury. All of these factors 
provide reassurance about the internal validity of our 
models. Th large sample size in relation to th numb r 
of prognostic variables examin d is anoth r particular 
trength . In relation to its xternal validity, only a f w 
prognostic models have been developed from patients 
in low-middle income countri s, and to the b st of our 
knowledge the models we d velop dare th first with a 
large ampl ize and adequate m thods.7 Th ternal 
validation confirm d th dis riminatory ability of th 
models in patients from high in om countries and 
showed good calibration for th computed tomogra 
phy model. Unlike 010 t publish d prognosti mod Is, 
• Risk of outcome in 10ths of patients with similar pr dieted 
probabilities 
- Relation betwe n observed fr ~uency and predict d 
probability of death or sever disability 
- Ideal r latlon between observed and predicted fr quency 
of outcome in model with perfect calibration 
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Fig 61 External validation of basic model for death or s ver 
disability at six months In IMPACT database 
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• Risk of outcome in 10ths of patients with similar predicted 
probabilities 
- Relation between observed frequency and predicted 
probability of death or severe disability 
- Ideal relation between observed and predicted frequency 
of outcome in model with perfect calibration 
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ProbablUty according to model 
Fig 7 IExternal validation of CT model for death or severe 
disabiUty at six months in IMPACT database 
we included the complete spectrum of patients with 
traumatic brain injury, ranging from mild to severe. 
Finally, the data required to make predictions with the 
model are easily available to clinicians, and we have 
developed a web based risk calculator. 
There are some limitations. The data from which the 
models were developed come from a clinical trial and 
this could therefore limit external validity. For 
example, patients were recruited within eight hours 
of injury and we cannot estimate the accuracy of the 
model s for patients evaluated beyond this time . 
Nevertheless, the CRASH tri.al was a pragmatic trial 
that did not require any additional tests and therefore 
included a diversity of "real life" patients. Another 
limitation was that for the validation we were forced to 
exclude the variables major extracranial injury and 
petechial haemorrhages because they were not avail-
ablein the IMPACT sample. Neither of these variables, 
however, was among the stronger predictors. The 
external validation showed good discriminatory abil-
ity, but this was somewhat lower than in the original 
data. This may be explained by a more homogeneous 
selected case mix in these other trials, which included 
only patients with moderate and severe Glasgow coma 
score. 
Implications of the study 
Most of the burden of traumatic brain injury is in low-
middle income countries, where case fatality is higher 
and resources are limited. We found that several 
predictors differed in their strength of association with 
outcome according to income level of country, 
suggesting that it may be inappropriate to extrapolate 
from models for high income countries to poorer 
settings. We have developed a methodologically valid, 
simple, and accurate model that may help decisions 
about health care for individual patients. It is important 
to emphasise, however, that while prognostic models 
may complement clinical decision making they cannot 
and should not replace clinical judgment. This is 
particularly important in the context of judgments 
about the withdrawal of care or clinical triage. These 
prognostic models can also help in the design and 
analysis of clinical trials, through prognostic stratifica-
tion, and can be used in clinical audit by allowing 
adjustment for case mix.22 
Future research 
The differences found between the prognostic models 
for low-middle and high income countries are impor-
tant. Although most of the burden of trauma occurs in 
low-middle income countries, most research takes 
place in high income countries.3 A recent systematic 
review found that few prognostic models for traumatic 
brain injury were developed in low-middle income 
countries. 7 More research is therefore needed to obtain 
reliable data from these settings. An improved under-
standing of the differences between these regions might 
also clarify the mechanisms of predictors that are not 
immediately obvious when we analyse a homogeneous 
population. Because our models were developed with 
data from a clinical trial , and validated only in patients 
from high income countries, further prospective 
validation in independent cohorts is needed to 
strengthen the generalisability of the models. Future 
research could also evaluate different ways, or form ats, 
for presenting the models to physicians; their use in 
clinical practice ; and whether ultimately they have any 
WHAT IS ALREADY KNOWN ON THIS TOPIC 
Traumatic brain injury is a leading cause of death and 
disability worldwide with most cases occurring in low-
middle income countries 
Prognostic models may improve predictions of outcome and 
help in clinical research 
Many prognostic models have been published but 
methodological quality is generally poor. sample sizes 
small, and only a few models have included patients from 
low-middle income countries 
WHAT THIS STUDY ADDS 
In a basic model prognostic indicators included age. 
Glasgow coma scale. pupil reactivity, and the presence of 
major extracraniallnjury 
In a eT model additional indicators were the presence of 
petechial haemorrhages. obliteration of the third ventricle or 
basal cisterns. subarachnoid bleeding. mid-line shift. and 
non-evacuated haematoma 
The strength of predictors of outcomes varies according to 
whether patients are from high or low-midd le income 
countries 
These prognostic models. that include simple variables. are 
available on the internet (www.crash2.lshtm.ac.ukj) 
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impact on the management and outcomes of patients 
with traumatic brain injury. 
CRASH trial collaborators by country (number of patients randomlsed) 
Albania (41 patients): Fatos Olldashi (national coordinator). Itan Muzha 
(Central Military University Hospital National Trauma Centre. 35); Nlkolln 
Filipi ( University Hospital ' Mother Teresa' Tirana. 6). 
Argentina (359 patients): Roberto Lede. Pablo Copertari. Carolina 
Traverse. Alejandro Copertari (lAM BE-national and regional 
coordinators for southern Latin America); Enrlque Alfredo Vergara. 
Carolina Montenegro. Roberto Ruiz de Huidobro. Pantale6n Saladino 
(Hospital San Bernardo. 106); Karina Surt. Jose Cialzeta. SlIvio Lazzerl 
(Hospital Escuela Jose de San Martin. 52); Gustavo Pinero. Fabian a Ciccloll 
(Hospital Municipal 'Or Leonidas Lucero," 3n: Waiter Videtta. Marla 
Fernanda Barboza (Hospital Dr Ram6n Carrillo. 35); SlIvana Svampa. 
Victor Sciuto (Hospital Castro Rendon. 28); Gustavo Domenlconl. Marcelo 
Bustamante (Hospital Zonal General De Agudos 'Heroes de Malvlnas," 
27); Maximiliano Waschbusch (Policlinico Sofia T de Santamarina. 20); 
Maria Paula Gullo (Hospital Municipal Or Hector J D'Agnlllo. 17); Daniel 
Alberto Drago (Hospital Nacional Profesor Alelandro Posadas. 11); Juan 
Carlos Arjona Linares (Hospital Espaiiol de Mendoza, 10); Luls (amputaro 
(Hospltalltallano. 10); Gustavo Tr6ccoJi (Hospital 'Dr Jose Penna: 5); 
Hernan GaJimbertl (Hospital Aleman. 1). 
Australia (13 patients); Mandy Tallott (Gold Coast Hospital. 13). 
Austria (21 patients): Christian Eybner. Waiter Buchinger 
(Waldviertelklinikum Standort Horn. 17); Sylvia Fitzal (Wllhelminenspital 
der Stadt Wien. 4). 
Belgium (403 patients): Guy Mazairac (national coordinator). Veronique 
Olelfe. Thierry Grollinger. Philippe Delvaux. Laurent Carller (Centre 
HospltaJier Regional de Namur. 356); Veronlque Braet (AZ Kllna Hospital. 
34); Jean-Marie Jacques (Hospital of Jolimont. 11); Danielle de Knoop 
(Clinique Salnt-Luc. 2). 
Brazil (119 patients): Luiz Nasi (national coordinator). Humberto Kukhuyn 
Choi, Mara Schmitt (Hospital de Pronto Socorro de Porta Alegre. 113); 
Andre Gentll (Hospital das Clinlcas da Faculdade de Medlclna da 
Universldade de Sao Paulo, 5); Flavlo Nacul (Cllnlca Sao Vlcente. 1). 
Chile (3 patients): Pedro Bedoya Barrlos (Hospital Regional Coplapo. 3). 
China (87 patients): Chen Xinkang. Un Shao Hua. Huang Han Tlan 
(Zhongshan (ity People's Hospital, 79); Cal Xlaodong (Sheng Zheng 
Second People's Hospital. B). 
Colombia (832 patients): Wllson Gualteros. Alvaro Ardlla Otero (Hospital 
Universitario San Jorge. 216); MIguel Arango (national coord inator. 
regional coordinator for northern Latin America and Caribbean). Juan Ciro. 
Hector Jaramlllo (Glorla GarclaCllnlca Las Americas. 199); Ignacio 
Gonzalez, Carolina Gomez (Hospital General de Medellin. 119); Arturo 
Arias. Marco Fonseca, Carlos Mora (Hospital Erasmo Meoz, 90); Edgar 
Glovanni Luna Cabrera. Jose LuiS Betancurth. Porfirio Mui'loz (Hospital 
Departamental de Narilio. 51); Jesus Alberto Qulii6nez. Marla Esther 
Gonzalez Castlllo (Hospital San Andres. 37); Orlando Lopez (Hospital 
Federico L1eras, 31); Rafael Perez Yepes. Dlana Leon Cuellar. Gerson Paez 
(Hospital El Tunal. 24); Hernsn Delgado Chaves. Pablo Emlllo Ordoi'lez 
(Hospital Civil de Iplales. 21); Rlcardo Plata. Martha Plneda (Hospital 
Universitarlo del Valle. 15); Llbardo Enrlque Pulldo (Hospital Regional de 
Dultama. 12); John Serglo Velez Jaramlllo (Hospital Timothy Brltton. 12); 
Carlos Rebolledo (Organlzacl6n Cllnlca General del Norte. 5). 
Costa Rica (20 patients): Oscar Palma (Hospital Mexico, 20). 
Cuba (404 patients): Carldad Soler (national coordinator); Irene Pastrana. 
Raul Falero (Hospital Abel Santamarla Cuadrado, 77); Marlo Domlnguel 
Perera. Agustln Arocha Garcla. Raydel OJiva (Hospital Unlversltarlo 
'Arnaldo Milliln Castro: 55): Hublel L6pez Delgado (Hospital PrOVincial 
Docente ' Manuel Ascunce Domenech," 43); Alda Madrazo Carnero, Borls 
Leyva L6pez (Hospital VI Lenin, 42); Angel Lacerda Gallardo, Amarllys 
Ortega Morales (Hospital General de Mor6n. 40); Humberto Lezcano 
(Hospital General Unlversltarlo 'Carlos Manuel de Cespedes: 3B); 
Marcos Iraola Ferrer (Hospital Un lversi tarlo 'Or Gustavo Alderegula Lima.' 
37); Irene Zamalea Bess. Gladys Rlvas Canlno (Hospital Mlguel Enrlquez. 
36); Ernesto Mlguel Piferrer Rulz (Hospital Cllnlco-Qulrurglco Docente 
"Saturnino Lora: 32); Orlando Garcla Cruz (Centro de Investlgaclones 
Medlco-Qulrurglcas, 4). 
Czech Republic (961 patients): Petr Svoboda (national coordinator), 1I0na 
Kantorova. Jiff Ochmann. Peter Scheer. Ladlslav Kozumpllk. )1tka Mar~ovtl 
(Research Institute for Special Surgery and Trauma, 852); Karel Edelmann 
(Masaryk Hospital. 41); Ivan Chytra. Roman Bosman (Charles University 
Hospital, Plzen. 35); Hana Andrejsovs (University Hospital Hradec 
Kralove, 15); Jan Pachl (Hospital Kralovske Vinohgrady. 9); Jan BOrger 
(Hospital Prlbram. n: Flllp Kramar (Unlverzlty Karlovy Neurocl11rurglcka 
Kllnlka. 2). 
Ecuador (258 patients): Marlo lzurleta Ulloa (national coordinator). Luls 
Gonzalez. Alberto Daccach. Antonlo Ortega. Stenlo Cevallos (Hospital Luls 
Vernaza. 202); Borls Zurlta Cueva (Hospital de la Pollcla Guayaqull. 16). 
Marcelo Ochoa (Hospital Jose Cwasco Arteaga. 11); Ja me Velssquel 
Tapla (Hospital Naval. 11): Jlmmy Hurtado (Cifn ica C nlral. 8). MIgucl 
Chung Sang Wong (Hospital Militar de Guayaqull. 5): Roberto S ntos 
(Hospital Regional del lESS 'Or Teodoro Maldonado Carbo," 5) 
Egypt (775 patients)· Husseln Khamls (national cOOfdlnator). Abdul Hamld 
Abaza. Abdalla Fekry. Salah El Kordy. Tarek Shawky (Matarla Teaching 
Hospital. 3611); Hesham EI-Sayed (national coordinator). Nabll Khalll. 
Nader Negm. Salem Flsal (Suez Canal University. 180): Mamdouh Alamln. 
Hany Shokry (Aswan Teaching Hospital. 160); Ahmed Yahla Elhusseny. 
Atlf Radwan. Magdl Rashld (Zagazlg University Hospital. 71) 
Georgia (56 patients): Tamar GoglchalsvllI (national coordinator), George 
Ingorokva. Nlkoloz Gongadze (Neurosurgery Department of Tbilisi State 
Medical University. 55); Alexander Otarashvlll (Tbillsl 4th Hospital. 1). 
Germany (27 patients): Waltraud Klelst (Ernst Moritz Arndt University. 14). 
Mathlas Kalkum (Kreiskrankenhaus Tlrschenreuth. 8): Peter Ulflch 
(Kllnlkum Offenbach, 5) . 
Ghana (7 patients)' Nil Andrews (Narh-Blta Hospital. n 
Greece (20 patients): George Nakos (Universi ty Hospital of loannlna. 8). 
Antonlos Karavells (University General Hospital of Larlssa. 5). George 
Archontakls (Chania General Hospltal "St George,' 11); Pavlos Myrlanthefs 
(KAT Hospital of Alhens. 3). 
India (973 patients): Yadram Yadav. Sharda Yadav. R Khatrl. Arvlnd Baghel 
(NSCB Medical College. 177); Mazhar Husaln (national coordinator for 
north India). Deepak Jha (King George Medical College. 105); Wu Hoong 
Cl1hang. Manohar Dhandhanla. Choden Fonnlng (North Bengal Neuro 
Research Centre, 65); S N Iyengar. San lay Gupta (G R Medical College. 51); 
R R Ravl. K 5 Boplah. Alay Herur (Medical Trust Hospital Kochl. 51); N K 
Venkataramana (national coordinator for south India). A Satish (Manlpal 
Hospital. 50): K Bhavadasan. Raymond Morris. Ramesh S (Medical College 
Hospital Trivandrum. 50); A Satlsh (Abhaya Hospital, 42); Yashblr Dewan, 
Yashpal Slngh (Christian Medical College. 36); Rajesh Bhagchandanl. 
Sanjana Bhagchandanl (Apex Hospital Bhopal. 32). Vljaya Ushanath 
Selhurayar (Meenakshl Mission Hospital and Research Cenlle. 32); Solsn 
Ipe, G Sreekumar (MOSC Medical College Hospital. 32): Manas Panlgrahl. 
Agastl Reddy (Nlzam's Institute of Medical Sciences. 28); V rlnder Khosla, 
Sunll Gupta (Postgraduate Insti tute of Medical Education and Research. 
2B): Haroon Pillay. Nlsha Thomas (Baby Memorial Hospital. 25); 
Krlshnamurthy Srldhar. Bobby Jose rv H 5 Hospital. 22). Nad kk wkakan 
Kurlan Oubllee Mission Hospital. 20): Shantl Prahara). Shlbu Plllal (N 1I0nal 
Institute of Mental Health and Neurosclences. 17); R mana (Care Hospllal 
(16); Sanjay Gupta. Smlta Gupta (Sri Sal Hospital, 16). Dlllp Klyawat (Hlrabl 
Cowasll Jehanglr Medical Research Instl tule, 15); Klshor Maheshwarl 
(Maheshwarl Orlhopaedlc Hospital, 13); DliJp Panlkar (Amllta InStitute 01 
Medical Sciences, 11); Jayant haw la (Hartel Maternity and NurSing Home. 
n: Satyanarayana Shenoy. Annaswamy Raja (KastUlba Medical Coli ge 
and Hospital, n; YeshomatJ Rupayana (Choltram Hospital and Research 
Centre. 6): Suryanarayan Reddy (Gowrl Gopal Supersp lallty Hospital. 
6); Nelanuthala Mohan (Apex Hospital Vlsakh patn m, 3), Shallcsh Kelkar 
(Cenlral lndla InstJluteo( Medical SCiences. 3). Yadram Y dav (Marble Ci ty 
Hospital and Research Centre. 3); J yant Chawla (Gov rnment Medical 
College Amrltsar. 1); Mukesh Johri Oohrl Hospital. 1): Yadram Yadav 
(National Hospital I balpur. 1) 
Indonesia (238 patients): Nyoman Gold n (notional cOOfdln tor). Sri 
MalJawan (Sangl h Gen ral Hospital. 222): Achmad Faull. Umar Farouk 
(Sldoarjo General Hospilal. 14). 
Iran (233 pal lents): Esma el Fakh rlan. Amlr Aram sh (Nil havl Ul1 lv rSlty 
Hospital. 110): Maasoumeh Eghtedarl. F rhad Ahm dlad h. Allr l 
Gholaml (Fatemeh Zahra Hospital, 85): Maasoum h Eghl d ri, Farhad 
Ahmadzadeh (Social Security Hospital. 38) 
Ireland (113 patients). P trick Plunk It. Cath rlne Rcdle n, 
McMahon (StJames's Hospital. 113) 
Italy (9 patients): M rla Ius ppln Annetta (Unlv rslt altollca d I 
Sacro Cuor .4): Homer Mouch, ty (Unlv rsltll dl fir III ,3), ro 
Bruzzone (Ospedale San M rtino. 2) 
Ivory Coast (3 pat enIS). Be trle Hording ( HU d Cocody. 3) 
Kenya (2 patients)· M hmood Qureshl (Aga Kh~n Ho~plt I, 2) 
Malaysia (176 p ti nts). Zamlurl Idrls. J, (rl Abdullah N , h l~lm 
Gl1azall, Abdul Rahm n Ilalnl h nl (Hosplt I Unlv rsl ty Sel nc M.Jlav lu. 
162): Fadzll Che h (Jpoh Sp I ilst Ho pUal. 14) 
Mexico (17 p tI nts); Alfr do C br ra (n tion le Idln, tor). 10 11 Lul 
Mella Gonlslcz (Hosp tal G n ral R glon I No 1, 12). Jo Lul M Iln 
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Gonzalez (Hospital General de Queretaro. 4); Jorge Lorla-Castelianos 
(Hospital General Regional No 25. 1). 
New Zealand (43 patients): SuzanneJackson. Robyn Hutchinson (Dunedln 
Hospital. 43). 
Nigeria (180 patients): Edward Komolafe (national coordinator). 
Augustine Adeolu. Morenikejl Komolafe (Obafeml Awolowo University 
Teaching Hospitals. 77): Olusanya Adeyeml-Doro. Feml Bankole (Lagos 
University Teaching Hospital. 43); Belio Shehu. Victoria Danlaml (Usmanu 
Danfodiyo University Teaching Hospital. 36): Olugbenga Odebode 
(University of 1I0rln Teaching Hospital. 15): Kehlnde Oluwadlya (Lautech 
Teaching Hospital. 7); Ahmed Sanni (Lagos State University Teaching 
Hospital. 1); Herb Glebel (Seventh Day Adventist Hospital. 1): Sushll Kumar 
(St Stephen's Hospital. 1). 
Pakistan (17 patients): Rashid Jooma Olnnah Postgraduate Medical Centre. 
17). 
Panama (7 patients): Jose Edmundo Mezquita (Complejo Hospitalarlo M 
A Guerrero. 7). 
Paraguay (10 patients): Carlos Ortlz Ovelar (lnstituto de Prevlslon Social. 
10). 
Peru (B patients): Marco Gonzales Portillo (Hospital Naclonal "Dos de 
Mayo." 6); Dlana Rodriguez (national coordinator) (Hospital Nacional 
Arzobispo Loayza. 2). 
Romania (319 patients): Laura Balica (national coordinator). Bogdan 
Oprita. Mircea Sklerniacof. Lulza Steflea. Laura Bandut (Spitalul Clinic de 
Urgenotua Bucureso ti. 282): Adam Danll. Remus IlIescu (Slantum 
Pantelimon Hospital. 28): Jean Ciurea (Prol Or 0 Bagdasar Clinical 
Emergency Hospital. 9). 
Saudi Arabia (32 patients): Abdelazeem EI-Dawlatly. Sherlf Alwatldy (King 
Khalid University Hospital. 24): Walid AI-Yafi. Megahld EI-Oawlatly (King 
Khalid National Guard Hospital. 8). 
Serbia (23 patients): Ranka Krunic-Protic. Vesna Janosevlc (Kllnlckl Centar 
Srbije. 23). 
Singapore (23 patients): James Tan (national coordinator) (National 
Neuroscience Institute. 21); Charles Seah (Changi General Hospital. 2). 
Slovakla (179 patients): Stefan Trenkler (national coordinator). Matus 
Humenansky. Tatlana Stajancova (Rei man Hospital. 71): Ivan Schwendt. 
Anton Laincz (NsP Poprad. 39); Zeman Julius. Stano Maros (Nemocnlca 
Bojnice. 25): Jozef Firment (FNsp Koslce. 12); Marla Cifranlcova (Ns 
P Treblsov. 11): Beata Saniova (Faculty Hospital In Martin. 10): Karol Kalig 
(NsP Ruzinov. 4); Solla Medekova (NsP Nove Zamky. 3); Radovan Wlszt 
(NsPLlptovsky Mlkulas. 2); NsP F 0 Roosevelt. 1); Ivan Macuga (NsP Zilina. 
1). 
South Africa (366 patients): Bennie Hartzenberg (national coordinator). 
Grant du Plessls. Zelda Houlie (Tygerberg Academic Hospital. 307): 
Narendra Nathoo. Sipho Khumalo (Wentworth Hospital. 57); Ralph Tracey 
(Curamed Kloof Hospital. 1). 
Spain (259 patients): Angeles Munoz-Sanchez (national coordinator). 
Francisco Murlllo-Cabezas NC. Juan Flores·Cordero. Dolores Rlnc6n-
Ferrarl (Hospital Universltario Virgen del Roclo. 133); Martin Rubl. Lopez 
Caler (Hospital Torrecardenas. 37); Maite Misls del Campo. Lulsa Bordeje 
Laguna (Hospital Unlversitarlo Germans Trlas I Pujol. 32); Juan Manuel 
Nava (Hospital Mutua de Terrassa. 20); MIguel Arruego Mlngul1l6n 
(Hospital Unlversitario de Glrona Or Josep Trueta. 12); Alfonso Mui'loz 
Lopez (Hospital Carlos Haya. 10); Luls Ramos-G6mez (Hospital General 
de La Palma. 6); Victoria de la Torre-Prados (Hospital Unlversltarlo Vlrgen 
de la Victoria. 5); Romero Pellejero (Hospital General Vague. 4). 
Sri Lanka (132 patients): Veronlque Laloii (national coordinator) . Bernhard 
Mandrelia. Suganthan (Battlcaloa General Hospltal-Medeclns Sans 
Frontieres. 84); Sunil Perera (National Hospital of Sri Lanka. 39); 
Veronlque Laloe. Kanapathlpillal Mahendran (Polnt-Pedro Base Hospital. 
9). 
Switzerland (160 patients): Reto Stocker (national coordinator). SlIke 
Ludwlg (national coordinator) (University Hospital of Zurich. 133): Helnz 
Zimmermann (University Hospital Bern. 15); Urs Oenzler (Kantonsspltal 
Schaffhausen. 12). 
Thailand (579 patients): Surakrant Yutthakasemsunt (national 
coordinator). Warawut Klttiwattanagul. Parnumas Plyavechvlrat. POjana 
Tapsal. Ajchara Namuang-jan (Khon Kaen Regional Hospital. 535); Upapat 
Chantaplmpa (Chiangral Prachanuko Hospital. 12); Chanothal Watanachal. 
Pusit Subsompon (Rayong Hospital. 11); Wlpurat Pussanakawatln. Pensrl 
Khunjan (Krabl Hospital. 10); Sakchal Tangchltvlttaya. Somsak Nllapong 
(Suratthanl Hospital. 8); Tanagorn Klangsang. Wlbul Taechakosol (Rol Et 
Hospital. 2); AUrat Srlnat (Lam pang Hospital. 1). 
Tunisia (63 patients): Zouhelr Jerbl (national coordinator). Neblha Borsali-
Falfoul. Monla Rezgul (Hospital Hablb Thameur. 63). 
Turkey (2 patients): Nahlt Cakar (Istanbul Medical Faculty. 2). 
Uganda (43 palients): Husseln Ssenyonjo. Olive Kobuslngye (M ker r 
Medical School. 113). 
UK (1391 pati nts): Gabrlelie Lomas. Davld Yates. Flona Lecky (Hope 
Hospital. 209); Anthony Bleetman. Alan Baldwln. Emma J nklnson.Shlela 
Pantrlnl (Birmingham Heartlands Hospital. 123). James Stewart. Nasreen 
Contractor. Trudy Roberts.Jlm Butler (North Manchester General Hospital. 
B5); Alan Pinto. Dlane Lee (Royal Albert Edward Infirmary. 83). Nlgel 
Brayley. Karly Robbshaw. Clare Dlx (Colchester General Hospital. 79). 
Sarah Graham. Sue Pye (Whlston Hospital. 69); Mareus Green. Annle 
Kellins (5eliy Oak Hospital. 61). Chns Moullon. Barbara Fogg (Royal Bolton 
Hospital. 51): Rowland Cottlngham. Sam Funnell. Utham Shanker 
(Eastbourne District General Hospital. 50). Clalre Summers. Loulse Mal k 
(Trafford General Hospital. 41). Rowland Cottlngham (national 
coordinator). Chrlstopher Ashcroft. Jacky Poweli (Royal Sussex County 
Hospital. 38); Steve Moore. Stepllanle Buckley (Countess of Chester 
Hospital. 36); Mandy Groeutt. Steve Chambers (Worthing Hospital. 34); 
Amanda Morrlce. Helen Marshali (Medway Maritime Hospital. 29); Julia 
Harrls. Wendy Matthews. Jane Tippet (Chelsea and Westminster Hospital. 
28); Slmon Mardell. Flona MacMillan. Anlta Shaw (Furness General 
Hospital. 27); Pramod Luthra. Gill Dlxon (Royal Old ham Hospital. 26). 
Mohammed Ahmed. John Butler. Mike Young (Stepping Hili Hospital. 26). 
Sue Mason. lan Loveday (Northern General Hospital. 25); Chrlsline Clark. 
Sam Taylor (Blackburn Royal In firmary. 23); Paul WIIson (Cheltenham 
General Hospital. 23). Kasslm All. Stuart Greenwood (Fair field General 
Hospital. 23); Martin White. Rosa Perez (Queen Elizabeth the Queen 
Mother Hospital. 21); Sam Eljamel (Ninewells Hospital and Medical School. 
19); Jonathan Wasserberg. Helen Shale (Queen EIIlabeth Hospital 
Birmingham. 18); Colin Read. John McCarron (Russell's Hali Hospital. 18). 
Aaron Pennell (Princess Alexandra Hospital. 16). Gautam Ray (Princess 
Royal Hospital. 1/1); John Thurston. Emma Brown (Darent Valley Hospital. 
13); Lawrence Jaffey. Mlchael Graves (Royalliverpool Universi ty Hospital. 
12); Richard Bailey. Nancy Loverldge (Chesterfield and North Derbyshire 
Royal Hospital. 10); Geralnt Evans. Shlrlcen Hughes. M jor Kafeel Ahmed 
(Wlthybush General Hospital. 10); Jeremy Rlchardson. Clalre Gallagher 
(Aberdeen Royal Infirmary. 8). Tltus Odedun. Karen Lees (Ormsklrk and 
District General Hospital. 8) ; Davld FOley. Nick Payne (Queen Mary's 
Hospital. 8); Alan Pennycook. Carl Gnffiths (Arrowe Park Hospital. 6). 
Davld Moore. Denlse Byrne (City Hospital Birmingham. 5). Sunll Dasan (St 
Helier Hospital. 4); Ashls Banerjee. Steve McGulnness (Whltllngton 
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Abstract 
Background: Traumatic brain injury (TBI) is an important cause of acquired disability. In evaluating 
the effectiveness of clinical interventions for TBI it is important to measure disability accurately. 
The Glasgow Outcome Scale (GOS) is the most widely used outcome measure In randomlsed 
controlled trials (RCTs) in TBI patients. However GOS measurement is generally collected at 6 
months after discharge when loss to follow up could have occurred. The objectives of this study 
were to evaluate the association and predictive validity between a simple disability scale at hospital 
discharge. the Oxford Handicap Scale (OHS). and the GOS at 6 months among TBI patients. 
Methods: The study was a secondary analysis of a randomised clinical trial among TBI patients 
(MRC CRASH Trial). A Spearman correlation was estimated to evaluate the association between 
the OHS and GOS. The validity of different dichotomies of the OHS for predicting GOS at 6 
months was assessed by calculating sensitivity. specificity and the C statistic. Uni and multlvariat 
logistic regression models were fitted including OHS as explanatory variable. For each model we 
analysed its discrimination and calibration. 
Results: We found that the OHS is highly correlated with GOS at 6 months (spearman correlation 
0.75) with evidence of a linear relationship between the two scales. The OHS dichotomy that 
separates patients with severe dependency or death showed the greatest discrlmln tlon (C 
statistic: 84.3). Among survivors at hospital discharge the OHS showed a very good discrimination 
(C statistic 0.78) and excellent calibration when used to predict GOS outcome at 6 months. 
Conclusion: We have shown that the OHS, a simple disability scale available at hospital dlscharg 
can predict disability accurately. according to the GOS, at 6 months. OHS could be used to improv 
the design and analysis of clinical trials In TBI patients and may also provide a valuable clinical tool 
for physicians to improve communication with patients and relatives wh n ass sslng a pad nt's 
prognosis at hospital discharge. 
Trial Registration Number: ISRCTN74459797 
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Background 
Traumatic brain injury (TBI) is an important cause of 
acquired disability. In evaluating the effectiveness of clin-
ical interventions for TBI it is important to measure disa-
bility accurately. The Glasgow Outcome Scale (GOS) is 
the most widely used outcome measure in randomised 
controlled trials (RCfs) in TBI patients.(1) However, 
because the GOS assesses how well patients function in 
their daily social interactions, it is only applicable after the 
patient has been discharged from hospital. 
Loss to follow up after hospital discharge is a common 
problem in clinical trials in TBI and some amount of miss-
ing data is often unavoidable.(21. If an early outcome 
measure was available that could predict long term disa-
bility, it could be valuable for dealing with missing data, 
and might potentially be used as a surrogate outcome. 
The MRC CRASH Trial was a large, randomised placebo 
controlled trial of the effects of a 48-hour infusion of cor-
ticosteroids on death and disability, among 10,008 
adults·13] Using data from this cohort of patients we have 
previously identified hospital admission variables that 
accurately predict 6 months GOS.(4] This cohort also 
presents an opportunity to evaluate the predictive validity 
of an early disability outcome measure for TBI patients. A 
modified version of the Oxford Handicap Scale (OHS) 
was completed at hospital discharge and the GOS was 
completed at 6 months after injury. The OHS, which was 
originally developed for stroke patients, comprises six cat-
egories: no symptoms, minor symptoms, minor handi-
cap, moderate handicap, moderately s~vere handicap, and 
severe handicap.(S] In the MRC CRASH Trial a modified 
http://www.biomedcentral.coml1471-228818172 
form of the OHS was used in which moderate handicap 
and moderately severe handicap were combined. 
Although the OHS has been previously used in brain 
injury trials, its association with GOS at 6 months in TBI 
patients has not been previously reported.(S) 
The aim of this paper is to describe the association 
between an tarly disability outcome (OHS), and a 6 
months disability outcome (GOS). Specifically the objec-
tives were to: 
1) Evaluate the correlation between OHS at hospital dis-
charge and GOS at 6 months 
2) Evaluate different dichotomies of the OHS at hospital 
discharge in predicting GOS at 6 months 
3) Evaluate the extent to which OHS at hospital discharge 
predicts GOS at 6 months in survivors 
Methods 
Potentia' predictor 
The OHS (table 1) was assessed at 14 days, hospital dis-
charge or death (whichever occur first). 
Variables that have previously been reported to be associ-
ated with the outcome were considered as potential con-
founders and included in an adjusted model: age, 
Glasgow Coma Scale (GCS) at randomization, pupil reac-
tivity, whether the patient sustained a major extra cranial 
injury and computerised tomography (Cf) scan 
results.(4] 
Table I: Original Oxford Handicap Scale and OHS used In the MRC CRASH Trial 
Original OHS Modified OHS used In CRASH 
Categories Cateaorle. 
No symptoms No symptoms 
Minor symptoms that do not Interfere with lifestyle Minor symptoms 
Minor handicap. symptoms that lead to some restriction In lifestyle but do not Interfere with Some restriction in lifestyle but Independent 
the patient's capacity to look after himself . 
Moderate handicap. symptoms that significantly restrict lifestyle and prevent totally Independent Oependent but not requlrlna constant attention 
existence 
Moderately severe handicap. symptoms that clearly prevent Independant existence thoua/l not 
needing constant attention 
Severe handicap. totally dependent patient requlrtna constant attention night and day Fully dependent requlrlna attention day and night 
Oeath 
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Enrolled in trial 
loo. 
..... 
99 no data on OHS at 14 days 
418 no data on GOS at 6 months 
36 no data on both OHS and GOS 
8 not TBI (GCS 15) 
9,447 (94.4 % ) Sam pie for objectives 1 and 2 
loo. 
• 
.... 1,948 died at 14 days 
7,499 (74.9 % ) Sam pie for obj ective 3 
Figure I 
Flowchart of patients used In the analysis. 
Outcome 
The outcome was GOS at 6 months. The GOS comprises 
five categories: death, persistent vegetative state, severe 
disability, moderate disability and good recovery.(6] GOS 
was dichotomised for analysis in the CRASH Trial into 
favourable outcome (good recovery or moderate disabil-
ity) and unfavourable outcome (severe disability, persist-
ent vegetative state or death). We created two further 
dichotomies: good recovery versus other outcomes, and 
survival versus death. 
The slImp/e of patients 
The MRC CRASH trial was a large international double-
blind randomised placebo-controlled trial of the effect of 
early administration of a 48-h infusion of a corticosteroid 
(methylprednisolone) on the risk of death and disability 
after TBI. The characteristics of the patients randomised, 
and results of the trial have already been reported in 
detail.[3,7] Briefly, adults (aged 16 years or older) with a 
head injury and a GCS of 14 or less were randomly allo-
cated to commence either a 48 hour infusion of methyl-
prednisolone or matching placebo within eight hours of 
injury; patients from 239 hospitals in 48 countries were 
randomised. All collaborating MRC CRASH investigators 
were required to secure local ethics or research committee 
approval before recruitment could begin. Patients with 
clinically significant head injury are unable to give valid 
informed consent. Local ethics committees set consent 
procedures for participating hospitals. Some allowed con-
sent waiver and others consent from a legal representative. 
We always adhered to these requirements. 
Of 10,008 study participants enrolled in the MRC CRASH 
Trial, 99 (1%) had missing data on the OHS, 418 (4.2%) 
had missing data on the GOS at 6 months, and 36 (0.3%) 
had missing data for both OHS and GOS. A further 8 
patients were excluded from analysis as they had a Glas-
gow Coma Scale (GCS) score of 15 at randomisation. 
Analysis for objectives 1 and 2 were therefore performed 
using data for 9,447 (94.4%) patients (figure 1). For the 
third objective (predictive validity of OHS among survi-
vors), the 1,948 patients who died within 14 days of 
admission were excluded and the analysis was based on 
data for the remaining 7,499 patients (figure 1). 
Analysis 
Objective I 
A cross-tabulation between the OHS and GOS categories 
was performed. Their relation was assessed with the Spear-
man rank correlation index. 
Objective 2 
The validity of the different dichotomies of the OHS for 
predicting GOS at 6 months was assessed by calculating 
sensitivity, specificity and the c statistic (an equivalent 
concept to area under the receiver operator characteristic 
curve). 
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Objective 3 
A logistic regression model was first fitted including only 
OHS as explanatory variables (model 1). A second model 
was then fitted that also induded demographic and clini-
cal variables (model 2) . Finally, a third model was fitted 
that included all variables in model 2, plus er scan varia-
bles. All the demographic, clinical and er variables have 
been previously reported as being independently associ-
ated with unfavourable outcome at 6 months .[4] For each 
model we analysed its discrimination using the c statistic 
and calibration (graphically and with the Hosmer-Leme-
show test). 
We then estimated the positive predictive value (with 95% 
confidence intervals) of each OHS category for GOS at 6 
months . 
Results 
General characteristics of the population 
Table 2 shows the characteristics of the sample included in 
the analysis. At 14 days 1,863 (19%) were dependent and 
1.948 patients had died (21 %). At 6 months, 3,525 
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(37.3%) patients were severely disabled or had died. Most 
deaths (84%) occurred within the firs t 14 days. OI-lS at 14 
days and GOS at 6 months were highly correlated (Spear-
man rank correlation coefficient 0.75 ) and they showed a 
linear relationship (figure 2) . 
OHS for predicting 6 months outcome 
Five dichotomies of the OHS were consider d (Table 3). 
When their validity was assessed in relation to unfavoura-
ble outcome as defined by the GOS (severe disability or 
death) , dichotomy 0 showed the highest discrimination 
(c statistic) with high specificity (Table 4). 
Among survivors at hospital discharge the OIlS showed a 
strong association with GOS at 6 months . The crude anal-
ysis showed that patients who were fully dependent at 14 
days had 24 higher odds of an unfavourabl outcome at 6 
months. Although adjusting for known prognostic factors 
attenuated the strength of the association, OHS remained 
a strong predictor with a highly stati tically significant test 
(Table 5) . Most importantly, when considered alone, 
3 4 
Oxford H andi eap Seal e 
Figure 2 
Relationship between Oxford Handicap Scale and unfavourable outcome (GOS) at 6 months. 
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Table 2: Glaslow Outcome Scale at 6 months by Oxford Handicap Scale at 14 days 
Oxford Handicap Scale at 14 days Good recovery 
n 
" 
No symptoms 1,910 79 
Minor symptoms 1,646 67 
Some restriction in Rfestyle but independent 354 46 
Dependent but not requiring constant attention 232 30 
Fully dependent requiring attention day & night 148 14 
Death 0 0 
Total 4,290 45 
OHS showed very good discrimination and excellent cali-
bration (H-L = 1) (figure 3). 
Table 6 shows the prediction of different 6 months out-
comes (as measured with GOS) according to the hospital 
discharge OHS. For example, a patient with minor symp-
toms at hospital discharge will have a probability of 
approximately 67% of good recovery, 890/0 of good recov-
ery or moderate disability and 980/0 of survival at 6 
months. 
Discussion 
Prlnclpa' findings 
We found that the OHS is highly correlated with GOS at 6 
months with evidence of a linear relationship between the 
two scales. The OHS dichotomy that separate patients 
who were severely dependent or dead (dichotomy D) 
showed the greatest discrimination. Among survivors at 
Glasaow Outcome Scale at 6 months 
Moderate disability Severe dIsability Death Toto' 
n 
" 
n 
" 
n 
" 
n 
334 14 150 6 17 2411 
537 22 233 9 42 2 2,458 
246 32 147 19 20 3 767 
273 35 221 29 45 6 771 
242 22 457 42 245 22 1,092 
0 0 0 0 1948 100 1948 
1,632 17 1,208 13 2317 25 9,477 
hospital discharge the OHS showed a very good discrimi-
nation and excellent calibration when used to predict 
GOS outcome at 6 months. 
Strenrth, and wHlme" of tlte study 
To our knowledge this is the first study that evaluated the 
predictive validity of a simple scale for disability at hospi-
tal discharge in TB! patients. The main strengths of our 
study include the large sample size which ensures preci-
sion in our estimates, and the inclusion of patients from 
both high and low & middle income countries, which 
increases the generalizability of our conclusions. The 
main limitation is that the measurement of OHS was not 
standardized between centres. However, because we 
would expect that any measurement error would result in 
non-differential misclassification, in general we would 
expect that the association reported would be underesti-
mated rather than overestimated. Finally, our study is the 
Table J: Dichotomies of OHS for determlnlns unfavourable outcome 
A 8 
No Symptoms No No 
Minor Symptoms Ye. No 
Some restriction In II(esryIe but Independent Ye. Ye. 
Dependent but not requiring constant attention Ye. Y •• 
Fully dependent requiting attention day and nlfht Yes Y •• 
Death Y •• Y •• 
C D £ 
No No No 
No No No 
No No No 
Y •• No No 
Y •• Yes No 
Yes Yes Y •• 
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Table 4: Validity of the Oxford Handicap Scale at 14 days for 
Glasgow Outcome Scale at 6 months 
OHS dichotomy Sensitivity Sensitivity C stat 
A 9S.3 37.9 66.6 
B 87.5 74.8 81.1 
C 82.7 84.9 83.8 
0 75.2 93.4 84.3 
E SS'] 100.0 77.6 
first to report this association which should therefore be 
examined in an external cohort of patients in order to con-
firm the findings. 
Comparison with other studies 
The incidence of unfavourable GOS outcome at 6 months 
in our cohort was lower in comparison to one reported in 
a series of TB I cohorts.(8)I [owever, unlike ours, most of 
these cohorts had been restricted to severe TBI patients. 
The 01 IS has previously been used in RGTs of brain injury 
patients, and Bamford et al. reported good inter-observer 
agreement (a weighted kappa of 0.72).[5] Ours is the first 
study in TBI which has evaluated the relationship between 
OIlS and GOS. Nevertheless, previous studies have shown 
a good agreement between the Modified Rankin Scale (the 
scale from which the OHS was derived) and the GOS.[91 
http://www.biomedcentral.com/14 71-2288/8n2 
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Figure 3 
Calibration of model I. 
Conclusion 
We have shown that 011 is strongly related and pr di ts 
accurately the GOS at 6 months. It may ther for b h Ip-
ful in tackling the problem of missing data in lini al trials 
in TB!. It might also serve as a pot ntial surrogate out om 
measure and this application hOllld b exp lored in fur-
ther studie . If our finding ar r plicated, OilS could be 
a simple and useful outcome mea ure to u in trials in 
settings for which long term follow-up is probl mati . 
Furthermore, 011 could be a useful variabl to 011 t in 
rehabilitation trials in TBI patients to nsur that th r i 
a similar distribution of disability among pani ipan\ 
Table 5: Association between OHS and unfavourable outcome (GOS) among survivors 
Model I Model 2 Model 3 
95% CI 95% Cl 95% Cl 
OHS OR lower Upper OR Lower Upper OR lower Upper 
1.0 1.0 
Minor symptoms 1.7 1,4 2. 1 1.6 1.3 1.9 1.6 1.3 2.0 
Some restriction In lifestyle but Independent 3.7 3.0 4.7 2.7 2. 1 3,4 2.7 2. 1 3.5 
Dependent but not requiring constant attention 7. 1 5.7 8.8 4.5 3.6 5.7 4.7 3.7 6.0 
Fully dependent requiring attention day & night 24. 1 19.8 29,4 12.9 10.3 16.2 13.3 10,4 16.9 
C statistic (or the model 0.78 0.83 0.83 
Model I: OHS 
Model 2: model I plus GCS, pupil reactiVity, major extra·cranial injury and age 
Model 3: model 2 plus eT findings (petechial haemorrhages, obliteration of the th ird ventricle or basal cisterns, subarachnoid bl d, mldlin shift, 
non evacuated haematoma) 
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Table 6: Prediction of three dichotomies of GOS at 6 months .ccordlng to OHS 
Good recovery Good recovery or Moderate dlsobility SurvlVlJl 
95% Cl 95% Cl 95% Cl 
OHS % Lower 
No symptoms 79.2 77.6 
Minor symptoms 67.0 65.1 
Some restriction In lifestyle but Independent 46.1 42.6 
Dependent but not requiring constant attention 30.1 26.8 
Fully dependent requiring attention day & night 13.6 11.5 
between groups at baseline. We have also shown that, 
among sUlVivors. the 0 HS is able to predict disability at 6 
months and thus may provide a valuable clinical tool for 
physicians to improve communication with patients and, 
relatives when assessing a patient's prognosis at hospital 
discharge. 
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